<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; San Francisco</title>
	<atom:link href="http://www.straightstocks.com/tag/san-francisco/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Wed, 25 Nov 2009 15:00:50 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Zacks Analyst Blog Highlights: Affiliated Computer Services Inc., Xerox Corp., Expedia Inc., Orbitz Worldwide and Priceline.com &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-affiliated-computer-services-inc-xerox-corp-expedia-inc-orbitz-worldwide-and-priceline-com-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-affiliated-computer-services-inc-xerox-corp-expedia-inc-orbitz-worldwide-and-priceline-com-press-releases/#comments</comments>
		<pubDate>Wed, 25 Nov 2009 13:00:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Affiliated Computer Services Inc.]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Dallas County]]></category>
		<category><![CDATA[Darwin Deason]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[Expedia Inc.]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[injunction]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[online travel]]></category>
		<category><![CDATA[Orbitz Worldwide]]></category>
		<category><![CDATA[Priceline.com]]></category>
		<category><![CDATA[Ricoh XR-X 3PF Film Camera;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Travelocity]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Xerox Corp.;]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27618/Zacks+Analyst+Blog+Highlights%3A+Affiliated+Computer+Services+Inc.%2C+Xerox+Corp.%2C+Expedia+Inc.%2C+Orbitz+Worldwide+and+Priceline.com+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 25, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Affiliated Computer Services Inc. </strong>(<a href="void(0)">ACS</a>), <strong>Xerox Corp. </strong>(<a href="void(0)">XRX</a>), <strong>Expedia Inc. </strong>(<a href="void(0)">EXPE</a>), <strong>Orbitz Worldwide </strong>(<a href="void(0)">OWW</a>) and <strong>Priceline.com </strong>(<a href="void(0)">PCLN</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Tuesday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Settlement in Xerox-ACS Merger </strong></p>
<p align="left"><strong>Affiliated Computer Services Inc. </strong>(<a href="void(0)">ACS</a>) announced that the complaint filed by ACS shareholders regarding its merger with <strong>Xerox Corp. </strong>(<a href="void(0)">XRX</a>) has been resolved. The plaintiffs have temporarily withdrawn their motion for an injunction to block the deal.</p>
<p align="left">The lawsuit was filed in October in Dallas County, Texas as Xerox was struggling to convince its shareholders to approve the deal.</p>
<p align="left">The plaintiffs agreed to drop the lawsuit only if ACS&#8217;s Board of Directors received a better proposal than Xerox&#8217;s current bid and Xerox did not force ACS&#8217;s Chairman Darwin Deason to exercise his voting power in favor of the Xerox acquisition. The previous agreement called for Mr. Deason to cast half his votes in favor of the Xerox bid. He controls 44% of the votes at ACS.</p>
<p align="left">Xerox has also decided not to force ACS to hold a shareholder meeting to vote on the Xerox transaction, and if requested by the Xerox&#8217;s shareholders ACS will terminate the Merger Agreement. Xerox also said that a pension fund has dropped a lawsuit over the purchase of ACS. However, a separate shareholder class action lawsuit is still pending in Delaware.</p>
<p align="left">In September, Xerox agreed to acquire Affiliated in a cash and stock transaction valued at $6.4 billion ($63.11 per ACS share in cash and Xerox stock). Affiliated shareholders will receive $18.60 in cash and 4.935 shares of Xerox for each ACS share. Xerox will also assume $2 billion of ACS&#8217;s debt and issue $300 million of convertible preferred stock to ACS shareholders.</p>
<p align="left"><strong>Downgrading Expedia to Neutral</strong></p>
<p align="left">We are downgrading shares of <strong>Expedia Inc. </strong>(<a href="void(0)">EXPE</a>) from Outperform to Neutral.</p>
<p align="left">The company reported strong results in the last quarter, but continued to benefit from promotional inventories provided by its hotel partners. When results are stripped off the benefits of promotional activities, a softer demand environment could become evident.</p>
<p align="left">We also do not expect the company to report better than seasonal sales growth in the current quarter.</p>
<p align="left">The company has sacrificed booking fees this year, which is telling on the average daily rates (ADRs). Therefore, ADRs could be the metric to watch rather than room nights at this point of time.</p>
<p align="left">We are also concerned about the incidence of transient occupancy taxes. Although municipalities and governments have decided that they will recover occupancy taxes from hotels if they lose out to online travel companies, we note that Expedia has already lost in Georgia and the company is slated to pay out $55 million to the City of San Francisco.</p>
<p align="left">A fresh suit has now been filed by Florida, and for the first time the company has been charged under the Florida Deceptive and Unfair Trade Practices Act. Five Florida counties have decided to charge Expedia, as well as other online travel companies such as <strong>Orbitz Worldwide </strong>(<a href="void(0)">OWW</a>), <strong>Priceline.com </strong>(<a href="void(0)">PCLN</a>) and Travelocity for recovery of transient occupancy taxes. The company made a hefty provision in the June quarter, but we fear that this could be insufficient if the cases continue. Fines of this magnitude have the potential to develop into a constant drain on cash.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-affiliated-computer-services-inc-xerox-corp-expedia-inc-orbitz-worldwide-and-priceline-com-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Downgrading Expedia to Neutral &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/downgrading-expedia-to-neutral-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/downgrading-expedia-to-neutral-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 22:18:12 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Expedia Inc.]]></category>
		<category><![CDATA[favorable online advertising market]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[online travel]]></category>
		<category><![CDATA[Orbitz Worldwide]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27608/Downgrading+Expedia+to+Neutral+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
We are downgrading shares of <strong>Expedia Inc.</strong> (<a href="http://www.zacks.com/stock/quote/expe">EXPE</a>) from Outperform to Neutral.<br />
<br />
The company reported strong results in the last quarter, but continued to benefit from promotional inventories provided by its hotel partners. When results are stripped off the benefits of promotional activities, a softer demand environment could become evident.<br />
<br />
We also do not expect the company to report better than seasonal sales growth in the current quarter.<br />
<br />
The company has sacrificed booking fees this year, which is telling on the average daily rates (ADRs). Therefore, ADRs could be the metric to watch rather than room nights at this point of time.<br />
<br />
We are also concerned about the incidence of transient occupancy taxes. Although municipalities and governments have decided that they will recover occupancy taxes from hotels if they lose out to online travel companies, we note that Expedia has already lost in Georgia and the company is slated to pay out $55 million to the City of San Francisco.<br />
<br />
A fresh suit has now been filed by Florida, and for the first time the company has been charged under the Florida Deceptive and Unfair Trade Practices Act. Five Florida counties have decided to charge Expedia, as well as other online travel companies such as <strong>Orbitz Worldwide </strong>(<a href="http://www.zacks.com/stock/quote/oww">OWW</a>), <strong>Priceline.com </strong>(<a href="http://www.zacks.com/stock/quote/pcln">PCLN</a>) and Travelocity for recovery of transient occupancy taxes. The company made a hefty provision in the June quarter, but we fear that this could be insufficient if the cases continue. Fines of this magnitude have the potential to develop into a constant drain on cash.<br />
<br />
The company also burned through cash in the last quarter due to a sudden drop off in deferred merchant bookings, and the interest coverage ratio was barely above 1.<br />
<br />
Although the above negatives paint a bleak picture, there are many positives to the stock as well. Expedia has a strong market position, extensive offerings and an attractive balance sheet. Additionally, international initiatives, cost control measures and a favorable online advertising market are expected to play a key role in the growth of both revenue and earnings.<br />
<br />
We expect the stock to continue trading in the current range over the next three to six months.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EXPE">Read the full analyst report on "EXPE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=OWW">Read the full analyst report on "OWW"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PCLN">Read the full analyst report on "PCLN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/downgrading-expedia-to-neutral-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Home Prices Continue to Rise &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/home-prices-continue-to-rise-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/home-prices-continue-to-rise-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 18:44:14 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[big banks]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chief Equity Strategist]]></category>
		<category><![CDATA[Cleveland]]></category>
		<category><![CDATA[Commentator]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[Dirk van Dijk]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[Fannie]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Freddie]]></category>
		<category><![CDATA[Lake Erie]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[mortgage insurance firms]]></category>
		<category><![CDATA[naturaldisaster]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[S&P Case Schiller;]]></category>
		<category><![CDATA[San Diego]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Southern California]]></category>
		<category><![CDATA[The Wall Street Journal]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wall Street Journal]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>
		<category><![CDATA[Zacks.com]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27604/Home+Prices+Continue+to+Rise+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
This morning the S&#38;P Case-Schiller index was released. The Composite 20 index (C-20), which covers 20 of the largest metropolitan areas in the country rose by 0.27% on a seasonally adjusted basis (home prices are seasonal, so the adjusted data is what you should be looking at -- most of the press makes a mistake by focusing on the unadjusted data, thus these figures might vary from what you read elsewhere). That was the fourth straight increase. The Composite 10 (C-10) index, which is a subset of the Composite 20, but which has a longer history, posted a 0.36% increase for the month.<br />
<br />
On a year over year basis, the C-20 is down by 9.39% while the C-10 is down 8.53%. While it was an increase, it was a smaller one than was expected. The consensus of economists was looking for a C-20 year-over-year decline of just 9.10%. The data is for September, not October like most of the data that has come out recently.<br />
<br />
The country was roughly split between areas where home prices increased during the month and areas where housing values continue to decline. Eleven metropolitan areas posted increases and nine suffered declines. Some of the areas with the biggest increases in home prices were a bit of a surprise.<br />
<br />
In California, San Francisco saw the largest monthly increase of any city, enjoying a 1.71% rise. It was one of the areas that was considered "bubble central," but has started to stage a comeback. Over the last year, prices in the City by the Bay are down 7.85%. Similarly, San Diego posted a 1.05% increase for the month, and it is now down just 5.72% year over year. Long-depressed Detroit saw prices increase by 1.25% for the month, although on a year-over-year basis, home prices are still down by 19.26%. The other areas that saw monthly increases of over 1.0% were the Twin Cities, up 1.31%, and Chicago, up 1.11%.<br />
<br />
On the negative side, the worst-hit city was Cleveland, which was down 1.20% for the month, although it is actually among the healthiest cities on a year-over-year basis with home prices down just 3.880%. Then again, the housing bubble was not centered on the beaches of Lake Erie, it was centered on the beaches of Southern California and Florida.<br />
<br />
Las Vegas, which is the city that has been hit the hardest by falling home prices overall, continued to see prices fall, down another 1.19% for the month, and off 28.63% from a year ago. From the peak, home prices are down 55.4%. The only other city that comes close, to that cumulative decline is Phoenix, down 52.0%.<br />
<br />
Also keep in mind that the home price declines had lasted for far more than just a year. The graph below (from <a href="http://www.calculatedriskblog.com/">http://www.calculatedriskblog.com/</a>) shows the cumulative decline from the peak pricing, which was hit in April of 2006 for both of the composite indexes, but is shown in the graph from each individual city peak. It breaks down the cumulative decline by time period, with the blue bar showing how much home prices fell through the end of 2007, yellow showing where things stood at the end of 2008, and blue indicating how far the city is now off its peak. Thus if the orange bar is shorter than the yellow bar, it means that city has actually seen home prices rise so far this year.<br />
<br />
It is encouraging to see home prices rise. If this continues, some of the people in underwater houses (meaning with a mortgage more than the value of the house) might just see the flood recede and regain some positive equity in the house. This would greatly reduce the number of foreclosures in the future. It would make it an economically rational thing for people to pay their mortgages again. As it stands today in big areas of the country, it isn&#8217;t.<br />
<br />
As a result, mortgage delinquencies have been skyrocketing, and eventually those delinquencies will lead to foreclosures. That could reignite a vicious circle, where the foreclosed houses flood the market, once again depressing prices, which causes more people to think there are better places to put their money than paying their mortgages.<br />
<br />
Rising home prices have the potential to turn that into a virtuous cycle. To the extent that happens, it has very positive implications for the entire mortgage complex, from the big banks like <strong>Bank of America </strong>(<a href="http://www.zacks.com/stock/quote/bac">BAC</a>) to the mortgage insurance firms like <strong>MGIC </strong>(<a href="http://www.zacks.com/stock/quote/mtg">MTG</a>) to the wards of the state, <strong>Fannie </strong>(<a href="http://www.zacks.com/stock/quote/fnm">FNM</a>) and <strong>Freddie</strong> (<a href="http://www.zacks.com/stock/quote/fre">FRE</a>).<br />
<br />
However, I fear that the increase in home prices is only temporary. That it is the product of extraordinary government efforts to prop up home prices, and that those efforts can not be sustained forever. These include the tax credit (recently expanded to include move up buyers), which is scheduled to end at the end of April, and the Fed&#8217;s program of buying up $1.25 Trillion in mortgage-backed paper to manipulate mortgage rates lower. They should finish up their purchases by the end of March.<br />
<br />
The FHA has also played a huge role in propping up the market, making far more loans than it ever has before, and only requiring down-payments of 3.5%. People can even use the tax credit for their down-payment. The FHA&#8217;s reserves are already dangerously low, and the delinquencies on the loans they insure are skyrocketing, particularly for mortgages it issued in 2007 and 2008. This year&#8217;s loans have not really had time to go bad yet. The FHA may end up going the way of Fannie and Freddie and require a massive federal bailout.<br />
<br />
All in all, the increase in home prices is good news, but it is coming with a big price from the Federal Treasury and may end up being ephemeral. The risk of a renewed downturn in the second quarter of 2010 is very big. If that were to occur, it would mean more pain for the mortgage complex.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1259088384.jpg" alt="" /><br />
<br />
<em>Dirk van Dijk, CFA is the Chief Equity Strategist for Zacks.com. With more than 25 years investment experience he has become a popular commentator appearing in the Wall Street Journal and on CNBC. Dirk is also the Editor in charge of the market-beating <a href="http://www.zacks.com/registration/strategicinvestor/welcome/?adid=SI_online_commentary_dvd">Zacks Strategic Investor</a> service.</em><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAC">Read the full analyst report on "BAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MTG">Read the full analyst report on "MTG"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FNM">Read the full analyst report on "FNM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FRE">Read the full analyst report on "FRE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/home-prices-continue-to-rise-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MetroPCS Upgraded to Neutral &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/metropcs-upgraded-to-neutral-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/metropcs-upgraded-to-neutral-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 16:00:11 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[4G Long Term Evolution (LTE)]]></category>
		<category><![CDATA[4G Long Term Evolution (LTE) wireless broadband service]]></category>
		<category><![CDATA[America Movil]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Ericsson]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[MetroPCS Communications]]></category>
		<category><![CDATA[Northeastern]]></category>
		<category><![CDATA[prepaid wireless segment]]></category>
		<category><![CDATA[product/services]]></category>
		<category><![CDATA[Samsung]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sprint Nextel]]></category>
		<category><![CDATA[ultra high-bandwidth multimedia data applications]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[wireless broadband]]></category>
		<category><![CDATA[wireless broadband service;]]></category>
		<category><![CDATA[wireless carriers]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27577/MetroPCS+Upgraded+to+Neutral+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
We upgrade our recommendation for <strong>MetroPCS Communications</strong> (<a href="http://www.zacks.com/stock/quote/PCS">PCS)</a> to Neutral following the company&#8217;s better-than-expected operating results in the last quarter. Reported earnings have outpaced the Zacks Consensus Estimate fueled by healthy revenue growth across the company&#8217;s Core and Northeast markets. MetroPCS is benefiting from its new unlimited international calling plan which is driving revenue per user. <br />
<br />
MetroPCS remains a leading low-cost service provider in the unlimited prepaid market in the US and will continue to benefit from the ongoing wireline replacement trend. The company is increasingly focused on strengthening its position in the unlimited prepaid segment by broadening its portfolio of discounted service plans.<br />
<br />
MetroPCS has initiated several steps to counter intense competition and drive subscriber accretion. The company is rolling out new product/services, upgrading network infrastructure and entering additional markets for growth. <br />
<br />
The company is currently enjoying meaningful traction in the Northeast region, which is evidenced by healthy subscriber growth. Gains from the Northeastern markets continue to offset declines in Core markets (including Atlanta, Dallas, Las Vegas, Los Angeles and San Francisco). A significant part of MetroPCS&#8217; network infrastructure deployment initiatives is centered on the lucrative Northeast region. <br />
<br />
MetroPCS has joined the league of the top-tier US wireless carriers such as <strong>Verizon</strong> (<a href="http://www.zacks.com/stock/quote/VZ">VZ</a>) and <strong>AT&#38;T</strong> (<a href="http://www.zacks.com/stock/quote/T">T</a>) as the company recently declared vendors for its 4G Long Term Evolution (LTE) wireless broadband service. MetroPCS has selected <strong>Ericsson </strong>(<a href="http://www.zacks.com/stock/quote/ERIC">ERIC</a>) as network infrastructure vendor and Samsung as the supplier of LTE enabled handsets. <br />
<br />
The company plans to launch 4G LTE service and several dual-mode smartphones across its metropolitan markets in second-half 2010. The ultra high bandwidth multimedia data applications supported by the 4G LTE network will boost revenue per user through increased minutes of use. <br />
<br />
However, despite these encouraging growth prospects, MetroPCS contends with subscriber retention problems as customer accretion continues to decelerate on a sequential basis due to intense competition in the prepaid wireless segment. The company is experiencing sustained customer attrition in its legacy Core markets. <br />
<br />
Churn (customer switch) level remains high due to increased customer defection as the company&#8217;s larger peers in the prepaid market such as <strong>Sprint Nextel</strong> (<a href="http://www.zacks.com/stock/quote/S">S</a>) and <strong>America Movil&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/AMX">AMX</a>) Tracfone continue to lure subscribers with competitive service plans and better product offerings.<br />
 <br />
While expansion into the Northeastern markets is expected to drive future growth, we feel that associated capital expenditures will strain balance sheet moving forward.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PCS">Read the full analyst report on "PCS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=T">Read the full analyst report on "T"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ERIC">Read the full analyst report on "ERIC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=S">Read the full analyst report on "S"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMX">Read the full analyst report on "AMX"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/metropcs-upgraded-to-neutral-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Money Supply on Fire, Spreads to Gold</title>
		<link>http://www.straightstocks.com/investing-lessons/money-supply-on-fire-spreads-to-gold/</link>
		<comments>http://www.straightstocks.com/investing-lessons/money-supply-on-fire-spreads-to-gold/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 06:00:00 +0000</pubDate>
		<dc:creator>Frank Holmes</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Dow Jones]]></category>
		<category><![CDATA[Frank Holmes;]]></category>
		<category><![CDATA[Frank Talk]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indonesia]]></category>
		<category><![CDATA[Laura Mandaro;]]></category>
		<category><![CDATA[MarketWatch reporter]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Pakistan]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[San Francisco]]></category>

		<guid isPermaLink="false">tag:www.usfunds.com://b70f8375d2c669909154c60e4f69ea4d</guid>
		<description><![CDATA[While in San Francisco to speak at the Hard Assets Investment Conference, I sat down with Dow Jones MarketWatch reporter Laura Mandaro to discuss the topic on a lot of investorsrsquo; minds these days mdash; gold. I highlighted some factors for Laura, including the effect rising money supply can have on gold prices.
Money supply is on fire in the E-7 and G-7 mdash; theyrsquo;re just printing awayhellip;Unless money supply shrinks dramatically in the G-20 countries and interest rates rise dramatically in the G-20 countries, I think gold is going to go through its 1980 inflation-adjusted price levels.
E-7 is a classification wersquo;ve created for the emerging worldrsquo;s most-populous countries ndash; the well-known BRIC countries (Brazil, Russia, India and China), plus Indonesia, Pakistan and Mexico. We believe that demographics are a key growth driver for developing countries, and that by monitoring the E-7, we gain valuable insights and can be early in spotting important new trends.





All opinions expressed and data provided are subject to change without notice. Some of these opinions may not be appropriate to every investor. #09-821]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/money-supply-on-fire-spreads-to-gold/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, STEM, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and StemCells Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-stem-drstockpick-com-stock-report-power-3-medical-products-inc-and-stemcells-inc-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-stem-drstockpick-com-stock-report-power-3-medical-products-inc-and-stemcells-inc-2/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 16:28:33 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual disease]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cell-based technologies]]></category>
		<category><![CDATA[Children’s Hospital]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[HuCNS-SC®]]></category>
		<category><![CDATA[Ira L. Goldknopf]]></category>
		<category><![CDATA[lead product candidate]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[neurodegenerative disorders;]]></category>
		<category><![CDATA[neurological disorder]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Neurosurgery]]></category>
		<category><![CDATA[Pelizaeus-Merzbacher Disease]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[President and Chief Scientific Officer]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[StemCells Inc.]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[treatment of two fatal neurodegenerative disorders]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.BestOTC.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.PennyOmega.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stemcellsinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.stock-pr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4916</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday Nov 23, 2009
DrStockPick.com Stock Report!
PWRM, STEM
**************************************************************
PWRM, Power 3 Medical Products Inc, PWRM.OB
PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-stem-drstockpick-com-stock-report-power-3-medical-products-inc-and-stemcells-inc-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sprint Expands 4G, Reduces Debt &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/sprint-expands-4g-reduces-debt-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/sprint-expands-4g-reduces-debt-analyst-blog/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 16:44:38 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3g]]></category>
		<category><![CDATA[3G wireless data plans]]></category>
		<category><![CDATA[4G ;]]></category>
		<category><![CDATA[4G networks]]></category>
		<category><![CDATA[4G service]]></category>
		<category><![CDATA[4G services]]></category>
		<category><![CDATA[4G wireless standard]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[Clearwire Corporation]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[mobile broadband technology]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[postpaid wireless]]></category>
		<category><![CDATA[San Antonio]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sprint]]></category>
		<category><![CDATA[Standard & Poor]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[wireless broadband]]></category>
		<category><![CDATA[wireless broadband network;]]></category>
		<category><![CDATA[wireless contract customer base]]></category>
		<category><![CDATA[wireless market]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27415/Sprint+Expands+4G%2C+Reduces+Debt+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Sprint Nextel </strong>(<a href="http://www.zacks.com/stock/quote/S">S</a>) has expanded its fourth-generation (4G) wireless broadband network to two more US cities. The third largest US carrier has officially launched commercial services in San Antonio and Austin in Texas. The company&#8217;s 4G services now covers about 25 markets in the US, with plans to address more than 120 million people by the end of 2009. <br />
 <br />
Subscribers across the newly launched markets can now enjoy lightning fast mobile broadband experience by paying just $10 per month over their existing 3G wireless data plans. The 4G WiMax network offers up to 10 times faster network speeds than the existing 3G deployments. The download speeds enabled by the 4G WiMax network average 3&#8722;6 megabits per second (Mbps), with peak speeds exceeding 10 Mbps.   <br />
 <br />
Sprint offers its 4G service under the "Sprint 4G" brand and leverages the WiMax (a mobile broadband technology) network operated by <strong>Clearwire Corporation</strong> (<a href="http://www.zacks.com/stock/quote/CLWR">CLWR</a>) in which it holds a 51% stake. Sprint recently announced its plan to invest an additional US$1.2 billion in Clearwire to facilitate the 4G service roll-out.<br />
 <br />
The 4G WiMax service is expected to play a critical role for Sprint&#8217;s survival in the domestic wireless market, given its continued market share losses to larger rivals. The company plans to continue the aggressive network deployments through 2010 with 4G service launches in key US markets such as Boston, Houston, New York , San Francisco and Washington D.C.<br />
 <br />
Sprint&#8217;s peers <strong>AT&#38;T</strong> (<a href="http://www.zacks.com/stock/quote/T">T</a>) and <a href="http://www.zacks.com/stock/quote/VZ">Verizon </a>(VZ) are preparing to deploy their own 4G networks in the 2010&#8722;2011 timeframe based on the Long-Term Evaluation (&#8220;LTE"), an emerging 4G wireless standard. LTE has demonstrated higher throughput levels than WiMax in technical trials.<br />
 <br />
Sprint has reportedly repaid US$1 billion debt using its existing cash resources. This has effectively erased all outstanding balance on the company&#8217;s US$4.5 billion revolving credit facility.<br />
 <br />
This significant debt reduction initiative follows the warning issued by Standard &#38; Poor&#8217;s Ratings Services for a possible credit rating downgrade due to the company&#8217;s lackluster operating results through third-quarter 2009. The company reported a bigger net loss and lower revenue in the last quarter due to the weak performance of its postpaid wireless business.<br />
 <br />
Sprint is increasingly focused on cost reduction as a declining subscriber base continued to weigh on its top-line. The company recently revealed a workforce reduction plan as it targets to downsize up to 2,500 jobs by the end of the current year. This is expected to help the company to reduce costs by at least $350 million. <br />
 <br />
While Sprint&#8217;s 4G expansion and cost-cutting measures appear encouraging, the company is expected to remain challenged by the sustained erosion in its wireless contract customer base through 2009. However, the healthy growth at Boost Monthly prepaid mobile business may offset most of these losses.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=S">Read the full analyst report on "S"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CLWR">Read the full analyst report on "CLWR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=T">Read the full analyst report on "T"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/sprint-expands-4g-reduces-debt-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Overvalued Stocks: Don’t Touch These Bloated Investments With a 10-Foot Pole</title>
		<link>http://www.straightstocks.com/investing-lessons/overvalued-stocks-don%e2%80%99t-touch-these-bloated-investments-with-a-10-foot-pole/</link>
		<comments>http://www.straightstocks.com/investing-lessons/overvalued-stocks-don%e2%80%99t-touch-these-bloated-investments-with-a-10-foot-pole/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 15:09:16 +0000</pubDate>
		<dc:creator>Investment U</dc:creator>
				<category><![CDATA[Contrarian Perspectives]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[actor]]></category>
		<category><![CDATA[American Idol;]]></category>
		<category><![CDATA[Asset Manager]]></category>
		<category><![CDATA[Danny Zuko]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[Expedia]]></category>
		<category><![CDATA[Harley Davidson]]></category>
		<category><![CDATA[healthy real  estate]]></category>
		<category><![CDATA[industrial materials manufacturer]]></category>
		<category><![CDATA[InvestmentU]]></category>
		<category><![CDATA[Marc Lichtenfeld;]]></category>
		<category><![CDATA[online travel sites]]></category>
		<category><![CDATA[Oxford Club]]></category>
		<category><![CDATA[Priceline]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Rogers;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Taylor  Hicks]]></category>
		<category><![CDATA[The Oxford Club]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/overvalued-stocks.html</guid>
		<description><![CDATA[Overvalued Stocks: Don&#8217;t Touch These Bloated Investments With a 10-Foot Pole
by Marc Lichtenfeld, Healthcare Expert
Wednesday,  November 18, 2009: Issue #1140
To celebrate my parents&#8217; anniversary, I took the family to  see Grease last weekend. As musical theater buffs, I figured that they&#8217;d  love the seeing the show, especially with my kids who had [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/overvalued-stocks-don%e2%80%99t-touch-these-bloated-investments-with-a-10-foot-pole/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>November 16th CEOcast Weekly Newsletter</title>
		<link>http://www.straightstocks.com/investing-lessons/november-16th-ceocast-weekly-newsletter/</link>
		<comments>http://www.straightstocks.com/investing-lessons/november-16th-ceocast-weekly-newsletter/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 20:21:30 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Advanced Cell Technologies]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Bank of America Merrill Lynch;]]></category>
		<category><![CDATA[BJ’s Wholesale]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Capstone facility]]></category>
		<category><![CDATA[CEL-SCI Corporation]]></category>
		<category><![CDATA[cell therapy]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Cleveland Clinic]]></category>
		<category><![CDATA[cloud storage networks]]></category>
		<category><![CDATA[credit monitoring]]></category>
		<category><![CDATA[Crystal City]]></category>
		<category><![CDATA[Dell]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[Deutsche Bank]]></category>
		<category><![CDATA[Dow Jones]]></category>
		<category><![CDATA[electronics supply chain management]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Enzo Biochem]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Ford Motor Company]]></category>
		<category><![CDATA[fresh bamboo health products]]></category>
		<category><![CDATA[green process manufacturer]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[H1N1 virus;]]></category>
		<category><![CDATA[health and security identification tools]]></category>
		<category><![CDATA[Health Solutions]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[healthcare services revenues]]></category>
		<category><![CDATA[herpes simplex]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Home-Depot]]></category>
		<category><![CDATA[Hythiam]]></category>
		<category><![CDATA[Iceweb]]></category>
		<category><![CDATA[immunization]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Kenneth S. Rosenthal]]></category>
		<category><![CDATA[Kobe]]></category>
		<category><![CDATA[Korea]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[Lazard]]></category>
		<category><![CDATA[LEAPS vaccine]]></category>
		<category><![CDATA[LEAPS vaccine technology]]></category>
		<category><![CDATA[Lowe’s]]></category>
		<category><![CDATA[Modular Lightweight Portable (MLP)]]></category>
		<category><![CDATA[Modular Lightweight Portable (MLP) server]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Northeastern Ohio Universities College of Medicine]]></category>
		<category><![CDATA[ONE Holdings]]></category>
		<category><![CDATA[Oppenheimer & Co.]]></category>
		<category><![CDATA[Optimus Capital Partners]]></category>
		<category><![CDATA[organic food product line]]></category>
		<category><![CDATA[outpatient behavioral health services]]></category>
		<category><![CDATA[philadelphia fed]]></category>
		<category><![CDATA[Pioneer Behavioral Health]]></category>
		<category><![CDATA[PositiveID Corp]]></category>
		<category><![CDATA[Professor of Immunology]]></category>
		<category><![CDATA[Professor of Immunology and Microbiology]]></category>
		<category><![CDATA[radio frequency identification systems]]></category>
		<category><![CDATA[RECEPTORS LLC;]]></category>
		<category><![CDATA[reporting]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Robert Lanza]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sears Holdings]]></category>
		<category><![CDATA[Seoul]]></category>
		<category><![CDATA[Seven Hills Behavioral Institute]]></category>
		<category><![CDATA[Sidoti & Co.]]></category>
		<category><![CDATA[SinoHub]]></category>
		<category><![CDATA[Sparta Commercial Services]]></category>
		<category><![CDATA[Steel Vault]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[supermarket operators]]></category>
		<category><![CDATA[target]]></category>
		<category><![CDATA[treatment of infectious diseases]]></category>
		<category><![CDATA[United Green Technology Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vaccine technology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[vegetable products]]></category>
		<category><![CDATA[VeriChip Corporation]]></category>
		<category><![CDATA[Virginia]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19352</guid>
		<description><![CDATA[Companies featured in this edition of the newsletter: ACTC, CVM, CHIP, ENZ, HYTM, IWEB, ONEZ, PHC, SIHI, SRCO
Markets continued their strong performance this week in the absence of any major market driving earnings or economic reports, as the broad based buying that characterized the previous week continued and led to gains in all of the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/november-16th-ceocast-weekly-newsletter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global corporates looking to invest heavily in cleantech &#8211; Ernst  Young</title>
		<link>http://www.straightstocks.com/investing-lessons/global-corporates-looking-to-invest-heavily-in-cleantech-ernst-young/</link>
		<comments>http://www.straightstocks.com/investing-lessons/global-corporates-looking-to-invest-heavily-in-cleantech-ernst-young/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 13:00:00 +0000</pubDate>
		<dc:creator>Dawn Van Zant</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[cleantech solutions]]></category>
		<category><![CDATA[Ernst  Young San Francisco]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[San Francisco]]></category>

		<guid isPermaLink="false">http://www.investorideas.com/News/renewable-energy/111309a.asp</guid>
		<description><![CDATA[San Francisco and London - November 13, 2009 - Despite ongoing uncertainty about the global economic situation, spending by the world's biggest companies of developing or acquiring cleantech solutions is robust and primed to accelerate.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/global-corporates-looking-to-invest-heavily-in-cleantech-ernst-young/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VIASPACE, Inc. (VSPC.OB) to Deliver Presentation at Next-Generation Biofuels Feedstocks USA Conference</title>
		<link>http://www.straightstocks.com/investing-lessons/viaspace-inc-vspc-ob-to-deliver-presentation-at-next-generation-biofuels-feedstocks-usa-conference/</link>
		<comments>http://www.straightstocks.com/investing-lessons/viaspace-inc-vspc-ob-to-deliver-presentation-at-next-generation-biofuels-feedstocks-usa-conference/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 16:16:14 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[advantageous energy crop]]></category>
		<category><![CDATA[Biofuels]]></category>
		<category><![CDATA[Carl Kukkonen]]></category>
		<category><![CDATA[chief executive]]></category>
		<category><![CDATA[clean energy company growing]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[energy crop]]></category>
		<category><![CDATA[energy crops]]></category>
		<category><![CDATA[energy producers]]></category>
		<category><![CDATA[Grass;]]></category>
		<category><![CDATA[King Grass]]></category>
		<category><![CDATA[Le Meridien Hotel]]></category>
		<category><![CDATA[renewable energy feedstocks]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[VIASPACE Inc.]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19242</guid>
		<description><![CDATA[
VIASPACE Inc., a clean energy company growing Giant King(TM) Grass as a renewable, low carbon, energy crop, announced this morning that its Chief Executive, Dr. Carl Kukkonen, will be presenting the company’s Giant King Grass at the Next-Generation Biofuels Feedstocks USA Conference to be held November 16-17, 2009, at Le Meridien Hotel in San Francisco.
Contrived [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/viaspace-inc-vspc-ob-to-deliver-presentation-at-next-generation-biofuels-feedstocks-usa-conference/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diedrich Coffee (DDRX) Reports Dramatic First Quarter Results</title>
		<link>http://www.straightstocks.com/investing-lessons/diedrich-coffee-ddrx-reports-dramatic-first-quarter-results/</link>
		<comments>http://www.straightstocks.com/investing-lessons/diedrich-coffee-ddrx-reports-dramatic-first-quarter-results/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 17:32:45 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[coffee maker;]]></category>
		<category><![CDATA[Diedrich Coffee]]></category>
		<category><![CDATA[Emeryville]]></category>
		<category><![CDATA[Gloria Jean]]></category>
		<category><![CDATA[Keurig Incorporated;]]></category>
		<category><![CDATA[office coffee service distributors]]></category>
		<category><![CDATA[Peet’s Coffee & Tea Inc.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[tea retailer]]></category>
		<category><![CDATA[temporary help]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[web stores]]></category>
		<category><![CDATA[wholesaler]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19042</guid>
		<description><![CDATA[Diedrich Coffee, a leading fine coffee roaster and wholesaler, reported impressive revenue and profit figures for the first quarter 2010 (ended September 16, 2009). Total quarterly revenue increased 52% over the same quarter last year, going from $10.4 million to $15.8 million. The jump was led by a 66%, $5.8 million, increase in the sale [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/diedrich-coffee-ddrx-reports-dramatic-first-quarter-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/04/09, ICXT, CVAT, AF, STL, CVGI, SPNC</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110409-icxt-cvat-af-stl-cvgi-spnc/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110409-icxt-cvat-af-stl-cvgi-spnc/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 17:18:20 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Astoria Financial Corporation]]></category>
		<category><![CDATA[Canaccord Adams]]></category>
		<category><![CDATA[Chad M. Utrup]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[Commercial Vehicle Group Inc;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Four Seasons hotel]]></category>
		<category><![CDATA[ICx Technologies Inc.;]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[integrated system solutions]]></category>
		<category><![CDATA[Mervin Dunn]]></category>
		<category><![CDATA[Monte N. Redman]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Nikko Hotel]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[president and chief operating officer]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[sensor ;]]></category>
		<category><![CDATA[sensor technologies;]]></category>
		<category><![CDATA[Spectranetics Corporation]]></category>
		<category><![CDATA[Sterling Bancorp]]></category>
		<category><![CDATA[Sterling National Bank]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4491</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Wednesday November 4, 2009
DrStockPick.com Stock Report!
**************************************************************
Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) announced recently that it has signed Miura Engineering Co., Ltd. Tokyo, Japan (www.miura21.co.jp) as its new agent to serve markets in Japan for CTI’s Nano-Cavitation Process Systems. Miura is a leading Engineering [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110409-icxt-cvat-af-stl-cvgi-spnc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/02/09, TRS, VSAT, VNO, FFIV, LJPC, GCHT</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-trs-vsat-vno-ffiv-ljpc-gcht-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-trs-vsat-vno-ffiv-ljpc-gcht-2/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 20:43:58 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(703) 639-1228]]></category>
		<category><![CDATA[(866) 261-7280]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Company Management]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[engineered and applied products]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[GC China Turbine Corp.]]></category>
		<category><![CDATA[GC Nordic Group]]></category>
		<category><![CDATA[La Jolla Pharmaceutical Company;]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Mandarin Oriental Hotel]]></category>
		<category><![CDATA[Monogram Aerospace Fasteners manufacturing  plant]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[Operating Partnership]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[TriMas Corporation]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[ViaSat Inc.]]></category>
		<category><![CDATA[Vornado Realty L.P.]]></category>
		<category><![CDATA[Vornado Realty Trust]]></category>
		<category><![CDATA[wind turbine manufacturer]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4425</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 2, 2009
DrStockPick.com Stock Report!
**************************************************************

TriMas Corporation  (Nasdaq: TRS) - a diversified manufacturer of engineered and applied  products - today announced that its Monogram Aerospace Fasteners manufacturing  plant in Los Angeles, California has passed the one millionth- hour mark without  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-trs-vsat-vno-ffiv-ljpc-gcht-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/02/09, TRS, VSAT, VNO, FFIV, LJPC, GCHT</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-trs-vsat-vno-ffiv-ljpc-gcht/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-trs-vsat-vno-ffiv-ljpc-gcht/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 20:43:58 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(703) 639-1228]]></category>
		<category><![CDATA[(866) 261-7280]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Company Management]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[engineered and applied products]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[GC China Turbine Corp.]]></category>
		<category><![CDATA[GC Nordic Group]]></category>
		<category><![CDATA[La Jolla Pharmaceutical Company;]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Mandarin Oriental Hotel]]></category>
		<category><![CDATA[Monogram Aerospace Fasteners manufacturing  plant]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[Operating Partnership]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[TriMas Corporation]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[ViaSat Inc.]]></category>
		<category><![CDATA[Vornado Realty L.P.]]></category>
		<category><![CDATA[Vornado Realty Trust]]></category>
		<category><![CDATA[wind turbine manufacturer]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4425</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 2, 2009
DrStockPick.com Stock Report!
**************************************************************

TriMas Corporation  (Nasdaq: TRS) - a diversified manufacturer of engineered and applied  products - today announced that its Monogram Aerospace Fasteners manufacturing  plant in Los Angeles, California has passed the one millionth- hour mark without  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-trs-vsat-vno-ffiv-ljpc-gcht/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/02/09, MMSI, PWRM, CATM, ED, IEC, OUTD</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-mmsi-pwrm-catm-ed-iec-outd/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-mmsi-pwrm-catm-ed-iec-outd/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 15:04:10 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[Canaccord Adams]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cardtronics Inc;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Comcast]]></category>
		<category><![CDATA[Consolidated Edison Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[electronics]]></category>
		<category><![CDATA[IEC Electronics Corp.]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Manitowoc]]></category>
		<category><![CDATA[Medical Devices]]></category>
		<category><![CDATA[Merit Medical Systems Inc]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[Nikko Hotel]]></category>
		<category><![CDATA[Outdoor Channel Holdings Inc.]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4414</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 2, 2009
DrStockPick.com Stock Report!
**************************************************************

Power3 Medical  Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and  cancer biomarkers and diagnostic tests, announces further international  recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf,  will deliver an [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-mmsi-pwrm-catm-ed-iec-outd/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/02/09, LAVA, PSFT, NLC, SONE, BVSN, MIPS</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-lava-psft-nlc-sone-bvsn-mips/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-lava-psft-nlc-sone-bvsn-mips/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 14:10:52 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[access processing  semiconductors]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Bedford Park]]></category>
		<category><![CDATA[BroadVision Inc.]]></category>
		<category><![CDATA[business  networking solutions]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[chip design software]]></category>
		<category><![CDATA[chip design;]]></category>
		<category><![CDATA[Clearing Plant]]></category>
		<category><![CDATA[cost-sensitive embedded  applications]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Enterprise 2.0]]></category>
		<category><![CDATA[Enterprise 2.0 business  networking solutions]]></category>
		<category><![CDATA[Financial Services]]></category>
		<category><![CDATA[higher-quality product]]></category>
		<category><![CDATA[home networking]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[implementation software]]></category>
		<category><![CDATA[Magma Design Automation Inc.]]></category>
		<category><![CDATA[material using state-of-the-art  technology]]></category>
		<category><![CDATA[MIPS Technologies Inc.;]]></category>
		<category><![CDATA[MIPS32]]></category>
		<category><![CDATA[Nalco;]]></category>
		<category><![CDATA[payments software solutions]]></category>
		<category><![CDATA[PowerSafe Technology Corporation]]></category>
		<category><![CDATA[processor]]></category>
		<category><![CDATA[S1 Corporation;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[secure business networks]]></category>
		<category><![CDATA[Semiconductors]]></category>
		<category><![CDATA[social  networking portal]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Talus]]></category>
		<category><![CDATA[Talus 1.1]]></category>
		<category><![CDATA[Talus platform]]></category>
		<category><![CDATA[Talus(R) 1.1 IC implementation software]]></category>
		<category><![CDATA[telecommunication infrastructure  solutions]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wintegra]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4407</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 2, 2009
DrStockPick.com Stock Report!
**************************************************************

PowerSafe Technology  Corporation (PSFT.PK) subsidiary Amplification Technologies Inc. (www.amplificationtechnologies.com)  (ATI), is offering higher performance thermoelectrically cooled discrete  amplification single photon counting solid state photodetectors. These  photodetectors are mounted on a two stage thermoelectric cooler inside [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-110209-lava-psft-nlc-sone-bvsn-mips/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 10/29/09, ADES, PSFT, IBM, S, GPX, BSQR</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-102909-ades-psft-ibm-s-gpx-bsqr/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-102909-ades-psft-ibm-s-gpx-bsqr/#comments</comments>
		<pubDate>Thu, 29 Oct 2009 17:42:07 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Ada Es Inc]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Bsquare Corporation]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Director of International Operations]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Services Group]]></category>
		<category><![CDATA[ES]]></category>
		<category><![CDATA[general  practitioner or primary osteopath]]></category>
		<category><![CDATA[General Physics Corporation]]></category>
		<category><![CDATA[GP Strategies Corporation]]></category>
		<category><![CDATA[Harvard Club]]></category>
		<category><![CDATA[Ibm]]></category>
		<category><![CDATA[Industrial Defender Inc.]]></category>
		<category><![CDATA[Mark McKinnies]]></category>
		<category><![CDATA[Matt Auer]]></category>
		<category><![CDATA[Michael D. Durham]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[pediatrician]]></category>
		<category><![CDATA[PowerSafe Technology Corporation]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Scott Mahan]]></category>
		<category><![CDATA[Sprint]]></category>
		<category><![CDATA[Sprint Foundation]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President and CFO]]></category>
		<category><![CDATA[W Hotel]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4341</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Thursday October 29, 2009
DrStockPick.com Stock Report!
**************************************************************

PowerSafe Technology Corporation  (PSFT.PK) subsidiary Amplification Technologies Inc. (www.amplificationtechnologies.com)  (ATI), is offering higher performance thermoelectrically cooled discrete  amplification single photon counting solid state photodetectors. These  photodetectors are mounted on a two stage thermoelectric cooler inside [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-102909-ades-psft-ibm-s-gpx-bsqr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cash is King</title>
		<link>http://www.straightstocks.com/investing-lessons/cash-is-king/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cash-is-king/#comments</comments>
		<pubDate>Wed, 28 Oct 2009 18:46:11 +0000</pubDate>
		<dc:creator>Trading School</dc:creator>
				<category><![CDATA[Commodities]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Trading Lessons]]></category>
		<category><![CDATA[American Stock Exchange]]></category>
		<category><![CDATA[bond trader]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chicago Board Of Trade]]></category>
		<category><![CDATA[Enron]]></category>
		<category><![CDATA[king]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[new york stock exchange]]></category>
		<category><![CDATA[Pacific Stock Exchange]]></category>
		<category><![CDATA[Paul Judd]]></category>
		<category><![CDATA[Philadelphia Stock Exchange]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[trading school]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[“blue chip]]></category>

		<guid isPermaLink="false">http://club.ino.com:80/trading/?p=1733</guid>
		<description><![CDATA[Please welcome Paul Judd to the Trader&#8217;s Blog stage where he will present to you a very interesting trick&#8230;BONDS ARE GOOD! Paul should know as he&#8217;s dedicated the last 14 years to treasury bonds where he&#8217;s learned the in&#8217;s and out&#8217;s that we should all take a look at! So please read the article below, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cash-is-king/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TAXS, SCHW, PSFT, DISH, PWRM, MMM, CSRH, WFC, CVAT, JPM, AQNM, DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/taxs-schw-psft-dish-pwrm-mmm-csrh-wfc-cvat-jpm-aqnm-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/taxs-schw-psft-dish-pwrm-mmm-csrh-wfc-cvat-jpm-aqnm-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 19:36:08 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3M Co.]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[Banking]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Brad Kerr]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[bronchitis]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Carrie Schwab-Pomerantz]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[Charles Schwab Corp.]]></category>
		<category><![CDATA[Chatsworth]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[clients with new and enhanced solutions]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Consumer Finance]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[CVAT]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[direct food contact]]></category>
		<category><![CDATA[Director of Sales and Business Development]]></category>
		<category><![CDATA[DISH Network Corp.;]]></category>
		<category><![CDATA[DISH Network L.L.C.]]></category>
		<category><![CDATA[diverse applications]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Engineering Department]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Far East]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Financial Services]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Industry]]></category>
		<category><![CDATA[food processor;]]></category>
		<category><![CDATA[food products]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[founder and chairman]]></category>
		<category><![CDATA[framework advisors]]></category>
		<category><![CDATA[Gavin Newsom]]></category>
		<category><![CDATA[General Manager]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[Internal Revenue Service IRS]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[JPM Asset Management]]></category>
		<category><![CDATA[JPM Funds]]></category>
		<category><![CDATA[JPMorgan Chase & Co.]]></category>
		<category><![CDATA[Kazushi Miyauchi]]></category>
		<category><![CDATA[Kirk Wiggins]]></category>
		<category><![CDATA[Koichi Takahagi]]></category>
		<category><![CDATA[Korea]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mayor]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[Miura Engineering Co. Ltd.]]></category>
		<category><![CDATA[Nano-Cavitation Process Systems]]></category>
		<category><![CDATA[National Basketball Association]]></category>
		<category><![CDATA[NBA]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online version]]></category>
		<category><![CDATA[ozone]]></category>
		<category><![CDATA[ozone equipment;]]></category>
		<category><![CDATA[ozone technology]]></category>
		<category><![CDATA[pneumonia]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[R. Schwab]]></category>
		<category><![CDATA[retail clients]]></category>
		<category><![CDATA[retail industries]]></category>
		<category><![CDATA[Retail Investors]]></category>
		<category><![CDATA[Roman Gordon]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[satellite TV;]]></category>
		<category><![CDATA[SCHW]]></category>
		<category><![CDATA[Schwab Foundation]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[Shigeru Miura]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Tactical Connections Inc.]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Tokyo]]></category>
		<category><![CDATA[toxic by-products]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[USDA]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[wastewater treatment]]></category>
		<category><![CDATA[Wealth Management]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[Wfc]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.miura21.co.jp]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4284</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Tuesday October 27, 2009
DrStockPick.com Stock Report!
TAXS, SCHW, PSFT, DISH, PWRM, MMM, CSRH, WFC, CVAT, JPM, AQNM
**************************************************************
TAXS, TaxMasters Inc., TAXS.OB
TAXS&#8216; commitment to helping taxpayers in the United States regain compliance with The Internal Revenue Service IRS.
TAXS finalized plans this week to take advantage of the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taxs-schw-psft-dish-pwrm-mmm-csrh-wfc-cvat-jpm-aqnm-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Green News &#8211; Secretary Chu Announcement of $151 Million in ARPA-E Grants</title>
		<link>http://www.straightstocks.com/investing-lessons/green-news-secretary-chu-announcement-of-151-million-in-arpa-e-grants/</link>
		<comments>http://www.straightstocks.com/investing-lessons/green-news-secretary-chu-announcement-of-151-million-in-arpa-e-grants/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 13:00:00 +0000</pubDate>
		<dc:creator>Dawn Van Zant</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Advanced Research Projects Agency;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chu Announcement]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Secretary]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investorideas.com/News/102709a.asp</guid>
		<description><![CDATA[San Francisco, Calif. - October 26, 2009 - Today, Secretary Chu announced the first $151 million in grant funding through the Advanced Research Projects Agency - Energy.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/green-news-secretary-chu-announcement-of-151-million-in-arpa-e-grants/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 10/23/09, NVAX, SHOO, PSFT, GLBC, SNDY, UTX</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-102309-nvax-shoo-psft-glbc-sndy-utx/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-102309-nvax-shoo-psft-glbc-sndy-utx/#comments</comments>
		<pubDate>Fri, 23 Oct 2009 15:23:18 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[DA platform technology]]></category>
		<category><![CDATA[Derco Aerospace]]></category>
		<category><![CDATA[detector systems]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Endoscopy Inc.]]></category>
		<category><![CDATA[Fred W.  Driscoll]]></category>
		<category><![CDATA[Global Crossing]]></category>
		<category><![CDATA[John Kritzmacher]]></category>
		<category><![CDATA[John Legere;]]></category>
		<category><![CDATA[L-100]]></category>
		<category><![CDATA[leading designer]]></category>
		<category><![CDATA[MammoView]]></category>
		<category><![CDATA[MammoView(TM) line of endoscopy  surgical instruments]]></category>
		<category><![CDATA[MammoView(TM) line of surgical  endoscopy instruments]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[Novavax Inc.]]></category>
		<category><![CDATA[Palace Hotel]]></category>
		<category><![CDATA[Platform Technology]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[security systems]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[semiconductor technology solution]]></category>
		<category><![CDATA[Sikorsky Aircraft Corp.]]></category>
		<category><![CDATA[Steve Madden]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Subsidiary Amplification Technologies]]></category>
		<category><![CDATA[telecommunications]]></category>
		<category><![CDATA[U.S. Department of Health and Human Services]]></category>
		<category><![CDATA[U.S. National Institute of Health]]></category>
		<category><![CDATA[United Technologies Corp]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[VP and CFO]]></category>
		<category><![CDATA[www.novavax.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4207</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Friday October 23, 2009
DrStockPick.com Stock Report!
**************************************************************

Powersafe Technology  Corp.’s (Other OTC: PSFT.PK) Subsidiary Amplification Technologies has  patented a revolutionary new solid-state semiconductor technology solution for  low-level signal detection: multichannel Discrete Amplification (DA). The  patented DA platform technology, invented by company scientists, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-102309-nvax-shoo-psft-glbc-sndy-utx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ophthalmic Imaging Systems, Inc. (OISI.OB) Soon to Launch New Products</title>
		<link>http://www.straightstocks.com/investing-lessons/ophthalmic-imaging-systems-inc-oisi-ob-soon-to-launch-new-products/</link>
		<comments>http://www.straightstocks.com/investing-lessons/ophthalmic-imaging-systems-inc-oisi-ob-soon-to-launch-new-products/#comments</comments>
		<pubDate>Thu, 22 Oct 2009 14:32:05 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[American Academy of Ophthalmology]]></category>
		<category><![CDATA[digital imaging]]></category>
		<category><![CDATA[digital imaging systems]]></category>
		<category><![CDATA[Digital Reporter]]></category>
		<category><![CDATA[eye disease]]></category>
		<category><![CDATA[healthcare demand]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[informatics solutions]]></category>
		<category><![CDATA[OIS PM]]></category>
		<category><![CDATA[OIS Symphony Web Image Management System]]></category>
		<category><![CDATA[Ophthalmic Imaging Systems;]]></category>
		<category><![CDATA[Ophthalmology;]]></category>
		<category><![CDATA[portable imaging device]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Symphony Digital Reporter]]></category>
		<category><![CDATA[Web Image Management System]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=18725</guid>
		<description><![CDATA[Ophthalmic Imaging Systems (“OIS”) designs, develops, manufactures and markets digital imaging systems and informatics solutions for the eye care market. The company has 25 years experience in the ophthalmic imaging business and is the leading provider of ophthalmic digital imaging systems.
The company today announced that it will launch two new products and improvements to the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/ophthalmic-imaging-systems-inc-oisi-ob-soon-to-launch-new-products/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Beige Book Improves Again &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/beige-book-improves-again-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/beige-book-improves-again-analyst-blog/#comments</comments>
		<pubDate>Wed, 21 Oct 2009 20:06:43 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Kansas City]]></category>
		<category><![CDATA[nonfinancial services;]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[residential real estate]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Simon Property Group]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/26241/Beige+Book+Improves+Again+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
The Fed released its Beige Book today, which is a collection of mostly anecdotal information from across the country. Presented below are key sections of the report along with my reactions to them.<br />
<br />
<em>"Reports from the 12 Federal Reserve Districts indicated either stabilization or modest improvements in many sectors since the last report, albeit often from depressed levels. Leading the more positive sector reports among Districts were residential real estate and manufacturing, both of which continued a pattern of improvement that emerged over the summer. </em><br />
<br />
<em>"Reports on consumer spending and nonfinancial services were mixed. Commercial real estate was reported to be one of the weakest sectors, although reports of weakness or moderate decline were frequently noted in other sectors."</em><br />
<br />
This sounds better than the last Beige Book, which in turn was more optimistic than the one before it. What seems clear to me is that the economy is getting better, but it is starting from a pretty awful place.<br />
<br />
Historically, commercial real estate (CRE) has lagged the overall economy, so it is not a huge surprise that is is not doing too well right now. It will pose a very serious problem for lots of banks, particularly the small-to-medium sized regional banks that are very heavilly exposed to it. In many areas, the value of CRE is off more than 40% from the peak.<br />
<br />
CRE mortgages are generally structured for only five years and come with big balloon payments. Banks are not going to want to roll over a mortgage when it is for far more than the value of the building. This is going to cause lots of CRE owners to default.<br />
<br />
Put it this way: the banks are not going to be hurting for office space, as they are going to own a ton of it as the owners turn over the keys. This is going to be an ugly situation for the REITs like <strong>Simon Property Group</strong> (<a href="http://www.zacks.com/stock/quote/spg">SPG</a>) and <strong>Vornado</strong> (<a href="http://www.zacks.com/stock/quote/vno">VNO</a>).<br />
 <br />
<em>"The weakest sector was commercial real estate, with conditions described as either weak or deteriorating across all Districts. Banking also faltered in several Districts, with Kansas City and San Francisco noting continued erosion in credit quality (often with more expected in the future).</em><br />
<br />
<em>"One bright spot in the banking sector was lending to new homebuyers, in response to the first-time homebuyer tax credit. Finally, labor markets were typically characterized as weak or mixed, but with occasional pockets of improvement."</em><br />
<br />
Those toxic assets have not gone away, even if the banks are allowed to hide them on their balance sheets. The tax credit is pretty expensive and not all that well targeted. "Cash for Castles," as I like to call it.<br />
<br />
Unlike "Cash for Clunkers," it does nothing to reduce the outstanding supply of housing units. It just shifts people from being renters to being owners, resulting in more vacant apartments and more pressure on rents, which pulls the price-to-rent ratio back out of whack (one of the key signals that we were in a housing bubble is when it soared), and will just result in more trouble in the apartment sector of CRE. Still, the Realtors have a very powerful lobby, so this turkey of a program will probably be extended (if not expanded).<br />
 <br />
<em>"Districts generally reported little or no increase to either price or wage pressures, but references to downward pressures were occasionally noted."</em><br />
 <br />
Inflation is not a problem, as was amply demonstrated by the recent CPI and PPI reports. A still very tentative recovery, extremely high levels of unemployment and very low levels of capacity utilization are the big problems. The Fed needs to stay easy for awhile to come now.<br />
<br />
The report is more evidence that we are on the right track, but still moving slowly on it -- and have a very long journey to get back to where we need to be.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#038;d_alert=rd_final_rank&#038;ADID=GENSYND_ZER&#038;t=SPG">Read the full analyst report on "SPG"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#038;d_alert=rd_final_rank&#038;ADID=GENSYND_ZER&#038;t=VNO">Read the full analyst report on "VNO"</a><br /><a href="http://www.zacks.com" alt="Investment Research">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/beige-book-improves-again-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>AMB Refinances Term Loan &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/amb-refinances-term-loan-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/amb-refinances-term-loan-analyst-blog/#comments</comments>
		<pubDate>Mon, 19 Oct 2009 18:34:48 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AMB Property Corp.;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Financial Services]]></category>
		<category><![CDATA[industrial real estate]]></category>
		<category><![CDATA[investment banking activities]]></category>
		<category><![CDATA[J.P. Morgan Securities Inc.]]></category>
		<category><![CDATA[JPMorgan Chase & Co.]]></category>
		<category><![CDATA[leading global owner]]></category>
		<category><![CDATA[non-bank subsidiary]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[real estate investment trust]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sumitomo Mitsui Banking Corp.;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/26098/AMB+Refinances+Term+Loan+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>AMB Property Corp.</strong> (<a href="http://www.zacks.com/stock/quote/AMB">AMB</a>), a leading real estate investment trust (REIT), recently refinanced a $325 million unsecured term loan facility scheduled to mature in September 2010, and replaced it with a $345 million loan facility maturing in October 2012.<br />
 <br />
The refinancing has enabled AMB to include Euro and Yen multi-currency options in the loan facility. Furthermore, under the terms of the refinancing deal, AMB has the option to increase the loan facility to $425 million at any given point of time prior to October 2011.<br />
 <br />
With the recent transaction, AMB has strengthened its financial position and displayed its continued ability to tap the debt markets under the current credit-constrained market. The deal had J. P. Morgan Securities Inc. and Sumitomo Mitsui Banking Corp. as the lead arrangers and book managers. Engaged in investment banking activities in the U.S., J.P. Morgan Securities is the primary non-bank subsidiary of the financial services giant <strong>JPMorgan Chase &#38; Co. </strong>(<a href="http://www.zacks.com/stock/quote/JPM">JPM</a>).<br />
 <br />
Based in San Francisco, AMB is a leading global owner, operator and developer of industrial real estate in North America, Asia and Europe. By the end of the second quarter, AMB had 156.9 million square feet of operating and development facilities across the globe.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMB">Read the full analyst report on "AMB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JPM">Read the full analyst report on "JPM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amb-refinances-term-loan-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AMB Continues Mexico Leasing &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/amb-continues-mexico-leasing-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/amb-continues-mexico-leasing-analyst-blog/#comments</comments>
		<pubDate>Wed, 14 Oct 2009 17:14:54 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AMB Continues Mexico]]></category>
		<category><![CDATA[AMB Property Corp.;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arauco Distribucion Mexico]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Guadalajara]]></category>
		<category><![CDATA[industrial real estate]]></category>
		<category><![CDATA[leading global owner]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Monterrey]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[real estate investment trust]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25894/AMB+Continues+Mexico+Leasing+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>AMB Property Corp.</strong> (<a href="http://www.zacks.com/stock/quote/AMB">AMB</a>), a leading real estate investment trust (REIT), has recently signed leasing agreements for approximately 271,000 square feet in Mexico, signifying the probable redemption of investor confidence across the country.<br />
<br />
About 118,000 square feet were leased in Monterrey in northeast Mexico by Arauco Distribucion Mexico, the Mexican subsidiary of Arauco &#8211; a wood pulp and forestry enterprise in Chile. As part of its expansion strategy in the Latin American markets, Arauco also leased 120,000 square feet of space in Guadalajara in the western Pacific area of Mexico. Besides the Arauco leases, AMB had leased 33,000 square feet in Monterrey to a premier logistics company in the country.<br />
<br />
With the lease, AMB has strengthened its competitive position in the market. In addition, the company has strategically partnered with a single partner in multiple locations in order to increase its flexibility and enhance operational efficiency.<br />
<br />
Based in San Francisco, AMB is a leading global owner, operator and developer of industrial real estate in North America, Asia and Europe. By the end of the second quarter, AMB had 156.9 million square feet of operating and development facilities across the globe, out of which 9.8 million square feet were located in Mexico.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMB">Read the full analyst report on "AMB"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amb-continues-mexico-leasing-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>URS JV Gets Orders &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/urs-jv-gets-orders-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/urs-jv-gets-orders-analyst-blog/#comments</comments>
		<pubDate>Tue, 13 Oct 2009 16:15:48 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AECOM Technology Corporation]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Broadview Research Corporation]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[clean air technologies;]]></category>
		<category><![CDATA[construction management services]]></category>
		<category><![CDATA[construction management;]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[engineer]]></category>
		<category><![CDATA[environmental management]]></category>
		<category><![CDATA[facility management]]></category>
		<category><![CDATA[Federal]]></category>
		<category><![CDATA[Federal Emergency Management Agency]]></category>
		<category><![CDATA[Fluor Corporation]]></category>
		<category><![CDATA[food preparation;]]></category>
		<category><![CDATA[Jacobs Engineering Group Inc]]></category>
		<category><![CDATA[KBR Inc.]]></category>
		<category><![CDATA[managing partner]]></category>
		<category><![CDATA[mass care solutions]]></category>
		<category><![CDATA[PBS&J]]></category>
		<category><![CDATA[pollution control]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Army]]></category>
		<category><![CDATA[URS Corporation;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Waste Management]]></category>
		<category><![CDATA[waste remediation]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25827/URS+JV+Gets+Orders+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>URS Corporation</strong> (<a href="http://www.zacks.com/stock/quote/URS">URS</a>) announced that an alliance between URS and PBS&#38;J has been awarded a contract by the Federal Emergency Management Agency (FEMA) to assist the agency in providing temporary housing and mass care solutions for the survivors of the disaster.<br />
<br />
The five-year contract has a maximum value of $375 million for the alliance, in which URS is the managing partner.<br />
<br />
The joint venture will be responsible for hauling and installing, the maintenance and deactivation of temporary mobile housing units, as well as the construction of temporary housing communities, as necessary. Additional responsibilities could include providing support for mass care initiatives, such as base camp development, food preparation and distribution and other life support functions as requested by FEMA.<br />
<br />
URS Corporation provides engineering, construction, and technical services to the power, infrastructure, Federal, and industrial and commercial market sectors in the United States and internationally. Its services for power sector include the plan, design, engineer, construct, retrofit, and maintain a range of power-generating facilities; and the systems that transmit and distribute electricity, as well as the development and installation of clean air technologies that reduce emissions. <br />
<br />
URS Corporation&#8217;s services for industrial and commercial sector includes front-end studies, engineering and process design, procurement, construction and construction management, facility management, and operations and maintenance, as well as due diligence, permitting, compliance, environmental management, pollution control, health and safety, waste management, and hazardous waste remediation. <br />
<br />
It has a joint venture with Jacobs Engineering Group Inc. to provide general design support and construction management services to the U.S. Army Corps of Engineers. The company was formerly known as Broadview Research Corporation and changed its name to URS Corporation in 1976. URS Corporation was founded in 1904 and is headquartered in San Francisco , California . Major competitors are <strong>AECOM Technology Corporation</strong> (<a href="http://www.zacks.com/stock/quote/ACM">ACM</a>), <strong>Fluor Corporation</strong> (<a href="http://www.zacks.com/stock/quote/FLR">FLR</a>) and <strong>KBR Inc.</strong> <a href="http://www.zacks.com/stock/quote/KBR">(KBR</a>).     <br />
<br />
We currently have a Neutral recommendation on URS.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=URS">Read the full analyst report on "URS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FLR">Read the full analyst report on "FLR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=KBR">Read the full analyst report on "KBR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ACM">Read the full analyst report on "ACM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/urs-jv-gets-orders-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BIO-key International, Inc. (BKYI.OB) Gains National Attention</title>
		<link>http://www.straightstocks.com/investing-lessons/bio-key-international-inc-bkyi-ob-gains-national-attention/</link>
		<comments>http://www.straightstocks.com/investing-lessons/bio-key-international-inc-bkyi-ob-gains-national-attention/#comments</comments>
		<pubDate>Fri, 09 Oct 2009 13:53:37 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Access Manager]]></category>
		<category><![CDATA[Bio]]></category>
		<category><![CDATA[biometric solutions]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Director and CEO]]></category>
		<category><![CDATA[Executive]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[ID Director]]></category>
		<category><![CDATA[identification technology]]></category>
		<category><![CDATA[identity solution]]></category>
		<category><![CDATA[identity solutions]]></category>
		<category><![CDATA[Mike DePasquale]]></category>
		<category><![CDATA[Moscone Center;]]></category>
		<category><![CDATA[New Jersey]]></category>
		<category><![CDATA[online solutions]]></category>
		<category><![CDATA[Oracle]]></category>
		<category><![CDATA[Oracle Identity Assurance Partner Alliance]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[Prism eSolutions]]></category>
		<category><![CDATA[product demonstrations]]></category>
		<category><![CDATA[professional consulting services]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[wireless public safety]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=18423</guid>
		<description><![CDATA[BIO-key International made a monumental announcement this week with the news that the young company will showcase their biometric solutions at the Oracle Openworld 2009 Conference which is being held at the Moscone Center in San Francisco from October 11-15, 2009.
The New Jersey based BIO-key has been gaining a renowned reputation as a pioneer in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/bio-key-international-inc-bkyi-ob-gains-national-attention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sprint Expands 4G WiMax Footprint &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/sprint-expands-4g-wimax-footprint-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/sprint-expands-4g-wimax-footprint-analyst-blog/#comments</comments>
		<pubDate>Thu, 08 Oct 2009 19:35:09 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3g]]></category>
		<category><![CDATA[3G wireless data plans]]></category>
		<category><![CDATA[4G ;]]></category>
		<category><![CDATA[4G networks]]></category>
		<category><![CDATA[4G service]]></category>
		<category><![CDATA[4G WiMax]]></category>
		<category><![CDATA[4G wireless standard]]></category>
		<category><![CDATA[Abilene]]></category>
		<category><![CDATA[Amarillo]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Baltimore]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Clearwire Corp.;]]></category>
		<category><![CDATA[Corpus Christi]]></category>
		<category><![CDATA[Corpus Christi Day]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[fiber-based networks]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Honolulu;]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Killeen-Temple]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[Lubbock;]]></category>
		<category><![CDATA[Midland]]></category>
		<category><![CDATA[Milledgeville]]></category>
		<category><![CDATA[mobile broadband services;]]></category>
		<category><![CDATA[mobile broadband technology]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Odessa]]></category>
		<category><![CDATA[Oregon]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[Portland]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Seattle]]></category>
		<category><![CDATA[Sprint]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[Waco]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Wichita Falls]]></category>
		<category><![CDATA[wireless broadband]]></category>
		<category><![CDATA[wireless broadband network coverage]]></category>
		<category><![CDATA[wireless broadband networks]]></category>
		<category><![CDATA[wireless market]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25680/Sprint+Expands+4G+WiMax+Footprint+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Sprint Nextel</strong> (<a href="http://www.zacks.com/stock/quote/S">S</a>) has further expanded its fourth-generation (4G) wireless broadband network coverage to ten more U.S. markets. The third largest US carrier has officially launched commercial services in Salem (Oregon), Milledgeville (Georgia) and Texas cities of Amarillo , Killeen-Temple, Corpus Christi , Lubbock , Waco , Wichita Falls , Abilene and Midland-Odessa. This follows Sprint&#8217;s 4G service launches in Atlanta, Portland and Las Vegas in August 2009.<br />
 <br />
Sprint offers its 4G service under the "Sprint 4G" brand and leverages the WiMax (a mobile broadband technology) network operated by <strong>Clearwire Corp.</strong> (<a href="http://www.zacks.com/stock/quote/CLWR">CLWR</a>) in which it holds 51% stake. The 4G WiMax network offers up to 10 times faster network speeds than the existing 3G deployments. The download speeds enabled by the 4G WiMax network averages 3-6 megabits per second (Mbps) with peak speed exceeding 10 Mbps.  <br />
 <br />
Subscribers across the newly launched markets can now enjoy lightning fast mobile broadband experience by paying just $10 per month over their existing 3G wireless data plans. This is enabled by the nation&#8217;s first dual-mode (operates on 3G and 4G networks) mobile broadband modem, which was launched by Sprint in December 2008.<br />
 <br />
Sprint made history by becoming the first U.S. carrier to deploy 4G WiMax mobile broadband services in the U.S with a commercial launch in Baltimore in October 2008. This was followed by subsequent launches in five more cities of Chicago, Dallas, Philadelphia, Seattle and Honolulu.<br />
 <br />
The company plans to continue the aggressive network deployments through 2010 with 4G service launches in key US markets such as Boston, Houston, New York, San Francisco and Washington, D.C.<br />
 <br />
Sprint&#8217;s 4G WiMax initiative is a response to its major competitors <strong>Verizon</strong> (<a href="http://www.zacks.com/stock/quote/VZ">VZ</a>) and <strong>AT&#38;T</strong> (<a href="http://www.zacks.com/stock/quote/T">T</a>), who are preparing to deploy their own advanced wireless broadband networks in the 2010-2011 timeframe based on the emerging 4G wireless standard known as Long-Term Evaluation (&#8220;LTE").<br />
 <br />
The 4G WiMax service is expected to play a critical role for Sprint&#8217;s survival in the wireless market as the company continues to lose market share to its larger rivals. Additionally, WiMax is expected facilitate the deployment of broadband in rural areas where the expansion of traditional fiber-based networks may not be feasible.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=S">Read the full analyst report on "S"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CLWR">Read the full analyst report on "CLWR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=T">Read the full analyst report on "T"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/sprint-expands-4g-wimax-footprint-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SurModics New Licensing Deal (NASDAQ:SRDX)</title>
		<link>http://www.straightstocks.com/stock-watch/surmodics-new-licensing-deal-nasdaqsrdx/</link>
		<comments>http://www.straightstocks.com/stock-watch/surmodics-new-licensing-deal-nasdaqsrdx/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 17:45:16 +0000</pubDate>
		<dc:creator>Jyotsna Ramani</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery Technology]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[Lucentis]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[SurModics Inc.]]></category>
		<category><![CDATA[Switzerland]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=1068</guid>
		<description><![CDATA[   On early Tuesday morning, SurModics announced their new licensing deal with Roche. SurModics Inc. said that they have licensed their drug delivery technology to Roche and Roche’s Genentech unit for a deal ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/surmodics-new-licensing-deal-nasdaqsrdx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AvalonBay Sells Asset &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/avalonbay-sells-asset-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/avalonbay-sells-asset-analyst-blog/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 15:45:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[District Of Columbia]]></category>
		<category><![CDATA[Faxon Park]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Washington DC]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25581/AvalonBay+Sells+Asset+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>AvalonBay Communities, Inc. </strong>(<a href="http:// http://www.zacks.com/stock/quote/AVB">AVB</a>), a leading real estate investment trust (REIT), has recently sold its 171-unit apartment complex in Quincy, Massachusetts for $27.2 million to CB Richard Ellis Investors, a global real estate investment management firm. <br />
<br />
The apartment complex, called &#8216;Faxon Park&#8217;, is 100 leased and includes various amenities like clubhouse, swimming pool, and playground. The property offers an ideal location for easy commute to Boston and other surrounding communities. <br />
<br />
CB Richard intends to upgrade the property and renovate common areas before utilizing it for commercial/residential purposes. AvalonBay&#8217;s portfolio has held up better than its peers in an economic downturn due to its assets in infill supply-constrained areas where new apartment construction activity is very limited. <br />
<br />
The company has Class A assets located in premium markets, such as Washington DC, New York City, and San Francisco, where the spread between renting and owning is still high despite home price declines. AvalonBay primarily focuses on developing high-quality, multi-family apartment communities for higher-income clients in high barrier-to-entry regions of the U.S. <br />
<br />
As of Jun 30, 2009, the company owned or held ownership interests in 174 apartment communities, with 50,511 apartment homes in 10 states in the U.S. and the District of Columbia, including 12 communities under construction and 7 under redevelopment.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AVB">Read the full analyst report on "AVB"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/avalonbay-sells-asset-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Hana Biosciences, Inc. (HNAB.OB) Attacks Pediatric Cancer</title>
		<link>http://www.straightstocks.com/investing-lessons/hana-biosciences-inc-hnab-ob-attacks-pediatric-cancer/</link>
		<comments>http://www.straightstocks.com/investing-lessons/hana-biosciences-inc-hnab-ob-attacks-pediatric-cancer/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 15:45:49 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Abbot Laboratories]]></category>
		<category><![CDATA[acute lymphoblastic leukemia]]></category>
		<category><![CDATA[Anne Hagey]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cancer Therapies]]></category>
		<category><![CDATA[Center for Cancer Research]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Chief Medical Officer]]></category>
		<category><![CDATA[deadly disease]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[editor-in-chief]]></category>
		<category><![CDATA[Hana Biosciences]]></category>
		<category><![CDATA[Marqibo;]]></category>
		<category><![CDATA[Marquibo]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[neuroblastoma;]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[rhabdomyosarcoma]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Steven R. Deitcher]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vincristine sulfate]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=18176</guid>
		<description><![CDATA[If there is one disease that has plagued our country and people across the globe, it would be cancer.  Perhaps there is not a more tragic situation than when a child is stricken down with the deadly disease.  One company is trying to make headway into Pediatric Cancer.  That company is Hana [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/hana-biosciences-inc-hnab-ob-attacks-pediatric-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gap Inc. &#8211; Growth And Income &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/gap-inc-growth-and-income-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/gap-inc-growth-and-income-zacks-rank-buy/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Alex Kolb</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[CEO and Chairman]]></category>
		<category><![CDATA[CEO and Chairman of the Board]]></category>
		<category><![CDATA[Chairman and Chief Executive Officer]]></category>
		<category><![CDATA[Chairman of the Board;]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[Co Founder]]></category>
		<category><![CDATA[Donald G. Fisher]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Gap Inc]]></category>
		<category><![CDATA[Gap store;]]></category>
		<category><![CDATA[Glenn Murphy]]></category>
		<category><![CDATA[GPS]]></category>
		<category><![CDATA[Ireland]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Old Navy]]></category>
		<category><![CDATA[online sales]]></category>
		<category><![CDATA[Personal Care Products]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[Sabrina Simmons]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Gap]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12261/Gap+Inc.+-+Growth+And+Income+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Gap Inc.</b> (<a href="http://www.zacks.com/stock/quote/gps">GPS</a>) reported comparable store sales slipping by 3% year-over-year. While sales were slightly lower, which is not unique amid the current economic environment, GPS shares continued climbing and are trading close to a 52-high. The company also recently released sad news, announcing that Donald G. Fisher, co-founder of Gap, died after a long and heroic battle with cancer.
<p>
<b>Company Description</b> 
</p><p>
Gap Inc. is a global specialty retailer that sells clothing, accessories and personal care products for men, women, children and babies under the Gap, Old Navy, Banana Republic, Piperlime and Athleta brands. The company operates stores in the United States, Canada, the United Kingdom, France, Ireland and Japan.
</p><p>
Gap also has franchise agreements with unaffiliated franchisees to operate Gap and Banana Republic stores in many other countries around the world. Under these agreements, third parties operate or will operate stores that sell apparel, purchased from Gap, under Gap's brand names.
</p><p>
<b>Co-founder Dies After a Long and Heroic Battle with Cancer</b>
</p><p>
The company recently announced that Donald G. Fisher, co-founder of Gap, died after a long and heroic battle with cancer. He was 81.
</p><p>
Donald Fisher opened his first Gap store 40 years ago last month. A life-long resident of San Francisco, he was also known for his commitment to philanthropic and civic activities. Along with his wife Doris, Mr. Fisher believed that opportunities existed for a retail company that could provide consumers with a variety of fit and style options. In 1969, the Fishers raised $63,000 to launch a single jeans and music store called The Gap (named for "the generation gap") in San Francisco.
</p><p>
"Today we lost a friend, a mentor and a great visionary," said Glenn Murphy, CEO and Chairman of the Board of Gap Inc.  "Don and Doris took a simple idea and turned it into a brand recognized as a cultural icon throughout the world and changed the face of retail forever. "
</p><p>
<b>Solid Back to School performance at Old Navy</b>
</p><p>
Gap posted net sales of $1.12 billion for the month of August, a 2% dip from the year-prior total. Comparable store sales slipped by 3% year-over-year.
</p><p>
"During August, customers responded well to our denim collections at Gap and Old Navy," said Sabrina Simmons, chief financial officer of Gap Inc. "We were especially pleased by the progress at Old Navy and its strong back to school performance, which helped support total company merchandise margins significantly above last year."
</p><p>
Old Navy sales came in 4% above the previous year's total.
</p><p>
<b>Bullish Forecasts</b>
</p><p>
Analysts polled by Zacks are bullish on earnings. Current full-year estimates of $1.37 per share up 2 cents in just the past week. For the following year, the Zacks Consensus Estimate of $1.48 per share was also bumped up by 2 cents over the past week. 
</p><p>   
Gap boasts an impeccable record of exceeding earnings projections. Dating back to December 2004, the company topped the Zacks Consensus every time with the exception of 1 match.   
</p><p>
<b>A Strong Second Quarter Helped Push Shares Higher</b>
</p><p>
In mid-August, the company reported second-quarter earnings 33 cents per share, beating the Zacks Consensus Estimate by 3% and outpacing last year's 32 cents. 
</p><p>
Net sales of $3.25 billion came in below the previous year's $3.50 billion. Comparable store sales declined 10% year-over-year. Online sales, however, showed an increase of 17% from the year-prior.         
</p><p>
"We're proud to deliver second quarter earnings per share above last year, especially during a
challenging environment," said Glenn Murphy, chairman and chief executive officer of Gap Inc. "Building
upon two years of work improving our economic model, we're now putting further emphasis on changing
the trajectory of our top line performance. Our focus is to find the right balance between maintaining our
cost discipline and making appropriate, targeted investments to gain back market share."
</p><p>
Shares, which are nearing a 52-week high, climbed higher after delivering a stellar second quarter, outperforming the market by about 10%. For the past year, GPS is more than 20% ahead of the market.
</p><p> 
<b>GPS Stacks Up Well Against Industry Numbers</b>
</p><p>
Gap, a Zacks #1 Rank (Strong Buy), has a solid balance sheet, showing no debt. The company's return on equity of 21% nearly triples the industry average of 8%. Its net profit margin of 7% eclipses the industry average of 1%. Gap also offers an industry-leading dividend yield of 1.6%.  


  
<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/gap-inc-growth-and-income-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>September 28th CEOcast Weekly Newsletter</title>
		<link>http://www.straightstocks.com/investing-lessons/september-28th-ceocast-weekly-newsletter/</link>
		<comments>http://www.straightstocks.com/investing-lessons/september-28th-ceocast-weekly-newsletter/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 21:05:11 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Advanced Cell Technologies]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Baltimore]]></category>
		<category><![CDATA[Bank of America Securities;]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Canadian Agency]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[CEL-SCI Corporation]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[central nervous system diseases]]></category>
		<category><![CDATA[chief]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[Clinical Research Organization]]></category>
		<category><![CDATA[clinical trial protocol]]></category>
		<category><![CDATA[cloning]]></category>
		<category><![CDATA[cloud computing initiative;]]></category>
		<category><![CDATA[Colon Cancer]]></category>
		<category><![CDATA[D. C.]]></category>
		<category><![CDATA[Deutsche Bank]]></category>
		<category><![CDATA[disk drive]]></category>
		<category><![CDATA[enabling ;]]></category>
		<category><![CDATA[enabling technology;]]></category>
		<category><![CDATA[Enzo Biochem]]></category>
		<category><![CDATA[eye diseases]]></category>
		<category><![CDATA[fantasy sports]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[General Mills]]></category>
		<category><![CDATA[geographic  information systems]]></category>
		<category><![CDATA[governmental agency]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[health care products]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[high-rate production tools]]></category>
		<category><![CDATA[host immune systems]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Iceweb]]></category>
		<category><![CDATA[identification technologies]]></category>
		<category><![CDATA[identity security products;]]></category>
		<category><![CDATA[ImmunoCellular Therapeutics Ltd.;]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[IND]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[integrated biotechnology;]]></category>
		<category><![CDATA[Integrated Security Unit]]></category>
		<category><![CDATA[Intevac Inc;]]></category>
		<category><![CDATA[Investigational New Drug (IND)]]></category>
		<category><![CDATA[Investigational New Drug (IND) application]]></category>
		<category><![CDATA[investigational therapy]]></category>
		<category><![CDATA[Iplicity]]></category>
		<category><![CDATA[Ism]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[local governmental agencies]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Lou Gehrig]]></category>
		<category><![CDATA[magnetic media deposition equipment]]></category>
		<category><![CDATA[Maxim Group]]></category>
		<category><![CDATA[Michio Kaku]]></category>
		<category><![CDATA[municipal agencies]]></category>
		<category><![CDATA[National Eye Institute]]></category>
		<category><![CDATA[National Institute of Health]]></category>
		<category><![CDATA[NEI’s Laboratory]]></category>
		<category><![CDATA[neural cells]]></category>
		<category><![CDATA[Neuralstem;]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Nike]]></category>
		<category><![CDATA[Obama administration]]></category>
		<category><![CDATA[online]]></category>
		<category><![CDATA[OptiquelÃ]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[Pepsi Bottling]]></category>
		<category><![CDATA[PositiveID Corp]]></category>
		<category><![CDATA[principal investigator]]></category>
		<category><![CDATA[protein engineering]]></category>
		<category><![CDATA[radio frequency identification systems]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[Research-In-Motion]]></category>
		<category><![CDATA[Robert Lanza]]></category>
		<category><![CDATA[Robert Nussenblatt]]></category>
		<category><![CDATA[Rodman & Renshaw]]></category>
		<category><![CDATA[S&P]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Scottsdale]]></category>
		<category><![CDATA[small cell lung cancer]]></category>
		<category><![CDATA[solar cell technologies]]></category>
		<category><![CDATA[Sparta Commercial Services]]></category>
		<category><![CDATA[sports news]]></category>
		<category><![CDATA[Steel Vault]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[storage technology company specializing]]></category>
		<category><![CDATA[swine flu diagnostic]]></category>
		<category><![CDATA[swine flu diagnostic technology]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[Tampa]]></category>
		<category><![CDATA[the 2010 Vancouver Games]]></category>
		<category><![CDATA[The 2010 Winter Olympics]]></category>
		<category><![CDATA[Thomas Weisel Partners;]]></category>
		<category><![CDATA[treatment of a range of macular degenerative diseases]]></category>
		<category><![CDATA[treatment of brain and other cancers]]></category>
		<category><![CDATA[treatment of various eye diseases]]></category>
		<category><![CDATA[U.S. government;]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[uveitis]]></category>
		<category><![CDATA[vaccine developer]]></category>
		<category><![CDATA[VANCOUVER]]></category>
		<category><![CDATA[VeriChip Corporation]]></category>
		<category><![CDATA[virus detection technology]]></category>
		<category><![CDATA[Walgreen]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[WBAI 99.5 FM]]></category>
		<category><![CDATA[XsunX;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=18112</guid>
		<description><![CDATA[Companies featured in this edition of the newsletter: ACTC, CHIP, CUR, CVM, ENZ, IMUC, IWEB, SRCO, SVUL, XSNX
Markets finally snapped their winning streak last week, as weakness in housing markets and durable goods orders led to broad-based declines in all of the major indices.  All told, the Dow surrendered 155 points on the week [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/september-28th-ceocast-weekly-newsletter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/28/09, CCTR, UTX, DAL, QASP, WTWO, KBALB</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-92809-cctr-utx-dal-qasp-wtwo-kbalb/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-92809-cctr-utx-dal-qasp-wtwo-kbalb/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 16:46:05 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Ambassador]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Breast  Cancer Research Foundation]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[China Crescent Enterprises Inc.]]></category>
		<category><![CDATA[comfortable chair]]></category>
		<category><![CDATA[Delta Air Lines]]></category>
		<category><![CDATA[Deutsche Bank]]></category>
		<category><![CDATA[Diesel plant]]></category>
		<category><![CDATA[distinctive furniture solutions]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Kimball International Inc.]]></category>
		<category><![CDATA[Lockheed Martin]]></category>
		<category><![CDATA[Melissa Etheridge]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Pratt & Whitney Rocketdyne]]></category>
		<category><![CDATA[Quasar Aerospace Industries Inc.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sunfilter Algae Reactor plant]]></category>
		<category><![CDATA[United Technologies Corp]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[W2 Energy]]></category>
		<category><![CDATA[Whitney Rocketdyne]]></category>
		<category><![CDATA[WTWO]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3680</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday September 28, 2009
DrStockPick.com Stock Report!
**************************************************************
China Crescent  Enterprises, Inc. (OTCBB: CCTR) plans to release an exclusive Webcast  on its corporate website tomorrow, September 29th. The Webcast agenda features  details on recently announced plans to increase the Company&#8217;s 2009 revenue  forecast [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-92809-cctr-utx-dal-qasp-wtwo-kbalb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>XRX, PWRM, ABT, CSRH, CMCSA,  CVAT, FMCN,  DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/xrx-pwrm-abt-csrh-cmcsa-cvat-fmcn-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/xrx-pwrm-abt-csrh-cmcsa-cvat-fmcn-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 16:34:01 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[adult and pediatric pharmaceuticals]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Affiliated Computer Services Inc.]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[anemia]]></category>
		<category><![CDATA[anesthesia products]]></category>
		<category><![CDATA[ankylosing spondylitis;]]></category>
		<category><![CDATA[anti-infectives]]></category>
		<category><![CDATA[Argentina]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[cable services;]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemicals maker;]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Chinese Ministry of Commerce]]></category>
		<category><![CDATA[Comcast Corporation;]]></category>
		<category><![CDATA[communication products]]></category>
		<category><![CDATA[communications products]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[credit card transaction processing]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[Cupertino;]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[digital media]]></category>
		<category><![CDATA[digital out-of-home advertising networks]]></category>
		<category><![CDATA[document equipment]]></category>
		<category><![CDATA[document management services]]></category>
		<category><![CDATA[Dow Chemical]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[dyslipidemia;]]></category>
		<category><![CDATA[electronic transaction processing;]]></category>
		<category><![CDATA[endometriosis]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Financial Services]]></category>
		<category><![CDATA[Focus Media Holding Ltd.]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[health care products]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[HIV infection]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[hypothyroidism]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[Los Altos]]></category>
		<category><![CDATA[migraines;]]></category>
		<category><![CDATA[Milpitas]]></category>
		<category><![CDATA[mobile handset advertising]]></category>
		<category><![CDATA[Mountain View]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[out-of-home advertising network]]></category>
		<category><![CDATA[outdated technologies]]></category>
		<category><![CDATA[Palo Alto;]]></category>
		<category><![CDATA[payment processing industry]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[precocious puberty]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[psoriatic arthritis;]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Ricoh XR-X 3PF Film Camera;]]></category>
		<category><![CDATA[Roman Gordon]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Rafael]]></category>
		<category><![CDATA[Santa Clara]]></category>
		<category><![CDATA[Saratoga]]></category>
		<category><![CDATA[secondary hyperparathyroidism]]></category>
		<category><![CDATA[SINA Corporation;]]></category>
		<category><![CDATA[Solvay]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sunnyvale]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[technology solutions]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[transaction processing industries;]]></category>
		<category><![CDATA[transactional processing systems;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[uterine fibroids;]]></category>
		<category><![CDATA[Vacaville]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[www.alsbio.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.dow.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xerox Corp.;]]></category>
		<category><![CDATA[XRX]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3681</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday September 28, 2009
DrStockPick.com Stock Report!
XRX, PWRM, ABT, CSRH, CMCSA,  CVAT, FMCN
**************************************************************
XRX, Xerox Corp.
XRX engages in the development, manufacture, marketing, servicing, and financing of document equipment, software, solutions, and services worldwide.
XRX said Monday it will buy Affiliated Computer Services Inc. for $6.4 billion [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/xrx-pwrm-abt-csrh-cmcsa-cvat-fmcn-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cepheid (CPHD) Announces FDA-Clearance for Global Marketing of Blood Clot Test</title>
		<link>http://www.straightstocks.com/investing-lessons/cepheid-cphd-announces-fda-clearance-for-global-marketing-of-blood-clot-test/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cepheid-cphd-announces-fda-clearance-for-global-marketing-of-blood-clot-test/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 13:44:01 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[ACL TOP]]></category>
		<category><![CDATA[ACL TOP(R)]]></category>
		<category><![CDATA[Alan H.B. Wu]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Centers For Disease Control And Prevention]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[CEO of IL]]></category>
		<category><![CDATA[Cepheid]]></category>
		<category><![CDATA[chief]]></category>
		<category><![CDATA[deep vein thrombosis]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[GeneXpert System]]></category>
		<category><![CDATA[Instrumentation Laboratory]]></category>
		<category><![CDATA[John Bishop]]></category>
		<category><![CDATA[Josep Manent]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Pharmacogenomics Laboratories]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Francisco General Hospital]]></category>
		<category><![CDATA[thrombophilia]]></category>
		<category><![CDATA[thrombosis]]></category>
		<category><![CDATA[Trauma Center]]></category>
		<category><![CDATA[U.S. Food & Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[Xpert HemosIL FII]]></category>
		<category><![CDATA[Xpert(R) HemosIL]]></category>
		<category><![CDATA[Xpert(R) HemosIL(R) FII]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=18084</guid>
		<description><![CDATA[Cepheid, a diagnostics company focused on the biothreat market, last week made a joint announcement with Instrumentation Laboratory (IL), a worldwide developer, manufacturer and distributor of vitro-diagnostics instruments, reporting that Cepheid has received clearance from the U.S. Food &#38; Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII &#38; FV test.
According to the Centers for [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cepheid-cphd-announces-fda-clearance-for-global-marketing-of-blood-clot-test/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Citi to Trim U.S. Branches &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/citi-to-trim-u-s-branches-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/citi-to-trim-u-s-branches-analyst-blog/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 14:34:29 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Bank Of America Corporation]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[D. C.]]></category>
		<category><![CDATA[JP Morgan Chase & Co.]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[retail branch network]]></category>
		<category><![CDATA[retail footprint;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[U.S. government;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington Mutual]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25196/Citi+to+Trim+U.S.+Branches+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Citigroup, Inc.</strong> (<a href="http://www.zacks.com/stock/quote/c">C</a>) plans to scale back its U.S. retail footprint to just six major metropolitan areas and limit lending mostly to wealthy customers.<br />
<br />
Citigroup, one of the biggest recipients of government bailout money, is looking to limit its overall consumer lending in the U.S. primarily to credit cards and "jumbo" mortgages, catering largely to well-heeled customers.<br />
<br />
The company&#8217;s executives are expected to present their plans to the board of directors in October to trim the retail branch network and concentrate mainly on the New York, Washington, D.C., Miami, Chicago, San Francisco and Los Angeles areas.<br />
<br />
Citi has a global footprint with its branches located internationally. The company currently operates about 1,000 U.S. branches, significantly lower than the 5,000-plus run by <strong>Bank of America Corporation </strong>(<a href="http://www.zacks.com/stock/quote/bac">BAC</a>), <strong>Wells Fargo</strong> (<a href="http://www.zacks.com/stock/quote/wfc">WFC</a>) and <strong>JP Morgan Chase &#38; Co.</strong> (<a href="http://www.zacks.com/stock/quote/jpm">JPM</a>), which expanded its network with the takeover of Washington Mutual last year.<br />
<br />
Citi is also considering the sale of its 120 branches in Texas and is mulling whether it should maintain a major presence in cities like Boston and Philadelphia. Citi holds few deposits in those locations compared with competitors.<br />
<br />
Citigroup, once the largest U.S. bank by assets, fell behind last year after a series of acquisitions by rivals. The bank, hurt by billions of losses and writedowns of problem loans and toxic assets, had to be rescued twice in the last year by the U.S. government. The move to scale back its branch network in the U.S. could spark criticism in Washington, since the government owns a 34% of equity stake in Citigroup.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=C">Read the full analyst report on "C"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAC">Read the full analyst report on "BAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JPM">Read the full analyst report on "JPM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFC">Read the full analyst report on "WFC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/citi-to-trim-u-s-branches-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Newsweek Ranks Wells Fargo Greenest Bank in U.S.</title>
		<link>http://www.straightstocks.com/investing-lessons/newsweek-ranks-wells-fargo-greenest-bank-in-u-s/</link>
		<comments>http://www.straightstocks.com/investing-lessons/newsweek-ranks-wells-fargo-greenest-bank-in-u-s/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 13:00:00 +0000</pubDate>
		<dc:creator>Dawn Van Zant</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Newsweek]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>

		<guid isPermaLink="false">http://www.investorideas.com/News/092509b.asp</guid>
		<description><![CDATA[SAN FRANCISCO - September 25, 2009 - Wells Fargo  Company (NYSE:WFC) announced today that it ranks number one among banks and insurance companies - and thirteenth overall - in Newsweek magazine's inaugural Green Rankings of the country's 500-largest companies.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/newsweek-ranks-wells-fargo-greenest-bank-in-u-s/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott Labs Sees Positive Results &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/abbott-labs-sees-positive-results-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/abbott-labs-sees-positive-results-analyst-blog/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 19:27:48 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abbott Labs]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Boston Scientific]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[thrombosis]]></category>
		<category><![CDATA[vascular products]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25180/Abbott+Labs+Sees+Positive+Results+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Abbott Labs</strong> (<a href="http://www.zacks.com/stock/quote/abt">ABT</a>) presented results on XIENCE V Everolimus Eluting Coronary Stent System from the SPIRIT IV trial yesterday at the annual Transcatheter Cardiovascular Therapeutics conference in San Francisco.<br />
<br />
Results showed that XIENCE V achieved superiority in the key safety and efficacy measures of target lesion failure (TLF) and target lesion revascularization (TLR) compared to <strong>Boston Scientific&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/bsx">BSX</a>) Taxus Express2 Paclitaxel-Eluting Coronary Stent System at one year. The study was conducted with about 3,690 patients.<br />
<br />
XIENCE V demonstrated a statistically significant 38% reduction in TLF compared to Taxus. Target lesion failure occurred in 4.2% of the XIENCE V patients compared to 6.8% of the patients in the Taxus arm. XIENCE V also demonstrated a statistically significant 46% reduction in TLR compared to Taxus. Target lesion revascularization occurred in 2.5% of the XIENCE V patients compared to 4.6% of the patients in the Taxus arm.<br />
<br />
Importantly, XIENCE V demonstrated an impressive low rate of stent thrombosis (blood clots) at one year. XIENCE V demonstrated an observed 80% reduction in stent thrombosis compared to Taxus (0.17% for XIENCE V vs. 0.85% for Taxus) at one year. Risk of blood clots has been a cause of major concern for interventional cardiologists.<br />
<br />
While the above results reinforce the safety and effectiveness of XIENCE, we note that XIENCE failed to achieve statistical significance in a sub-group of diabetic patients. Diabetes patients are typically sicker and have more challenging artery diseases. Results showed that there was no difference in TLF between XIENCE V and Taxus at one year (6.4% for XIENCE V vs. 6.9% for Taxus). Statistically significant results in this sub-group would have helped XIENCE V gain additional share from Taxus.<br />
<br />
Following the launch of XIENCE V, Abbott has become a major player in the drug-eluting stent (DES) market, where it competes primarily with Taxus,<strong> Medtronic&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/mdt">MDT</a>) Endeavor, and <strong>Johnson &#38; Johnson&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/jnj">JNJ</a>) Cypher (sirolimus-eluting system) drug-eluting stents. Abbott's Vascular Products segment should continue posting robust growth mainly due to the strong performance of XIENCE V. We have a Neutral rating on Abbott.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ABT">Read the full analyst report on "ABT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BSX">Read the full analyst report on "BSX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MDT">Read the full analyst report on "MDT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JNJ">Read the full analyst report on "JNJ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/abbott-labs-sees-positive-results-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Taubman Writes Down Asset Values &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/taubman-writes-down-asset-values-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/taubman-writes-down-asset-values-analyst-blog/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 20:12:22 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Denver]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[J. C. Penney Co. Inc.]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Orlando]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[Pier Shops]]></category>
		<category><![CDATA[Retail shopping]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sears Holding Corp.]]></category>
		<category><![CDATA[Tampa]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington DC]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25135/Taubman+Writes+Down+Asset+Values+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Taubman Centers Inc.</strong> (<a href="http://www.zacks.com/stock/quote/TCO">TCO</a>) recently said it would record impairment charges of $161 million to $169 million in the third quarter. The real estate investment trust is writing down book values of its The Pier Shops at Caesars asset in New Jersey and Regency Square in Virginia to fair values due to the continued economic downturn.
<p align="left">The Pier Shops at Caesars is a 282,000 square feet shopping center in which Taubman owns a 77.5% stake. The company considers net operating income from the property to be insufficient to repay its $135 million non-recourse mortgage debt. Thus, it will write down book value of the asset by $106 million to $111 million, out of which Taubman has a share of about $100 million to $105 million.</p>
<p align="left">Regency Square is an 820,000 square feet shopping center housing leading fashion retailers like <strong>Macy&#8217;s Inc.</strong> (<a href="http://www.zacks.com/stock/quote/M">M</a>), <strong>J. C. Penney Co. Inc.</strong> (<a href="http://www.zacks.com/stock/quote/JCP">JCP</a>) and <strong>Sears Holding Corp.</strong> (<a href="http://www.zacks.com/stock/quote/SHLD">SHLD</a>). Taubman anticipates cash flow from the property to be hurt by the decline in its net operating income and necessary capital expenditures. It is accordingly writing down book value of the asset by $55 million to $58 million to approximately $30 million.</p>
<p align="left">Taubman owns, develops, acquires and operates regional and super-regional shopping centers throughout the U.S. and Asia. Retail shopping centers spanning over 400,000 square feet of gross leaseable area (GLA) are generally referred to as regional shopping centers, while those with GLA in excess of 800,000 square feet are called super-regional shopping centers. A large number of these shopping centers are strategically located in major metropolitan areas, including Los Angeles, San Francisco, Denver, Detroit, Phoenix, Miami, Dallas, Tampa, Orlando and Washington DC.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TCO">Read the full analyst report on "TCO"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=M">Read the full analyst report on "M"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JCP">Read the full analyst report on "JCP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SHLD">Read the full analyst report on "SHLD"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taubman-writes-down-asset-values-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>FIG, ETLY,  DrStockPick.com Watch List! for Wednesday September 23, 2009, Fortress Investment Group LLC and ECOtality Inc., ETLY.OB</title>
		<link>http://www.straightstocks.com/stock-watch/fig-etly-drstockpick-com-watch-list-for-wednesday-september-23-2009-fortress-investment-group-llc-and-ecotality-inc-etly-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/fig-etly-drstockpick-com-watch-list-for-wednesday-september-23-2009-fortress-investment-group-llc-and-ecotality-inc-etly-ob/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 23:25:55 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Charging Systems]]></category>
		<category><![CDATA[Charlotte]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[ECOtality Inc.]]></category>
		<category><![CDATA[electric technologies;]]></category>
		<category><![CDATA[electric vehicle charging equipment]]></category>
		<category><![CDATA[ETLY]]></category>
		<category><![CDATA[Fortress Investment Group Llc]]></category>
		<category><![CDATA[Frankfurt]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[leading global alternative asset manager]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Munich]]></category>
		<category><![CDATA[New Canaan]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[Rome]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[shanghai]]></category>
		<category><![CDATA[Shenzhen Goch Investment Ltd.]]></category>
		<category><![CDATA[storage ;]]></category>
		<category><![CDATA[storage technologies]]></category>
		<category><![CDATA[Sydney]]></category>
		<category><![CDATA[Tokyo]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.ecotality.com]]></category>
		<category><![CDATA[www.fortressinv.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3582</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
DrStockPick.com Watch List!
My Picks for Wednesday September 23, 2009, are:
**************************************************************
FIG, Fortress Investment Group LLC
FIG is a leading global alternative asset manager with approximately $31.0 billion in assets under management (fee paying) as of June 30, 2009. FIG is headquartered in New York and has [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fig-etly-drstockpick-com-watch-list-for-wednesday-september-23-2009-fortress-investment-group-llc-and-ecotality-inc-etly-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Positive Data on Abbott&#8217;s XIENCE V &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/positive-data-on-abbotts-xience-v-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/positive-data-on-abbotts-xience-v-analyst-blog/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 19:44:06 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abbott;]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Boston Scientific]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[vascular products]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25084/Positive+Data+on+Abbott%27s+XIENCE+V+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Yesterday, <strong>Abbott</strong> (<a href="http://www.zacks.com/stock/quote/ABT">ABT</a>) presented positive long-term data on the XIENCE V Everolimus Eluting Coronary Stent System from the pivotal SPIRIT III study conducted in the U.S.
<p>Results showed that clinical advantages associated with the use of XIENCE V continued to increase compared to <strong>Boston Scientific</strong>'s (<a href="http://www.zacks.com/stock/quote/BSX">BSX</a>) Taxus Express2 Paclitaxel-Eluting Coronary Stent System.</p>
<p>At three years, XIENCE V demonstrated a reduction in the risk of major adverse cardiac events (9.1% for XIENCE V compared to 15.7% for Taxus). XIENCE V also demonstrated a reduction in the risk of Target Lesion Failure (8.3% for XIENCE V versus 14.4% for Taxus), a reduction in the risk of Target Vessel Failure (13.5% for XIENCE V compared to 19.2% for Taxus) and a reduction in the risk of heart attacks (3.7% for XIENCE V compared to 6.3% for Taxus).</p>
<p>These results were presented at the 2009 Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. The new data should support further uptake of the product, which has helped Abbott become a major player in the drug-eluting stent (DES) market.</p>
<p>XIENCE V has been taking significant domestic and international share from Taxus, <strong>Medtronic</strong>'s (<a href="http://www.zacks.com/stock/quote/MDT">MDT</a>) Endeavor, and <strong>Johnson &#38; Johnson</strong>'s (<a href="http://www.zacks.com/stock/quote/JNJ">JNJ</a>) Cypher (sirolimus-eluting system) drug-eluting stents.</p>
<p>Abbott is currently working on a next-generation drug-coated stent called XIENCE PRIME. PRIME is already available in Europe and other countries throughout Asia-Pacific and Latin America, and is currently in a large scale clinical program called SPIRIT PRIME in the U.S. If approved, PRIME could hit the U.S. market in the first half of 2012.</p>
<p>Abbott's Vascular Products segment should continue posting robust growth mainly due to the strong performance of XIENCE V. We have a Neutral rating on Abbott.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ABT">Read the full analyst report on "ABT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BSX">Read the full analyst report on "BSX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MDT">Read the full analyst report on "MDT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JNJ">Read the full analyst report on "JNJ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/positive-data-on-abbotts-xience-v-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tetra Tech Gets Govt. Orders &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/tetra-tech-gets-govt-orders-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/tetra-tech-gets-govt-orders-analyst-blog/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 19:15:11 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[dck/TtEC LLC]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[GMAC]]></category>
		<category><![CDATA[Navy]]></category>
		<category><![CDATA[pollution prevention and sustainable water infrastructure]]></category>
		<category><![CDATA[program management;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[services addressing resource management]]></category>
		<category><![CDATA[Shaw Group Inc.]]></category>
		<category><![CDATA[Tetra Tech]]></category>
		<category><![CDATA[U.S. Department of Defense]]></category>
		<category><![CDATA[URS Corp]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/25082/Tetra+Tech+Gets+Govt.+Orders+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Tetra Tech Inc.</strong> (<a href="http://www.zacks.com/stock/quote/TTEK">TTEK</a>) recently won a $25 million contract for providing technical support to several programs run by the US Environmental Protection Agency in the Pacific Southwest Region Water Division.
<p align="left">During the five-year term of the agreement, Tetra Tech will support pollution prevention and sustainable water infrastructure activities associated with the Clean Water Act, the Marine Protection and Sanctuaries Research Act and the Safe Drinking Water Act.</p>
<p align="left">The company also received a $13.1 million contract from the Navy for a sanitary sewer system, storm drain removal and other services at Hunters Point Shipyard in San Francisco. This project is expected to be completed by March 2011.</p>
<p align="left">Tetra Tech said that the dck/TtEC LLC was one of four contractors awarded a global multiple-award construction (GMAC) contract with the U.S. Navy. The indefinite delivery contract has a shared ceiling value of $900 million, with one base year and four option years. The dck/TtEC LLC combines Tetra Tech&#8217;s resources with those of dck worldwide, a global construction company. The GMAC includes design-build and design-bid-build projects at US Department of Defense installations worldwide.</p>
<p align="left">Tetra Tech is a leading provider of consulting, engineering, program management, construction and technical services addressing resource management and infrastructure markets. The company supports government and commercial clients by providing innovative solutions focused on water, environment and energy. With more than 10,000 employees worldwide, Tetra Tech&#8217;s capabilities span the entire project life cycle. Its major competitors include <strong>Shaw Group Inc.</strong> (<a href="http://www.zacks.com/stock/quote/SHAW">SHAW</a>) and <strong>URS Corp.</strong> (<a href="http://www.zacks.com/stock/quote/URS">URS</a>).</p>
<p align="left">We currently have a Neutral recommendation on the stock.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TTEK">Read the full analyst report on "TTEK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SHAW">Read the full analyst report on "SHAW"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=URS">Read the full analyst report on "URS"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/tetra-tech-gets-govt-orders-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>KWK, DSTI, GTLA,  DrStockPick.com Watch List! for Tuesday September 22, 2009, Quicksilver Resources Inc., DayStar Technologies, Inc. and GT Legend Automotive Holdings Inc., GTLA.PK</title>
		<link>http://www.straightstocks.com/stock-watch/kwk-dsti-gtla-drstockpick-com-watch-list-for-tuesday-september-22-2009-quicksilver-resources-inc-daystar-technologies-inc-and-gt-legend-automotive-holdings-inc-gtla-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/kwk-dsti-gtla-drstockpick-com-watch-list-for-tuesday-september-22-2009-quicksilver-resources-inc-daystar-technologies-inc-and-gt-legend-automotive-holdings-inc-gtla-pk/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 03:14:49 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[American Benevolent Association]]></category>
		<category><![CDATA[British Columbia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Chinese Benevolent Association]]></category>
		<category><![CDATA[crude oil exploration]]></category>
		<category><![CDATA[DayStar Technologies Inc.]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[DSTI]]></category>
		<category><![CDATA[EPOD Solar Inc.]]></category>
		<category><![CDATA[Fujien American Benevolent Association]]></category>
		<category><![CDATA[GT Legend Automotive Holdings Inc.]]></category>
		<category><![CDATA[GTLA]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Peter Alan Lacey]]></category>
		<category><![CDATA[Quicksilver Resources Inc.;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Shale Gas]]></category>
		<category><![CDATA[solar photovoltaic products;]]></category>
		<category><![CDATA[Sovereign Transfer Services Corp.]]></category>
		<category><![CDATA[thin-film deposition]]></category>
		<category><![CDATA[thin-film deposition technology]]></category>
		<category><![CDATA[unconventional natural gas reserves]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.DayStarTech.com]]></category>
		<category><![CDATA[www.qrinc.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3552</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
DrStockPick.com Watch List!
My Picks for Tuesday September 22, 2009, are:
**************************************************************
KWK, Quicksilver Resources Inc.
KWK is a natural gas and crude oil exploration and production company engaged in the development and acquisition of long-lived, unconventional natural gas reserves, including coalbed methane, shale gas, and tight sands [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/kwk-dsti-gtla-drstockpick-com-watch-list-for-tuesday-september-22-2009-quicksilver-resources-inc-daystar-technologies-inc-and-gt-legend-automotive-holdings-inc-gtla-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSCO, PWRM, CVAT, CSRH, PER, ABT, DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/csco-pwrm-cvat-csrh-per-abt-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/csco-pwrm-cvat-csrh-per-abt-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Mon, 21 Sep 2009 20:04:21 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Biofuels]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cisco Systems Inc]]></category>
		<category><![CDATA[Columbia]]></category>
		<category><![CDATA[Columbia University Medical Center]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[Dell Inc]]></category>
		<category><![CDATA[Desmet Ballestra Group]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[edible oil]]></category>
		<category><![CDATA[electronic transaction processing;]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Financial Services]]></category>
		<category><![CDATA[financial services solutions]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[green energy technology]]></category>
		<category><![CDATA[Gregg W. Stone]]></category>
		<category><![CDATA[H. Ross Perot;]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Heart Attack]]></category>
		<category><![CDATA[Hewlett-Packard Co.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[information ;]]></category>
		<category><![CDATA[Information Technology]]></category>
		<category><![CDATA[information technology services]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Internet Protocol]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[Myocardial Infarction]]></category>
		<category><![CDATA[Nano Cavitation Reactor]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[PER]]></category>
		<category><![CDATA[Perot Systems Corp .]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Professor of Medicine]]></category>
		<category><![CDATA[Reactor]]></category>
		<category><![CDATA[Reactor technology]]></category>
		<category><![CDATA[renewable energy projects]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sarix(TM)]]></category>
		<category><![CDATA[Schneider Electric]]></category>
		<category><![CDATA[shares services]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[technology agreement]]></category>
		<category><![CDATA[technology services]]></category>
		<category><![CDATA[technology solutions]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Thailand]]></category>
		<category><![CDATA[Trans Screen Group]]></category>
		<category><![CDATA[transaction processing industries;]]></category>
		<category><![CDATA[transactional processing systems;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil industry]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.desmetballestra.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3547</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday September 21, 2009
DrStockPick.com Stock Report!
 CSCO, PWRM, CVAT, CSRH, PER, ABT
**************************************************************
CSCO, Cisco Systems, Inc.
CSCO designs, manufactures, and sells Internet Protocol (IP)-based networking and other products to the communications and IT industry worldwide.
Pelco by Schneider Electric, and CSCO  today announced a strategic technology [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/csco-pwrm-cvat-csrh-per-abt-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Merck, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Abbott Labs &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-merck-bristol-myers-squibb-gilead-sciences-glaxosmithkline-and-abbott-labs-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-merck-bristol-myers-squibb-gilead-sciences-glaxosmithkline-and-abbott-labs-press-releases/#comments</comments>
		<pubDate>Fri, 18 Sep 2009 13:45:10 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abbott Labs]]></category>
		<category><![CDATA[Aids]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Antimicrobial Agents and Chemotherapy]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Bristol Myers Squibb]]></category>
		<category><![CDATA[Centers For Disease Control And Prevention]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[efavirenz]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Gilead Sciences]]></category>
		<category><![CDATA[Glaxosmithkline]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Isentress]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[new infections]]></category>
		<category><![CDATA[Peaceful Trading - Vlad Moraru]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Treatment Of Hiv]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24992/Zacks+Analyst+Blog+Highlights%3A+Merck%2C+Bristol-Myers+Squibb%2C+Gilead+Sciences%2C+GlaxoSmithKline+and+Abbott+Labs+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; September 18, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Merck </strong>(<a href="void(0)">MRK</a>), <strong>Bristol-Myers Squibb </strong>(<a href="void(0)">BMY</a>), <strong>Gilead Sciences </strong>(<a href="void(0)">GILD</a>), <strong>GlaxoSmithKline </strong>(<a href="void(0)">GSK</a>) and <strong>Abbott Labs </strong>(<a href="void(0)">ABT</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left">Here are highlights from Thursday&#8217;s <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><strong>Approval for Merck's Isentress</strong></p>
<p align="left">The European Union (EU) recently expanded the approval of <strong>Merck&#8217;s </strong>(<a href="void(0)">MRK</a>) Isentress (raltegravir) for the first line treatment of HIV patients. Earlier, it was approved for patients who had not responded to other treatment options. In the US, following a recent Food and Drug Administration (FDA) approval, Isentress can be used in combination therapy for previously untreated patients as well.</p>
<p align="left">Isentress recorded worldwide sales of $172 million for the second quarter of 2009, an increase of 123% compared with the year-ago period. We believe the recent FDA and EU approval (for previously untreated patients) could increase the number of targeted patients considerably, leading to a significant rise in sales. We expect the drug to record more than $1 billion in revenues by 2011.</p>
<p align="left">Recently, at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held at San Francisco, Merck presented data from a study comparing Isentress with <strong>Bristol-Myers Squibb&#8217;s </strong>(<a href="void(0)">BMY</a>) Sustiva (efavirenz) for 96 weeks in 563 previously untreated HIV patients. Patients who entered the study were required to have HIV viral loads greater than 5000 copies/mL.</p>
<p align="left">The study found that treatment with Isentress resulted in similar virologic control as witnessed with patients treated with an efavirenz-based combination treatment. About 81% of the patients assigned to the raltegravir treatment arm had undetectable levels (below 50 copies/mL) of circulating HIV RNA compared to the 79% of patients treated with efavirenz.</p>
<p align="left">According to the Centers for Disease Control and Prevention (CDC), in 2006 there were more than one million people in US living with HIV and AIDS. An estimated 33 million people are living with HIV and AIDS worldwide, and about 2.7 million new infections occurred worldwide in 2007. AIDS is one of the top causes of infectious disease-related mortality worldwide, responsible for approximately two million deaths in 2007 alone.</p>
<p align="left"><strong>Gilead Sciences </strong>(<a href="void(0)">GILD</a>), Bristol-Myers Squibb, <strong>GlaxoSmithKline </strong>(<a href="void(0)">GSK</a>) and <strong>Abbott Labs </strong>(<a href="void(0)">ABT</a>) are the major players in this segment.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-merck-bristol-myers-squibb-gilead-sciences-glaxosmithkline-and-abbott-labs-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cousins to Record Charge in Q3 &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/cousins-to-record-charge-in-q3-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/cousins-to-record-charge-in-q3-analyst-blog/#comments</comments>
		<pubDate>Tue, 15 Sep 2009 19:10:10 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[bank of america corp]]></category>
		<category><![CDATA[Charlotte]]></category>
		<category><![CDATA[general corporate purposes]]></category>
		<category><![CDATA[J P Morgan]]></category>
		<category><![CDATA[JPMorgan Chase & Co.]]></category>
		<category><![CDATA[leasing and management services]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[property manager]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[retail landlords]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Underwriter]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington DC]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24847/Cousins+to+Record+Charge+in+Q3+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Real estate investment trust <strong>Cousins Properties Inc.</strong> (<a href="http://www.zacks.com/stock/quote/CUZ">CUZ</a>) recently said it would record an impairment charge of $39 million, or 74 cents per share, in the third quarter relating to its joint venture interest in Terminus 200. This 565,000 square feet office building in Atlanta, in which Cousins holds a 50% stake, was completed last month.
<p align="left">The company said the impairment charge would not impact its ownership interest in the project and it would continue to be the property manager and leasing agent of the asset.</p>
<p align="left">In a separate development, Cousins announced a public offering of 32 million common shares and an underwriter option to purchase an additional 4.8 million shares. The company plans to use the proceeds to repay its debt under the revolving credit facility and for general corporate purposes. J. P. Morgan of <strong>JPMorgan Chase &#38; Co.</strong> (<a href="http://www.zacks.com/stock/quote/JPM">JPM</a>), <strong>Bank of America Corp.</strong> (<a href="http://www.zacks.com/stock/quote/BAC">BAC</a>) and <strong>Morgan Stanley</strong> (<a href="http://www.zacks.com/stock/quote/MS">MS</a>) are the joint book-running managers for the offering.</p>
<p align="left">Cousins acquires, finances, develops, manages and leases office, retail and industrial properties throughout the U.S., including Atlanta, Charlotte, Austin, San Francisco, Los Angeles and Washington DC. The company also provides leasing and management services to third-party investors.</p>
<p align="left">Market fundamentals are deteriorating for office and retail landlords throughout the country due to the continued economic downturn. With high market vacancies and no job growth, rental rate growth on new leases will also be non-existent for some time. Consequently, with no short-term growth indicators, we expect continued volatility in the sector.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CUZ">Read the full analyst report on "CUZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAC">Read the full analyst report on "BAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MS">Read the full analyst report on "MS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JPM">Read the full analyst report on "JPM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cousins-to-record-charge-in-q3-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hot Stocks: Motorola Throws Hat Into Smartphone Ring</title>
		<link>http://www.straightstocks.com/market-commentary/hot-stocks-motorola-throws-hat-into-smartphone-ring/</link>
		<comments>http://www.straightstocks.com/market-commentary/hot-stocks-motorola-throws-hat-into-smartphone-ring/#comments</comments>
		<pubDate>Tue, 15 Sep 2009 17:21:43 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Android]]></category>
		<category><![CDATA[App Store]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[Avian Securities LLC]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[Carl Ichan;]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Cliq]]></category>
		<category><![CDATA[Cliq smartphone]]></category>
		<category><![CDATA[communication devices;]]></category>
		<category><![CDATA[communications]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Deutsche Telecom AG]]></category>
		<category><![CDATA[electronics maker]]></category>
		<category><![CDATA[Facebook Inc.;]]></category>
		<category><![CDATA[fashionable and useful high-tech gadget]]></category>
		<category><![CDATA[Google Inc]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Iphone]]></category>
		<category><![CDATA[Ipod]]></category>
		<category><![CDATA[Mark Sue;]]></category>
		<category><![CDATA[Matt Thornton]]></category>
		<category><![CDATA[Maynard Um]]></category>
		<category><![CDATA[Mobile Phones]]></category>
		<category><![CDATA[Motorola Inc.]]></category>
		<category><![CDATA[Myspace]]></category>
		<category><![CDATA[News Corp]]></category>
		<category><![CDATA[operating system]]></category>
		<category><![CDATA[Razr]]></category>
		<category><![CDATA[Razr  clamshell-style phone]]></category>
		<category><![CDATA[RBC Capital Markets Corp.;]]></category>
		<category><![CDATA[Research In Motion Ltd]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sanjay Jha]]></category>
		<category><![CDATA[social networking content]]></category>
		<category><![CDATA[T-Mobile USA Inc.]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[Twitter Inc.]]></category>
		<category><![CDATA[Ubs Ag]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[Verizon Wireless;]]></category>
		<category><![CDATA[Videocon Industries Ltd.]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[wireless carriers]]></category>
		<category><![CDATA[wireless phones]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=20554</guid>
		<description><![CDATA[pMotorola Inc. (NYSE: a href="http://www.google.com/finance?q=NYSE:MOT"MOT/a) last Thursday charmed  investors when it revealed its Cliq smartphone, which will compete head on with  Apple Inc.’s (Nasdaq: a href="http://www.google.com/finance?q=AAPL"AAPL/a)  iPhone and a href="http://www.google.com/finance?q=RIM"Research in Motion  Ltd./a’s Blackberry./p
pMotorola’s stock is up nearly 12% since the announcement, as investors are hoping the new phone will be enough to win back some of the company’s lost market share./p
pHowever, saving Motorola’s mobile division – which the company plans to spin off – is a daunting task. The company – which invented the cell phone, as well as a plethora of other communication devices used by police and military – has seen its global market share of wireless phones fall to 2% in its second quarter this year from 31% in#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/hot-stocks-motorola-throws-hat-into-smartphone-ring/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>September 14th CEOcast Weekly Newsletter</title>
		<link>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/september-14th-ceocast-weekly-newsletter/</link>
		<comments>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/september-14th-ceocast-weekly-newsletter/#comments</comments>
		<pubDate>Mon, 14 Sep 2009 21:16:48 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Adobe Systems]]></category>
		<category><![CDATA[Amnon Gonenne]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[balance sheet financing solutions]]></category>
		<category><![CDATA[Best Buy]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology publications]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[CEL-SCI Corporation]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[central nervous system diseases]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[Enzo Biochem]]></category>
		<category><![CDATA[Enzo Clinical Labs]]></category>
		<category><![CDATA[Enzo Labs]]></category>
		<category><![CDATA[Enzo Life Sciences]]></category>
		<category><![CDATA[Fedex]]></category>
		<category><![CDATA[fulfillment services]]></category>
		<category><![CDATA[genetic engineering]]></category>
		<category><![CDATA[Goldman Sachs Communacopia Conference]]></category>
		<category><![CDATA[Green Planet Bioengineering]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Head of Science and Innovation Portfolio Development]]></category>
		<category><![CDATA[health care products]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[healthcare groups]]></category>
		<category><![CDATA[healthcare industry experts]]></category>
		<category><![CDATA[Healthcare Services]]></category>
		<category><![CDATA[Henderson]]></category>
		<category><![CDATA[Highland Ridge Hospital]]></category>
		<category><![CDATA[Highland Ridge PHC]]></category>
		<category><![CDATA[identification tools]]></category>
		<category><![CDATA[identity security products;]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[ImmunoCellular Therapeutics Ltd.;]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[integrated biotechnology;]]></category>
		<category><![CDATA[Jefferies & Co. Technology]]></category>
		<category><![CDATA[Jianou Lvjian FoodsStuff Co. Ltd]]></category>
		<category><![CDATA[JP Morgan Diversified Industries]]></category>
		<category><![CDATA[MabCure Inc.]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[Mohan Chellani]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[Nasdaq 100]]></category>
		<category><![CDATA[Neuralstem;]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[ONE Holdings]]></category>
		<category><![CDATA[Oracle]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[PALM]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PHC Inc.]]></category>
		<category><![CDATA[philadelphia fed]]></category>
		<category><![CDATA[PositiveID Corporation]]></category>
		<category><![CDATA[potential solutions]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[RBC Capital Markets]]></category>
		<category><![CDATA[Roche Group;]]></category>
		<category><![CDATA[Salt Lake City]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Senior Management]]></category>
		<category><![CDATA[senior manager]]></category>
		<category><![CDATA[Seven Hills Behavioral Institute]]></category>
		<category><![CDATA[Steel Vault]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[Therapeutic Applications]]></category>
		<category><![CDATA[ThinkEquity;]]></category>
		<category><![CDATA[Thomas Weisel Partners;]]></category>
		<category><![CDATA[three day Deutsche Bank Securities Technology]]></category>
		<category><![CDATA[Toronto]]></category>
		<category><![CDATA[Trade Finance Solutions]]></category>
		<category><![CDATA[transplantation]]></category>
		<category><![CDATA[treatment of brain and other cancers]]></category>
		<category><![CDATA[Treatment Of Cancer]]></category>
		<category><![CDATA[treatment of infectious diseases]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[UBS]]></category>
		<category><![CDATA[United States Patent Office]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Utah]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[VeriChip Corp.]]></category>
		<category><![CDATA[Veteran’s Administration]]></category>
		<category><![CDATA[Vice President of Scientific Affairs]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=17807</guid>
		<description><![CDATA[Companies featured in this edition of the newsletter: CUR, CVM, ENZ, IMUC, MBCI, ONEZ, PHC, SVUL
Markets finished in positive territory yet again during this holiday shortened week despite the lack of any significant developments on either the corporate or economic fronts.  All told, the Dow gained 164 points to close at 9605, up 1.7% [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/small-cap-and-micro-cap-stocks/september-14th-ceocast-weekly-newsletter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/14/09, OPTR, NBY, SCS, CHH, GEOY, SEP</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91409-optr-nby-scs-chh-geoy-sep/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91409-optr-nby-scs-chh-geoy-sep/#comments</comments>
		<pubDate>Mon, 14 Sep 2009 19:26:11 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[anniversary of  GeoEye-1]]></category>
		<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Antimicrobial Agents and Chemotherapy]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Choice Hotels International Inc;]]></category>
		<category><![CDATA[clinical investigator]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Daily Dividends]]></category>
		<category><![CDATA[diarrhea]]></category>
		<category><![CDATA[Dollar Thrifty Automotive Group]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[fungal infections]]></category>
		<category><![CDATA[Geoeye Inc]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Greenwich]]></category>
		<category><![CDATA[Gregory J. Rizzo]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[Master Limited]]></category>
		<category><![CDATA[National Association of Publicly  Traded Partnerships]]></category>
		<category><![CDATA[NovaBay Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Optimer Pharmaceuticals Inc;]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[Robert  Steffen]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Spectra Energy Partners LP;]]></category>
		<category><![CDATA[Steelcase Inc]]></category>
		<category><![CDATA[travel agent]]></category>
		<category><![CDATA[travel agents]]></category>
		<category><![CDATA[U.S.  Environmental Protection Agency]]></category>
		<category><![CDATA[Vandenberg Air Force Base]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3384</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Monday September 14, 2009



**************************************************************

Optimer  Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the presentation  of results from its second prulifloxacin Phase 3 clinical study for the  treatment of infectious diarrhea in travelers, by clinical investigator Robert  Steffen, M.D., at the annual Interscience Conference on Antimicrobial Agents and  Chemotherapy (ICAAC) [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91409-optr-nby-scs-chh-geoy-sep/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FRX Presents Encouraging Data &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/frx-presents-encouraging-data-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/frx-presents-encouraging-data-analyst-blog/#comments</comments>
		<pubDate>Mon, 14 Sep 2009 15:35:29 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Antimicrobial Agents and Chemotherapy]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[ceftaroline]]></category>
		<category><![CDATA[ceftriaxone]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Forest Laboratories Inc.;]]></category>
		<category><![CDATA[Forest Laboratories;]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pneumonia]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[structure infections;]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24766/FRX+Presents+Encouraging+Data+-+Analyst+Blog</guid>
		<description><![CDATA[<p>We are pleased to hear that <strong>Forest Laboratories</strong> (<a href="http://www.zacks.com/stock/quote/FRX">FRX</a>) presented encouraging data from its phase III trial of ceftaroline for the treatment of community-acquired pneumonia (CAP) in hospitalized patients. The company presented new data from two multicenter studies &#8211; FOCUS 1 and FOCUS 2 &#8211; at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. In addition to CAP, ceftaroline is also being studied for complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria.</p>
<p>The randomized, double-blind trial compared ceftaroline with ceftriaxone in hospitalized adult patients with moderate to severe CAP. Following both the trials, it was found that patients treated with ceftaroline demonstrated a better cure rate (84.3%) compared to those treated with ceftriaxone (77.7%). In addition, the overall microbiological response rate in the microbiologically evaluable (ME) population was 87% for ceftaroline and 81% for ceftriaxone, while in the microbiological modified intent-to-treat (MITT) population it was 84.8% for ceftaroline and 80.4% for ceftriaxone. <br />
<br />
Based on the positive result, Forest expects to file a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for ceftaroline for the treatment of both cSSSI and CAP by year end.</p>
<p>Earlier, in August, Forest entered into a deal with <strong>AstraZeneca </strong>(<a href="http://www.zacks.com/stock/quote/AZN">AZN</a>) for ceftaroline. The contract involves co-development and commercialization of the drug in all markets other than the U.S. , Canada and Japan . We believe the deal to be quite beneficial for Forest as the company will receive substantial funds from its partner through signing fee, royalties from sales and payments tied to certain specific sales milestones.</p>
<p>On approval, ceftaroline will have to face tough competition from several players especially from <strong>Pfizer</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/PFE">PFE</a>) Zyvox and <strong>Wyeth</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/WYE">WYE</a>) Tygacil. The latest drug to get FDA approval for the treatment of infection caused by gram-positive bacteria is <strong>Theravance</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/THRX">THRX</a>) Vibativ. There are many pipeline candidates as well, including <strong>Johnson &#38; Johnson</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/JNJ">JNJ</a>) ceftobiprole.</p>
<p>We are concerned about longer-term growth of Forest, especially towards the beginning of the next decade when Lexapro, which accounts for over half of the company&#8217;s top line, gets exposed to generic competition. That puts a lot of pressure on the pipeline to come through.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FRX">Read the full analyst report on "FRX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WYE">Read the full analyst report on "WYE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=THRX">Read the full analyst report on "THRX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JNJ">Read the full analyst report on "JNJ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/frx-presents-encouraging-data-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fed’s Fake Recovery</title>
		<link>http://www.straightstocks.com/market-commentary/fed%e2%80%99s-fake-recovery/</link>
		<comments>http://www.straightstocks.com/market-commentary/fed%e2%80%99s-fake-recovery/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 19:47:45 +0000</pubDate>
		<dc:creator>Bill Bonner</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[ben bernanke]]></category>
		<category><![CDATA[Bernanke & Co.]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[hair stylist]]></category>
		<category><![CDATA[Janet Yellen]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[monetary stimulus]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President of San Francisco branch]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[Tim Geithner;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Treasury]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=20519</guid>
		<description><![CDATA[pThe press attributed this week’s rise in gold to benign causes. The end of the world seems to have been postponed – indefinitely. emBloomberg/em reported that a clear majority of those polled thought the world economy was recovering./p
pWith no more fear of the deflation devil investors feel they are in the arms of angels. Surely Ben Bernanke watches over them even when they sleep. Even the President of the United States thinks he saved the nation./p
pstrongAs for Tim Geithner, he takes no chances; he sings his own praises./strong Speaking to a gathering of the G20, he congratulated them all:/p
p“…facing the greatest challenge to the world economy in generations, the G-20 gathered here in London and committed to an unprecedented program of policies to#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/fed%e2%80%99s-fake-recovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/11/09, CMI, GENZ, PBI, HPQ, WG, XRX</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91109-cmi-genz-pbi-hpq-wg-xrx/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91109-cmi-genz-pbi-hpq-wg-xrx/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 17:30:06 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[CAMMS223]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cummins Inc]]></category>
		<category><![CDATA[digital color printing]]></category>
		<category><![CDATA[Digital print systems]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[European Committee for Treatment and Research]]></category>
		<category><![CDATA[Genzyme Corporation]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Governor]]></category>
		<category><![CDATA[graphic communications event]]></category>
		<category><![CDATA[Group Vice President]]></category>
		<category><![CDATA[Hangzhou Public Transit Group]]></category>
		<category><![CDATA[Hp]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[Mitch Daniels;]]></category>
		<category><![CDATA[MS therapy]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[New England Journal]]></category>
		<category><![CDATA[Pitney Bowes Inc.;]]></category>
		<category><![CDATA[print technology]]></category>
		<category><![CDATA[Print;]]></category>
		<category><![CDATA[production color  printing system]]></category>
		<category><![CDATA[Rebif]]></category>
		<category><![CDATA[relapsing-remitting multiple sclerosis;]]></category>
		<category><![CDATA[Research in Multiple Sclerosis]]></category>
		<category><![CDATA[Ricoh XR-X 3PF Film Camera;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Steve Chapman]]></category>
		<category><![CDATA[technical officer]]></category>
		<category><![CDATA[the New England Journal of Medicine]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Willbros Group Inc;]]></category>
		<category><![CDATA[Xerox Corporation;]]></category>
		<category><![CDATA[Zhejiang]]></category>
		<category><![CDATA[Zhejiang provincial government]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3359</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Friday September 11, 2009



**************************************************************

How Cummins Inc.  (NYSE:CMI) and its Chinese customers cooperate in developing and using  clean power was highlighted this week during a visit from Indiana Gov. Mitch  Daniels, who is leading an Indiana delegation on a six-day visit to China. The  governor was joined by representatives [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-91109-cmi-genz-pbi-hpq-wg-xrx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, Power 3 Medical Products Inc. and  STEM, StemCells, Inc., Tracking The Footprints of Disease</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-power-3-medical-products-inc-and-stem-stemcells-inc-tracking-the-footprints-of-disease/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-power-3-medical-products-inc-and-stem-stemcells-inc-tracking-the-footprints-of-disease/#comments</comments>
		<pubDate>Thu, 10 Sep 2009 17:52:08 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advance on-line publication]]></category>
		<category><![CDATA[analytic technology]]></category>
		<category><![CDATA[Batten Disease;]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cell culture media products]]></category>
		<category><![CDATA[cell-based technologies]]></category>
		<category><![CDATA[Children’s Hospital]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[HuCNS]]></category>
		<category><![CDATA[HuCNS-SC]]></category>
		<category><![CDATA[HuCNS-SC® product candidate]]></category>
		<category><![CDATA[lead product candidate]]></category>
		<category><![CDATA[Myelination Disorder]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[neurodegenerative disorders;]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[neuronal ceroid lipofuscinosis]]></category>
		<category><![CDATA[NuroPro PD]]></category>
		<category><![CDATA[Pelizaeus-Merzbacher Disease]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[StemCells]]></category>
		<category><![CDATA[StemCells Inc.]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Transgenomic Inc.;]]></category>
		<category><![CDATA[treatment of two fatal neurodegenerative disorders]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stemcellsinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3331</guid>
		<description><![CDATA[PWRM, Power 3 Medical Products Inc, PWRM.OB
STEM, StemCells, Inc.
DrStockPick.com Report!









Dr Stock Pick HOT News &#38; Alerts!
PWRM, Power 3 Medical Products Inc. and STEM, StemCells, Inc., Tracking
The Footprints of Disease






&#160;


Thursday September 10, 2009
**************************************************************
STEM, StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
STEM is focused on the development and commercialization of cell-based technologies. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-power-3-medical-products-inc-and-stem-stemcells-inc-tracking-the-footprints-of-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News for September 10, 2009 &#8211; Corporate Summary</title>
		<link>http://www.straightstocks.com/stock-watch/company-news-for-september-10-2009-corporate-summary/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-news-for-september-10-2009-corporate-summary/#comments</comments>
		<pubDate>Thu, 10 Sep 2009 14:19:03 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[Bp]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[disney]]></category>
		<category><![CDATA[Hsbc]]></category>
		<category><![CDATA[Ipod]]></category>
		<category><![CDATA[JP-Morgan]]></category>
		<category><![CDATA[Mcdonalds]]></category>
		<category><![CDATA[Monsanto]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Texas Instruments]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[VIVUS]]></category>
		<category><![CDATA[Yahoo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24643/Company+News+for+September+10%2C+2009+-+Corporate+Summary</guid>
		<description><![CDATA[<p align="justify">&#8226; McDonald's (NYSE:MCD), reported August same-store-sales rose 2.2%, but noted US comps were up a less-than-expected 1.7%, noting rising unemployment levels and increased competition from price-cutting rivals hurt revenues</p>
<p align="justify">&#8226; Apple's (NASDAQ:AAPL) San Francisco event once again saw the shares move lower, this year off 1%, despite the welcome appearance of Jobs, and iPod price cuts and improvements.  An 8 GB iPod Nano will include built-in video and an FM radio; price cuts of as much as $120 were made.  This morning JP Morgan (NYSE:JPM) upped its rating on Apple to "outperform" from "market perform," with a $200 price target</p>
<p align="justify">&#8226; Texas Instruments (NYSE:TXN) raised its third quarter earnings and sales guidance, with third quarter guidance increased to 37 cents to 41 cents a share from prior range of 29 cents to 39 cents a share; revenues guidance was lifted to $2.73 billion to $2.87 billion from prior $2.5 billion to $2.8 billion, with estimates at $$2.68 billion</p>
<p align="justify">&#8226; Vivus (NASDAQ:VVUS) noted its experimental obesity drug showed dramatic results in two late-stage clinical trials</p>
<p align="justify">&#8226; Disney (NYSE:DIS) reported improvements in local ad markets with increased activity from automakers nationally, although still anticipating lower theme park hotel bookings for the September quarter</p>
<p align="justify">&#8226; Monsanto (NYSE:MON) said it continues to see 2009 results from continuing operations at the lower end of its prior guidance of $4.40-$4.50; the Street has expected $4.41. For 2010 the company expects $3.10-$3.30, off consensus estimates of $4.12</p>
<p align="justify">&#8226; Yahoo (NASDAQ:YHOO) shares were upgraded by Bank of America (NYSE:BAC) to "buy," with a price target hike to $19 from $17</p>
<p align="justify">&#8226; BP (NYSE:BP) shares were lowered to "neutral" by analysts at HSBC (NYSE:HBC). The company's Tiber Field, last week's "giant discovery" 9km beneath the Gulf seabed, is unofficially estimated to contain 500m-1 billion recoverable barrels of oil</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-news-for-september-10-2009-corporate-summary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 9/09/09, BEHL, FTGX, SAAS, ES, SLE, PCG</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-90909-behl-ftgx-saas-es-sle-pcg/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-90909-behl-ftgx-saas-es-sle-pcg/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 18:41:00 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[agent optimization tools]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bio-Diesel manufacturing facility]]></category>
		<category><![CDATA[BioCentric Energy Holdings Inc.;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[Dow Jones Sustainability North  America]]></category>
		<category><![CDATA[Dow Jones Sustainability World]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[EnergySolutions Inc.]]></category>
		<category><![CDATA[ENVIROTEK]]></category>
		<category><![CDATA[FiberNet Telecom Group Inc.]]></category>
		<category><![CDATA[inContact]]></category>
		<category><![CDATA[Internet beginning]]></category>
		<category><![CDATA[Market Leader]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[North Las  Vegas]]></category>
		<category><![CDATA[Omni San Francisco Hotel]]></category>
		<category><![CDATA[on-demand contact center software]]></category>
		<category><![CDATA[PG&E Corporation]]></category>
		<category><![CDATA[Philip Strawbridge]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[sara lee corp]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[www.inContact.com]]></category>
		<category><![CDATA[www.saralee.com]]></category>
		<category><![CDATA[Zayo Group LLC]]></category>
		<category><![CDATA[Zayo Merger Sub Inc.]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3297</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Wednesday September 9, 2009



**************************************************************

BIOCENTRIC ENERGY  HOLDINGS, INC. (PINKSHEETS: BEHL) ANNOUNCES: The company today agreed  to a joint venture with California-based ENVIROTEK (PINKSHEETS: INCL) for the  construction and development of a Bio-Diesel manufacturing facility in North Las  Vegas, Nevada.

FiberNet Telecom  Group, Inc. (Nasdaq: FTGX) today announced that at [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-90909-behl-ftgx-saas-es-sle-pcg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News for September 9, 2009 &#8211; Corporate Summary</title>
		<link>http://www.straightstocks.com/stock-watch/company-news-for-september-9-2009-corporate-summary/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-news-for-september-9-2009-corporate-summary/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 14:14:59 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Dupont]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Illinois Tool Works;]]></category>
		<category><![CDATA[Ipod]]></category>
		<category><![CDATA[JP-Morgan]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[PALM]]></category>
		<category><![CDATA[PRE]]></category>
		<category><![CDATA[Pre smartphone]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Talbots;]]></category>
		<category><![CDATA[Ups]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24588/Company+News+for+September+9%2C+2009+-+Corporate+Summary</guid>
		<description><![CDATA[<p align="justify">&#8226; A JP Morgan (NYSE:JPM) estimated the adverse impact of possible regulatory reform may lower investment banks' long-term profitability by almost one-third, resulting in further job eliminations and bonus cuts. Hardest hit will be Morgan Stanley (NYSE:MS) and Goldman Sachs (NYSE:GS), according to the report</p>
<p align="justify">&#8226; Talbots (NYSE:TLB) reported an adjusted fiscal second quarter loss of 33 cents a share, versus estimates of a 52 cents per share loss on revenues of $304.6 million, versus estimates of $309.34 million.  The firm said it sees third quarter losses of 24-30 cents a share, ex-items</p>
<p align="justify">&#8226; JP Morgan (NYSE:JPM) upgraded UPS (NYSE:UPS) to "overweight" from "neutral" and raised the price target on the firm to $70 from $57</p>
<p align="justify">&#8226; Goldman Sachs (NYSE:GS) downgraded DuPont (NYSE:DD) on valuation concerns with a price target of $32</p>
<p align="justify">&#8226; Goldman Sachs (NYSE:GS) upped Illinois Tool Works (NYSE:ITW) and added the firm to its Conviction Buy List with a $55 price target</p>
<p align="justify">&#8226; Palm (NASDAQ:PALM) cut prices on its Pre smartphone, introducing a cheaper and thinner model, "Pixi"</p>
<p align="justify">&#8226; Apple's (NASDAQ:AAPL) San Francisco event is expected to see a fresh iPod launch, new iTune offerings, an Apple TV tune-up, with hopes of a Steve Jobs appearance</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-news-for-september-9-2009-corporate-summary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GenVec’s TNFerade Nears NDA Status (NASDAQ:GNVC)</title>
		<link>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/</link>
		<comments>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 06:06:14 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[adenovector delivery]]></category>
		<category><![CDATA[adenovector delivery technology]]></category>
		<category><![CDATA[adenovector technology]]></category>
		<category><![CDATA[adenovector vaccine candidate]]></category>
		<category><![CDATA[adenovirus]]></category>
		<category><![CDATA[Agricultural Research Service]]></category>
		<category><![CDATA[Allergy]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[and Lead Investment Analyst]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Antigenics Inc.]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[Associate Professor]]></category>
		<category><![CDATA[balance disorders]]></category>
		<category><![CDATA[bank of america corp]]></category>
		<category><![CDATA[Barclays]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[care for patients with balance disorders]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[clinical disease]]></category>
		<category><![CDATA[Dendreon Corporation;]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[Douglas J. Swirsky]]></category>
		<category><![CDATA[esophageal cancer]]></category>
		<category><![CDATA[Executive Vice President]]></category>
		<category><![CDATA[Executive Vice President of Research and Development]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fibrosis;]]></category>
		<category><![CDATA[Food Supply]]></category>
		<category><![CDATA[foot-and-mouth disease]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Gaithersburg;]]></category>
		<category><![CDATA[gene expression]]></category>
		<category><![CDATA[gene therapy]]></category>
		<category><![CDATA[GenVec Inc.]]></category>
		<category><![CDATA[Head And Neck Cancer]]></category>
		<category><![CDATA[hearing loss;]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Laszlo Zsak]]></category>
		<category><![CDATA[lead therapeutic product candidate]]></category>
		<category><![CDATA[locally advanced pancreatic cancer]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[manager]]></category>
		<category><![CDATA[Marvin Grubman]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[meat products]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[multi-purpose products]]></category>
		<category><![CDATA[National Institute of Allergy]]></category>
		<category><![CDATA[National Institute of Allergy and Infectious Diseases of the National Institutes of Health]]></category>
		<category><![CDATA[Naval Medical Research Center]]></category>
		<category><![CDATA[necrosis]]></category>
		<category><![CDATA[Oncologix Inc.]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[parasitic disease]]></category>
		<category><![CDATA[Patrick Swazy]]></category>
		<category><![CDATA[Paul H. Fischer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Ph.D.]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Plum Island Animal Disease Center]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[Professor of Human Oncology]]></category>
		<category><![CDATA[Q1]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[rectal cancer]]></category>
		<category><![CDATA[Researchers of the Livestock Sciences]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Royce Micro]]></category>
		<category><![CDATA[SAIC-Frederick Inc.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[second-generation vaccine candidate]]></category>
		<category><![CDATA[Spartan Micro]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[Steve Jobs]]></category>
		<category><![CDATA[targeted radiation therapy]]></category>
		<category><![CDATA[therapy for locally advanced pancreatic cancer]]></category>
		<category><![CDATA[TherAtoh]]></category>
		<category><![CDATA[TNFerade;]]></category>
		<category><![CDATA[TNFerade™;]]></category>
		<category><![CDATA[transcriptional start site]]></category>
		<category><![CDATA[treatment of inoperable]]></category>
		<category><![CDATA[treatment of locally advanced pancreatic cancer;]]></category>
		<category><![CDATA[treatment of pancreatic cancer]]></category>
		<category><![CDATA[treatment of various cancers;]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[U.S. Department  of Agriculture]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California at San Francisco]]></category>
		<category><![CDATA[University of California Irvine  Comprehensive Digestive Disease Center]]></category>
		<category><![CDATA[University of Denver]]></category>
		<category><![CDATA[University Of Wisconsin]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[USDA]]></category>
		<category><![CDATA[vaccine candidate]]></category>
		<category><![CDATA[Vaccine Research Center]]></category>
		<category><![CDATA[Vaccine Research Center/National Institute]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Vice President and Chief Financial Officer]]></category>
		<category><![CDATA[Vice President of Research and Development]]></category>
		<category><![CDATA[Wisconsin]]></category>
		<category><![CDATA[Yahoo]]></category>
		<category><![CDATA[yale]]></category>
		<category><![CDATA[Yale University School of Medicine]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=465</guid>
		<description><![CDATA[GenVec, Inc.
(Public, NASDAQ:GNVC)
StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PennyOmega.com Stock Report! 9/08/09, ARRS, BXG, RFMD, AWSR, EPD, MIDSX</title>
		<link>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90809-arrs-bxg-rfmd-awsr-epd-midsx/</link>
		<comments>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90809-arrs-bxg-rfmd-awsr-epd-midsx/#comments</comments>
		<pubDate>Tue, 08 Sep 2009 16:42:57 +0000</pubDate>
		<dc:creator>PennyOmega.com</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3rd Annual Technology]]></category>
		<category><![CDATA[America West Resources Inc.]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[ARRIS]]></category>
		<category><![CDATA[Barclays Capital]]></category>
		<category><![CDATA[Bluegreen Corporation]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chairman & CEO]]></category>
		<category><![CDATA[Colorful Places]]></category>
		<category><![CDATA[compliant coal producer]]></category>
		<category><![CDATA[continuous miner]]></category>
		<category><![CDATA[domestic compliant coal producer]]></category>
		<category><![CDATA[Enterprise Products Partners L. P.]]></category>
		<category><![CDATA[executive vice president and Chief Financial Officer]]></category>
		<category><![CDATA[Horizon Mine]]></category>
		<category><![CDATA[Mandarin Oriental Hotel]]></category>
		<category><![CDATA[Microsoft Vista]]></category>
		<category><![CDATA[Midas Fund]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[PennyOmega.com]]></category>
		<category><![CDATA[Peoria]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[Portfolio Manager]]></category>
		<category><![CDATA[re-starting mining activities]]></category>
		<category><![CDATA[related new mining equipment]]></category>
		<category><![CDATA[RF Micro Devices Inc.]]></category>
		<category><![CDATA[Robert Stanzione]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[telecommunications]]></category>
		<category><![CDATA[ThinkEquity;]]></category>
		<category><![CDATA[Tom Winmill]]></category>
		<category><![CDATA[W. Randall (Randy) Fowler]]></category>

		<guid isPermaLink="false">http://pennyomega.com/?p=912</guid>
		<description><![CDATA[<p>&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;</p>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90809-arrs-bxg-rfmd-awsr-epd-midsx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Orders for Jacobs &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/new-orders-for-jacobs-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-orders-for-jacobs-analyst-blog/#comments</comments>
		<pubDate>Thu, 03 Sep 2009 18:30:56 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[airport operator]]></category>
		<category><![CDATA[Bournemouth]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[construction management services]]></category>
		<category><![CDATA[construction services]]></category>
		<category><![CDATA[East Midlands]]></category>
		<category><![CDATA[Fluor Corp]]></category>
		<category><![CDATA[Foster Wheeler AG;]]></category>
		<category><![CDATA[Humberside]]></category>
		<category><![CDATA[Jacobs Engineering Group Inc]]></category>
		<category><![CDATA[Manchester]]></category>
		<category><![CDATA[Manchester Airports Group]]></category>
		<category><![CDATA[professional engineering services]]></category>
		<category><![CDATA[psychiatric emergency services]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Francisco General Hospital]]></category>
		<category><![CDATA[services]]></category>
		<category><![CDATA[Trauma Center]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24457/New+Orders+for+Jacobs+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Jacobs Engineering Group Inc.</strong> (<a href="http://www.zacks.com/stock/quote/JEC">JEC</a>) announced that it received a new framework to deliver a range of professional engineering services to the <strong>Manchester Airports Group</strong> (<a href="http://www.zacks.com/stock/quote/MAG">MAG</a>) in the United Kingdom.<br />
MAG owns and operates four regional airports - Manchester, East Midlands, Bournemouth and Humberside - making it the second largest airport operator in the U.K.</p>
<p>Jacobs will provide airfield civil engineering, and mechanical and electrical engineering for MAG's building stock, including both airport facilities and non airport-related developments. Jacobs is the exclusive provider of these services.</p>
<p>The company also received a contract from the City and County of San Francisco, California, to provide construction management services for the San Francisco General Hospital and Trauma Center Rebuild Program.</p>
<p>The rebuild was approved by San Francisco voters in November 2008. They authorized the City and County to finance the project with $887.4 million general obligation bonds.</p>
<p>The San Francisco General Hospital and Trauma Center Rebuild Program will replace the existing hospital building with a facility that complies with the state's seismic safety requirements. San Francisco General Hospital and Trauma Center is the sole provider of trauma and psychiatric emergency services for the City and County of San Francisco. A comprehensive medical center, SFGH serves some 100,000 patients per year and provides 20 percent of the city's inpatient care.<br />
 <br />
Jacobs, with annual revenues exceeding $12 billion, is one of the world's largest and most diverse providers of technical, professional, and construction services. Its major competitors are <strong>Foster Wheeler AG</strong> (<a href="http://www.zacks.com/stock/quote/FWLT">FWLT</a>) and <strong>Fluor Corp.</strong> (<a href="http://www.zacks.com/stock/quote/FLR">FLR</a>).</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JEC">Read the full analyst report on "JEC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MAG">Read the full analyst report on "MAG"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FWLT">Read the full analyst report on "FWLT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FLR">Read the full analyst report on "FLR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-orders-for-jacobs-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Apple Inc., Palm, Nokia, Motorola and Research in Motion &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-apple-inc-palm-nokia-motorola-and-research-in-motion-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-apple-inc-palm-nokia-motorola-and-research-in-motion-press-releases/#comments</comments>
		<pubDate>Thu, 03 Sep 2009 13:15:26 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[digital camera]]></category>
		<category><![CDATA[Ipod]]></category>
		<category><![CDATA[iTunes media management software]]></category>
		<category><![CDATA[iTunes online store]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[media event]]></category>
		<category><![CDATA[Motorola]]></category>
		<category><![CDATA[online store]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[Research-In-Motion]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Steve Jobs]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24434/Zacks+Analyst+Blog+Highlights%3A+Apple+Inc.%2C+Palm%2C+Nokia%2C+Motorola+and+Research+in+Motion+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; September 3, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Apple Inc. </strong>(<a href="void(0)">AAPL</a>), <strong>Palm </strong>(<a href="void(0)">PALM</a>), <strong>Nokia </strong>(<a href="void(0)">NOK</a>), <strong>Motorola </strong>(<a href="void(0)">MOT</a>) and <strong>Research in Motion </strong>(<a href="void(0)">RIMM</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left">Here are highlights from Wednesday&#8217;s <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><strong>Apple's New iPod</strong></p>
<p align="left"><strong>Apple Inc. </strong>(<a href="void(0)">AAPL</a>) is expected to unveil a new line up of iPod portable music players for the holiday period when it will hold a special media event in San Francisco on Sept 9. Apple declined to name the products.</p>
<p align="left">It is widely believed that Apple will use the event to announce major updates to the iPod Touch, the classic iPod and the iPod Nano. The upgrades could include adding a digital camera to the devices, while the iPod Touch could also be augmented with a video camera. No updates to iPod Shuffle are expected.</p>
<p align="left">Apple is also expected to provide an update to the iTunes media management software at the event. Rumor has it that Steve Jobs may appear for the first time at the event after he returned to Apple from his temporary leave of absence.</p>
<p align="left">Apple&#8217;s resurgence has been driven by the tremendous success of its iPod portable music and video players and iTunes online store. Apple unveiled the iPod nano in 2005, which was followed by the launch of iPod Touch in 2007. Apple&#8217;s iPod remains popular, as evident from the 6% increase in unit shipments to 54.8 million in fiscal 2008 compared to 2007.</p>
<p align="left">However, growth in the digital music player market may slow down as the core market becomes saturated. Apple suffered declining year-over-year sales of its iPods in the first nine months of 2009 as demand fell due to global recession. The company could sell only 44.1 million iPods during the first nine months of 2009. iPod revenues were down 13.0%.</p>
<p align="left">Apple faces significant competition from <strong>Palm </strong>(<a href="void(0)">PALM</a>), <strong>Nokia </strong>(<a href="void(0)">NOK</a>), <strong>Motorola </strong>(<a href="void(0)">MOT</a>) and <strong>Research in Motion </strong>(<a href="void(0)">RIMM</a>) in all areas of its business.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-apple-inc-palm-nokia-motorola-and-research-in-motion-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AMB Makes Big Lease in Paris &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/amb-makes-big-lease-in-paris-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/amb-makes-big-lease-in-paris-analyst-blog/#comments</comments>
		<pubDate>Wed, 02 Sep 2009 20:50:33 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AMB Property Corporation]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[highway network]]></category>
		<category><![CDATA[industrial real estate]]></category>
		<category><![CDATA[integrated logistics services]]></category>
		<category><![CDATA[leading global owner]]></category>
		<category><![CDATA[Lincoln Electric Holdings Inc]]></category>
		<category><![CDATA[Necotrans Group]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[Port of Rouen]]></category>
		<category><![CDATA[real estate investment trust]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Schenker France]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24414/AMB+Makes+Big+Lease+in+Paris+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>AMB Property Corporation</strong> (<a href="http://www.zacks.com/stock/quote/amb">AMB</a>), a leading real estate investment trust (REIT), has recently signed a leasing agreement for approximately 65,000 square feet in Paris. The deal was signed with <strong>Lincoln Electric Holdings Inc.</strong> (<a href="http://www.zacks.com/stock/quote/leco">LECO</a>), a leading welding equipment manufacturing company.<br />
<br />
With the deal, the facility at AMB Port of Rouen spanning 275,000 square feet is now fully leased. AMB had earlier leased 210,000 square feet of space at the site to Schenker France, one of the leading international providers of integrated logistics services, and Necotrans Group, another premier logistics company.<br />
<br />
Port of Rouen is strategically located at a prime location and provides immediate access to major centers of commerce in the region through highway network, a dense railway system and two major airports at Roissy and Orly. Lincoln Electric intends to utilize these transportation facilities to strengthen its position in the market. The leased facility is also located in close proximity of its French headquarters.<br />
<br />
Based in San Francisco, AMB is a leading global owner, operator and developer of industrial real estate in North America, Asia and Europe. By the end of the second quarter of 2009, AMB had more than 14 million square feet of operating and development facilities in Europe, out of which 4.8 million square feet was located in France.<br />
<br />
Industry focused REITs have been one of the worst performing sectors in 2009. With a sagging global GDP, demand for industrial space continues to dry up. However, AMB is better equipped than its peers to weather the current downturn due to its strong portfolio and continued leasing activities.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMB">Read the full analyst report on "AMB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LECO">Read the full analyst report on "LECO"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amb-makes-big-lease-in-paris-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Apple iPods  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/new-apple-ipods-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-apple-ipods-analyst-blog/#comments</comments>
		<pubDate>Wed, 02 Sep 2009 17:30:09 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[digital camera]]></category>
		<category><![CDATA[Ipod]]></category>
		<category><![CDATA[iTunes media management software]]></category>
		<category><![CDATA[iTunes online store]]></category>
		<category><![CDATA[media event]]></category>
		<category><![CDATA[Motorola]]></category>
		<category><![CDATA[online store]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[Research-In-Motion]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Steve Jobs]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24392/New+Apple+iPods++-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Apple Inc.</strong> (<a href="http://www.zacks.com/stock/quote/AAPL">AAPL</a>) is expected to unveil a new line up of iPod portable music players for the holiday period when it will hold a special media event in San Francisco on Sept 9. Apple declined to name the products.<br />
 <br />
It is widely believed that Apple will use the event to announce major updates to the iPod Touch, the classic iPod and the iPod Nano. The upgrades could include adding a digital camera to the devices, while the iPod Touch could also be augmented with a video camera. No updates to iPod Shuffle are expected.<br />
 <br />
Apple is also expected to provide an update to the iTunes media management software at the event. Rumor has it that Steve Jobs may appear for the first time at the event after he returned to Apple from his temporary leave of absence.<br />
 <br />
Apple&#8217;s resurgence has been driven by the tremendous success of its iPod portable music and video players and iTunes online store. Apple unveiled the iPod nano in 2005, which was followed by the launch of iPod Touch in 2007. Apple&#8217;s iPod remains popular, as evident from the 6% increase in unit shipments to 54.8 million in fiscal 2008 compared to 2007.<br />
 <br />
However, growth in the digital music player market may slow down as the core market becomes saturated. Apple suffered declining year-over-year sales of its iPods in the first nine months of 2009 as demand fell due to global recession. The company could sell only 44.1 million iPods during the first nine months of 2009. iPod revenues were down 13.0%.<br />
 <br />
Apple faces significant competition from <strong>Palm</strong> (<a href="http://www.zacks.com/stock/quote/PALM">PALM</a>), <strong>Nokia</strong> (<a href="http://www.zacks.com/stock/quote/NOK">NOK</a>), <strong>Motorola</strong> (<a href="http://www.zacks.com/stock/quote/MOT">MOT</a>) and <strong>Research in Motion</strong> (<a href="http://www.zacks.com/stock/quote/RIMM">RIMM</a>) in all areas of its business.<br />
 <br />
To revamp the slowing demand, updates to the company&#8217;s iPod line will be a major driver. We expect a growth in more advanced iPod Touch units in the next few quarters. We believe the event will be quite important as Apple&#8217;s new product launches will be a thing to watch out for.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AAPL">Read the full analyst report on "AAPL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PALM">Read the full analyst report on "PALM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NOK">Read the full analyst report on "NOK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MOT">Read the full analyst report on "MOT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=RIMM">Read the full analyst report on "RIMM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-apple-ipods-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PennyOmega.com Stock Report! 9/01/09, MTSC, DVN, ISLN, RTN, NTRI, FCS</title>
		<link>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90109-mtsc-dvn-isln-rtn-ntri-fcs/</link>
		<comments>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90109-mtsc-dvn-isln-rtn-ntri-fcs/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 16:04:41 +0000</pubDate>
		<dc:creator>PennyOmega.com</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[aerospace applications]]></category>
		<category><![CDATA[consumer products]]></category>
		<category><![CDATA[Dahlewitz]]></category>
		<category><![CDATA[Devon Energy Corporation]]></category>
		<category><![CDATA[Fairchild Semiconductor;]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[industrial/embedded systems]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Led]]></category>
		<category><![CDATA[Leslie Sansone]]></category>
		<category><![CDATA[mechanical test equipment]]></category>
		<category><![CDATA[Minox FC-S Flash;]]></category>
		<category><![CDATA[Moscone Center;]]></category>
		<category><![CDATA[MTS Systems Corporation]]></category>
		<category><![CDATA[NutriSystem Inc]]></category>
		<category><![CDATA[online capacity optimization solutions]]></category>
		<category><![CDATA[PennyOmega.com]]></category>
		<category><![CDATA[Raytheon Company;]]></category>
		<category><![CDATA[Rolls-Royce Mechanical Test Operations Centre]]></category>
		<category><![CDATA[Rolls-Royce;]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[storage optimization solution]]></category>
		<category><![CDATA[Storwize]]></category>
		<category><![CDATA[Taiwan]]></category>
		<category><![CDATA[U.S. Army Aviation and Missile Command]]></category>
		<category><![CDATA[ultra-portable devices]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://pennyomega.com/?p=867</guid>
		<description><![CDATA[<p>&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;</p>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-90109-mtsc-dvn-isln-rtn-ntri-fcs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News for September 1, 2009 &#8211; Corporate Summary</title>
		<link>http://www.straightstocks.com/stock-watch/company-news-for-september-1-2009-corporate-summary/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-news-for-september-1-2009-corporate-summary/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 14:28:10 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Aig]]></category>
		<category><![CDATA[Amazon.com]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[Boeing]]></category>
		<category><![CDATA[CEO and CFO]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Credit Suisse]]></category>
		<category><![CDATA[Dreamliner]]></category>
		<category><![CDATA[Ebay]]></category>
		<category><![CDATA[google]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Ipod]]></category>
		<category><![CDATA[media event]]></category>
		<category><![CDATA[Nokia]]></category>
		<category><![CDATA[Robert W. Baird]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Skype]]></category>
		<category><![CDATA[Sony]]></category>
		<category><![CDATA[undisclosed buyer;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wal Mart]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24314/Company+News+for+September+1%2C+2009+-+Corporate+Summary</guid>
		<description><![CDATA[<p align="justify">&#8226; The head of Boeing's (NYSE:BA) aircraft division announced plans to retire, following last week's long-awaited release of its Dreamliner schedule</p>
<p align="justify">&#8226; AIG (NYSE:AIG) and its former CEO and CFO have reportedly agreed to terms of binding arbitration in settling claims from shareholders regarding lost investments due to financial restatements</p>
<p align="justify">&#8226; Apple (NASDAQ:AAPL) will host a September 9, music-themed media event in San Francisco, expected to include a new iPod line, with a Beatles' catalogue available on its iTunes store</p>
<p align="justify">&#8226; Sony (NYSE:SNE) will distribute Google's (NASDAQ:GOOG) Chrome browser on its Vaio PCs</p>
<p align="justify">&#8226; Media reports said Bank of America (NYSE:BAC) is planning to repay part of the $45 billion in government aid recovered from TARP, beginning with a $20 billion repayment.  The move would remove its status as a recipient of "exceptional aid," allowing certain government oversight measures to be lifted</p>
<p align="justify">&#8226; EBay (NASDAQ:EBAY) is expected to announce plans to sell its Skype Internet calling division to private investors.  The company has said it wants about $2 billion for the unit</p>
<p align="justify">&#8226; Wal-Mart (NYSE:WMT) began website sales of merchandise not carried in its stores in a revenue-sharing exchange similar to Amazon.com's (NASDAQ:AMZN)</p>
<p align="justify">&#8226; Citigroup (NYSE:C) said its sold $1.3 billion in credit-card assets to an undisclosed buyer.  Terms of the sale were also not revealed</p>
<p align="justify">&#8226; Credit Suisse cut its Nokia (NYSE:NOK) rating to "underperform" from "outperform," and removed the company from its focus list.  The firm also cut its estimate for 2010 by 28%. Credit Suisse expects Nokia to lose smart phone market share next year</p>
<p align="justify">&#8226; Robert W. Baird upped its price target for Wells Fargo (NYSE:WFC) to $33 from $30</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-news-for-september-1-2009-corporate-summary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prince Alwaleed Remains Richest Saudi</title>
		<link>http://www.straightstocks.com/investing-in-energy-markets/prince-alwaleed-remains-richest-saudi/</link>
		<comments>http://www.straightstocks.com/investing-in-energy-markets/prince-alwaleed-remains-richest-saudi/#comments</comments>
		<pubDate>Sat, 29 Aug 2009 17:01:00 +0000</pubDate>
		<dc:creator>Michael E. Brisky</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Abdulaziz Al-Saud]]></category>
		<category><![CDATA[Airbus A380]]></category>
		<category><![CDATA[Alwaleed bin Talal]]></category>
		<category><![CDATA[Alwaleed Remains Richest]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[billionaire]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[businessman]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[Dubai]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Fahd]]></category>
		<category><![CDATA[Forbes]]></category>
		<category><![CDATA[FULL]]></category>
		<category><![CDATA[king]]></category>
		<category><![CDATA[Kingdom Holding Co.]]></category>
		<category><![CDATA[lower oil prices]]></category>
		<category><![CDATA[Media Assets]]></category>
		<category><![CDATA[Menlo College]]></category>
		<category><![CDATA[michael brisky]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[News Corp]]></category>
		<category><![CDATA[Persian Gulf]]></category>
		<category><![CDATA[Prince]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Riyadh]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Saudi Arabia]]></category>
		<category><![CDATA[Time Warner Inc.;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">tag:blogger.com,1999:blog-819581243324579563.post-110738121857279604</guid>
		<description><![CDATA[As an investor I've always been interested in, Prince Alwaleed carries an interesting story. His Citigroup investment has been well documented, first as a wild success, and then, well we all know what happened to Citigroup in 2008. I read his biography and reviewed it awhile back (a href="http://briskycapital.blogspot.com/2007/11/book-review-alwaleed-by-riz-khan.html"Click here to read review and purchase book/a).br /br /Today, I found a a href="http://www.bloomberg.com/apps/news?pid=20601087amp;sid=aGiKNISJrIkc"piece from Bloomberg /agiving us an update on how he has survived the recession. So far, it looks like he's done well:br /br /br /blockquotepAug. 29 (Bloomberg) -- Prince Alwaleed bin Talal, Citigroup Inc.’s largestbr /individual investor, was ranked the richest Saudi national by Arabian Business,br /even after losing 4.6 percent of his personal wealth in the past year.br /br /Alwaleed’s assets are valued at $16.3 billion, compared with $17.1 billionbr /last year, the Dubai-based magazine said today in its 2009 Saudi Rich List,br /citing the accounts of Kingdom Holding Co., the prince’s investment company.br /br /The global credit crisis, lower oil prices and a decline in demand for crude have hurt investment and energy companies operating in Saudi Arabia. Kingdom Holding’s second-quarter profit slumped 83 percent as returns on Alwaleed’s investments in stock markets and hotels fell.br /br /“Today, some of his more ambitious investments are showing the strain ofbr /the global economic slowdown,” Arabian Business said. “The depreciation in valuebr /of his 5 percent stake in Citigroup, for example, has been well-documented.”br /Citigroup lost 73 percent of its value in the past 12 months as investmentbr /losses eroded its capital.br /br /Alwaleed, nephew of the late King Fahd bin Abdulaziz al- Saud, stands outbr /among more than 2,000 Saudi princes because he has made money. After earning abr /bachelor’s degree from Menlo College near San Francisco, he returned to thebr /Persian Gulf and parlayed an inheritance of less than $1 million into a billion-br /dollar fortune in the 1980s, mostly through real-estate investments, accordingbr /to Riz Khan’s biography “Alwaleed: Businessman, Billionaire, Prince”(Williambr /Morrow, 2005).br /br /Apple, Time Warnerbr /The prince, 54, built his fortune by investing in brand- name companies he considered undervalued, including Apple Inc., News Corp. and Time Warner Inc. Forbes magazine estimated he was worth $13.3 billion in March, ranking him 22nd among the world’s billionaires. This year, Alwaleed’s investments haven’t kept pace with the Saudi benchmark. Shares of Riyadh-based Kingdom Holding have declined 4.3 percent. The Tadawul All-Share Index, the largest market in the Middle East by market value, has gained 19 percent.br //ppKingdom Holding’s assets are valued at $7.26 billion, while the Prince owns $3.18 billion of real estate and $1.56 billion of media assets such as LBC and Rotana Holding, Arabian Business said, citing his financial accounts. Alwaleed’s other major assets, including an Airbus A380, are valued at $1.7 billion.br /br /The value of the prince’s cash remains confidential, the magazine said, adding that “we are assured it has not changed significantly since we were allowed to see the verified total figure in December.”br //p/blockquotediv class="blogger-post-footer"img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/819581243324579563-110738121857279604?l=briskycapital.blogspot.com'//div]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-energy-markets/prince-alwaleed-remains-richest-saudi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 8/27/09, MDAS, F, AA, PEP, RBRM, NGHI</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82709-mdas-f-aa-pep-rbrm-nghi/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82709-mdas-f-aa-pep-rbrm-nghi/#comments</comments>
		<pubDate>Thu, 27 Aug 2009 16:00:26 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alcoa]]></category>
		<category><![CDATA[Alcoa Wheel]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Dearborn Truck Plant]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Escape;]]></category>
		<category><![CDATA[Executive]]></category>
		<category><![CDATA[Executive Vice President]]></category>
		<category><![CDATA[financial data comparing steel]]></category>
		<category><![CDATA[Ford F-150]]></category>
		<category><![CDATA[Ford Motor Company]]></category>
		<category><![CDATA[Ireland]]></category>
		<category><![CDATA[Kansas City Assembly Plant]]></category>
		<category><![CDATA[Massimo d’Amore]]></category>
		<category><![CDATA[MedAssets Inc.]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[Nevada Gold Holdings Inc.;]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[North America Beverages]]></category>
		<category><![CDATA[on-line tool]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[PepsiCo]]></category>
		<category><![CDATA[PepsiCo Americas Beverages]]></category>
		<category><![CDATA[PepsiCo Americas Beverages  CEO]]></category>
		<category><![CDATA[peripheral neuropathy]]></category>
		<category><![CDATA[ReBuilder Medical Technologies Inc.]]></category>
		<category><![CDATA[Salman Amin]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[steel duals]]></category>
		<category><![CDATA[ThinkEquity;]]></category>
		<category><![CDATA[Tom Greco]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[vice president -  Sales]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3045</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Thursday August 27, 2009




**************************************************************

MedAssets, Inc. (NASDAQ:  MDAS) today announced that its management team will participate in  investment firm conferences in September 2009. The Company is scheduled to  present at Baird&#8217;s 2009 Health Care Conference on Thursday, September 10 at 9:00  am ET in New York City. The Company [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82709-mdas-f-aa-pep-rbrm-nghi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 8/27/09, CROX, GRB, LKMG, CRGE, BMY, MEDX</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82709-crox-grb-lkmg-crge-bmy-medx/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82709-crox-grb-lkmg-crge-bmy-medx/#comments</comments>
		<pubDate>Thu, 27 Aug 2009 12:52:36 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company;]]></category>
		<category><![CDATA[Clenergen Corporation Limited]]></category>
		<category><![CDATA[Clenergen India Private Limited]]></category>
		<category><![CDATA[Crocs Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Enabling Linked Media Group]]></category>
		<category><![CDATA[Gerber Scientific Inc]]></category>
		<category><![CDATA[integrated automation solutions]]></category>
		<category><![CDATA[Linked Media Group Inc.]]></category>
		<category><![CDATA[Medarex Inc.]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Puma Acquisition Corporation]]></category>
		<category><![CDATA[Rip Cloud LLC]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[social media platform;]]></category>
		<category><![CDATA[Twitter]]></category>
		<category><![CDATA[United Biofuels Private Limited]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[Worldwide Leader]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=3038</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Thursday August 27, 2009




**************************************************************

Known for bringing innovative  footwear to market, Crocs, Inc. (NASDAQ: CROX) today announced  its newest iconic style - the Crocband. The next generation of Crocs&#8217; celebrated  Beach and Cayman styles, the Crocband Collection combines the very best features  of Crocs original designs including world renowned [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-82709-crox-grb-lkmg-crge-bmy-medx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>House Prices Actually RISING &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/house-prices-actually-rising-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/house-prices-actually-rising-analyst-blog/#comments</comments>
		<pubDate>Tue, 25 Aug 2009 18:10:55 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Charlotte]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Denver]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[Equity Residential]]></category>
		<category><![CDATA[Fannie]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Freddie]]></category>
		<category><![CDATA[Las Angeles]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[lax accounting rules]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Minneapolis]]></category>
		<category><![CDATA[mortgage buyer]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[Portland]]></category>
		<category><![CDATA[San Diego]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Tampa]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/24005/House+Prices+Actually+RISING+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
The Case-Schiller composite index of housing prices in 20 major metropolitan areas rose 0.7% on a seasonally adjusted basis in June, following an essentially unchanged reading in May. The not-seasonally-adjusted numbers were even better (and what most of the press coverage were initially focused on). However, there is a distinct seasonal pattern to housing prices, so it is better to focus on the seasonally adjusted numbers.<br />
<br />
The increase in prices was widespread, with 15 of the 20 areas seeing an increase -- better than expected, and extremely good news. In May, nine of the 20 cities were up. The news is still tentative, with much of the good news coming from a reduction in supply as banks have been letting the foreclosure pipeline build, and an increase in demand from the first-time homebuyer tax credit, which expires at the end of November.<br />
<br />
On a year-over-year basis, the composite 20 index was down 15.5%. The Composite 10 index, which has a longer history, was down 15.1% (also up 0.7% on a monthly basis).<br />
<br />
All 20 metro areas are down on a year-over-year basis. Of course, the housing bubble did not pop a year ago -- the decline has been going on a lot longer than that. The peak in both of the composite indexes was in May 2006. Since that time, the composite 20 index is down 31.5% and the composite 10 index is down 32.6%.<br />
<br />
This has destroyed the wealth of most of the middle class and resulted in millions of people being underwater in their homes. When people are underwater on their homes, they are far more likely to stop paying on their mortgages than if they have equity in their homes. This, in turn, has led to massive (and still partially hidden due to very lax accounting rules) losses at the banks. This has depleted their capital and made it much more difficult to lend.<br />
<br />
The collapse in housing values is probably the single most important factor in causing the world-wide economic decline. Signs that it is reversing are thus extremely important. <br />
<br />
Not all areas have been equally affected by the bursting of the housing bubble. In two markets, Phoenix (-54.1%) and Las Vegas (-54.5%), prices have been more than cut in half since May 2006. In six other markets, Las Angeles, San Diego, San Francisco, Miami, Tampa and Detroit, prices are down by more than 40%. On the other hand, three markets, Dallas (-3.8%), Charlotte (-4.2%) and Denver (-9.4%) are down by less than 10%, and five more are down less than 20% from the nationwide peak (individual peaks varied by a few months).<br />
<br />
Similarly, the increases over the last month have been very uneven. Five markets, surprisingly lead by Cleveland (3.3%) reported seasonally adjusted increases of 2.0% or more. The others were San Francisco (3.1%), Portland (2.9%), D.C. (2.2%) and Minneapolis (2.0%).<br />
<br />
The big warning signs that we were in a housing bubble were that housing prices were getting out of line with rents and with median incomes. The slide in prices over the last three years has brought us back to more normal levels. This can be seen in the two graphs below (from <a href="http://www.calculatedriskblog.com/">http://www.calculatedriskblog.com/</a>).<br />
<br />
Most of the adjustment in home prices is behind us, but I am not totally sure we are out of the woods. With the soft economy and rising unemployment, median incomes are not going up and are probably falling.<br />
<br />
Major apartment REITs like <strong>Equity Residential </strong>(<a href="http://www.zacks.com/stock/quote/eqr">EQR</a>) and <strong>Apartment Investors</strong> (<a href="http://www.zacks.com/stock/quote/aiv">AIV</a>) have been reporting that they have had to lower stated rents recently and effective rents even more (i.e. throwing in a few free months of rent when you sign a lease). This means that rents are most likely going down nationwide, although it has not yet shown up in Owners Equivalent Rents, which is how the government tracks housing for calculating inflation. Declining rents and incomes will put more pressure on housing prices. <br />
<br />
This will be particularly true once the artificial prop of the first-time home-buy tax credit expires. The other major prop to the market has been the Federal Reserve, which has turned into the mortgage buyer of first and last resort as it is in the process of buying $1.25 trillion in <strong>Fannie</strong> (<a href="http://www.zacks.com/stock/quote/fnm">FNM</a>) and <strong>Freddie</strong> (<a href="http://www.zacks.com/stock/quote/fre">FRE</a>) backed securities. Eventually the Fed will have to reverse those actions (or inflation will spiral out of control), and when it does, the mortgage market is likely to get much, much tighter.<br />
<br />
Still, it is abundantly clear from the charts that we are much closer to the bottom than we are from the top. We are unlikely to see a major rise in home prices going forward, but just stopping the freefall is very good news indeed. It does not repair the very significant damage that has already been done, but it does mean that things are not getting materially worse.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1251219381.jpg" alt="" /><br />
<img src="http://www.zacks.com/images/upload_dir/1251219395.jpg" alt="" /><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EQR">Read the full analyst report on "EQR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AIV">Read the full analyst report on "AIV"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FNM">Read the full analyst report on "FNM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FRE">Read the full analyst report on "FRE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/house-prices-actually-rising-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Making The Fed Reserve Accountable!</title>
		<link>http://www.straightstocks.com/market-commentary/making-the-fed-reserve-accountable/</link>
		<comments>http://www.straightstocks.com/market-commentary/making-the-fed-reserve-accountable/#comments</comments>
		<pubDate>Tue, 25 Aug 2009 15:46:11 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[bank holiday]]></category>
		<category><![CDATA[ben bernanke]]></category>
		<category><![CDATA[Big Al Greenspan]]></category>
		<category><![CDATA[BRIC MarketSafe CD]]></category>
		<category><![CDATA[BRL]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[DKK]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[EUR]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[football]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[HKD]]></category>
		<category><![CDATA[HUF]]></category>
		<category><![CDATA[INR]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[judge]]></category>
		<category><![CDATA[Koruna]]></category>
		<category><![CDATA[Loretta Preska]]></category>
		<category><![CDATA[Manhattan Chief U.S. District Judge]]></category>
		<category><![CDATA[Marco Island;]]></category>
		<category><![CDATA[New Orleans]]></category>
		<category><![CDATA[oil play;]]></category>
		<category><![CDATA[Peso]]></category>
		<category><![CDATA[PLN;]]></category>
		<category><![CDATA[premier]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[S&P/CaseShiller]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[SEK]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wen Jiabao]]></category>
		<category><![CDATA[West Coast]]></category>
		<category><![CDATA[Westclox BIG BEN 1939  Clock Radio;]]></category>
		<category><![CDATA[World Trade Organization]]></category>
		<category><![CDATA[ZAR]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=20133</guid>
		<description><![CDATA[pCurrencies sold overnight#8230;  But rebound in early morning trading#8230;  China throws cold water on stock values#8230; German exports rival the Big Kahuna! And Now#8230; Today#8217;s Pfennig!br /
Good day#8230; And a Terrific Tuesday to you! I returned home from San Francisco last night, and am back in the saddle today! Not the way I like to travel, where I get a day when returning home to recharge the batteries, but it is what it is#8230; I did an interview with MarketWatch yesterday morning, talking about#8230; Well, what else? The deficits, and diversification! My presentations in S.F. were well attended#8230; On Saturday, my power point froze up, but I carried on in spite of the technical difficulties!/p
pYou know#8230; I really, heard a lot of people talking#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/making-the-fed-reserve-accountable/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>European Orders Support the Euro</title>
		<link>http://www.straightstocks.com/market-commentary/european-orders-support-the-euro/</link>
		<comments>http://www.straightstocks.com/market-commentary/european-orders-support-the-euro/#comments</comments>
		<pubDate>Mon, 24 Aug 2009 14:34:01 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[Admiral]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[America falls]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[bank of england]]></category>
		<category><![CDATA[ben bernanke]]></category>
		<category><![CDATA[Boom]]></category>
		<category><![CDATA[BRL]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chicago airport]]></category>
		<category><![CDATA[Chicago Fed]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Chuck ;]]></category>
		<category><![CDATA[Columbia]]></category>
		<category><![CDATA[Columbia University]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[DKK]]></category>
		<category><![CDATA[Ecb]]></category>
		<category><![CDATA[ECB President]]></category>
		<category><![CDATA[economics professor]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[EUR]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Frank Trotter]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[George Banks]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[HKD]]></category>
		<category><![CDATA[HUF]]></category>
		<category><![CDATA[Hungary]]></category>
		<category><![CDATA[INR]]></category>
		<category><![CDATA[Jack]]></category>
		<category><![CDATA[Jean Claude Trichet]]></category>
		<category><![CDATA[John Smoltz]]></category>
		<category><![CDATA[Joseph Stiglitz;]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[Koruna]]></category>
		<category><![CDATA[Kristin Kuchem;]]></category>
		<category><![CDATA[Margaret  Thatcher]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[Nobel Prize winning economist]]></category>
		<category><![CDATA[Norway]]></category>
		<category><![CDATA[Personal]]></category>
		<category><![CDATA[Peso]]></category>
		<category><![CDATA[PLN;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Reagan;]]></category>
		<category><![CDATA[real estate woes;]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[S&P/CaseShiller]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[SEK]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[St. Louis]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Government]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Westclox BIG BEN 1939  Clock Radio;]]></category>
		<category><![CDATA[ZAR]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=20084</guid>
		<description><![CDATA[pEuropean orders increase more than expected#8230; Was Cash for Clunkers necessary?#8230; Roubini sees a #8216;W#8217; not a #8216;V#8217;#8230;br /
Lessons from Mary Poppins#8230;And Now#8230; Today#8217;s Pfennig!/p
pGood day#8230; And welcome to another week, the last one in August! The weather here in St. Louis has shifted toward fall, which is my favorite season. Chuck is flying back home from San Francisco today and will be back in the saddle tomorrow. Both he and the big boss, Frank Trotter, sent me some great Pfennig pfodder over the weekend so lets get right to it./p
pThe dollar continued to drift lower throughout the trading day on Friday, with the commodity currencies of Australia, South Africa, and New Zealand leading the way. Confidence is returning to the markets, and#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/european-orders-support-the-euro/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lung Cancer Medical Breakthrough (OTC:BMOD)</title>
		<link>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/</link>
		<comments>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/#comments</comments>
		<pubDate>Sun, 23 Aug 2009 01:58:32 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[Albuquerque City Attorney’s Office]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Ampex]]></category>
		<category><![CDATA[Angela Montoya]]></category>
		<category><![CDATA[automated technology]]></category>
		<category><![CDATA[Biomoda Inc.]]></category>
		<category><![CDATA[Biotechnology Associates]]></category>
		<category><![CDATA[Bladder Cancer]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer detection;]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Cfo]]></category>
		<category><![CDATA[chair]]></category>
		<category><![CDATA[Cleveland]]></category>
		<category><![CDATA[College of Santa Fe]]></category>
		<category><![CDATA[Constance Dorian]]></category>
		<category><![CDATA[Corporate Secretary and Director]]></category>
		<category><![CDATA[Corporate Secretary and Director of Administration]]></category>
		<category><![CDATA[Director of Administration]]></category>
		<category><![CDATA[electronics]]></category>
		<category><![CDATA[electronics engineer]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[executive and entrepreneur]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[General Counsel]]></category>
		<category><![CDATA[Gordon Bennett]]></category>
		<category><![CDATA[Gustave Roussy]]></category>
		<category><![CDATA[insurance billing codes]]></category>
		<category><![CDATA[John Cousins]]></category>
		<category><![CDATA[John J. Cousins]]></category>
		<category><![CDATA[Lab Technician]]></category>
		<category><![CDATA[Los Alamos National Laboratories]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[lung cancers]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[member]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[New England Journal]]></category>
		<category><![CDATA[New Mexico]]></category>
		<category><![CDATA[New Mexico Department of Veterans Services]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Optical Society of America and the New Mexico State Bar]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[President and a Director]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[prevention for cancer]]></category>
		<category><![CDATA[public company CFO]]></category>
		<category><![CDATA[San Diego State University]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Subsequent product]]></category>
		<category><![CDATA[technology works]]></category>
		<category><![CDATA[the New England Journal of Medicine]]></category>
		<category><![CDATA[Tim Zannes]]></category>
		<category><![CDATA[Treatment Of Cancer]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[University of New Mexico]]></category>
		<category><![CDATA[University of North Carolina]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verrity Gershin]]></category>
		<category><![CDATA[Vice President of Technical Operations]]></category>
		<category><![CDATA[Wharton School]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=401</guid>
		<description><![CDATA[Biomoda, Inc.
(Public, OTC:BMOD)
StocksHaven Investments profiles one of the most promising up and coming small cap biotech companies, Biomoda Inc, which has established a medical breakthrough for early lung cancer detection. It is a development-stage company. The Company is an invitro diagnostics company that develops assays, or tests, to detect cancer. These assays are performed in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Gusher of Federal Money…</title>
		<link>http://www.straightstocks.com/investing-lessons/real-estate/a-gusher-of-federal-money%e2%80%a6/</link>
		<comments>http://www.straightstocks.com/investing-lessons/real-estate/a-gusher-of-federal-money%e2%80%a6/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 19:05:39 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[ben bernanke]]></category>
		<category><![CDATA[Big Ben Bernanke]]></category>
		<category><![CDATA[BRL]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Chuck Butler]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[copy cat media types]]></category>
		<category><![CDATA[Curtis Melbourne]]></category>
		<category><![CDATA[DKK]]></category>
		<category><![CDATA[EUR]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[HKD]]></category>
		<category><![CDATA[HUF]]></category>
		<category><![CDATA[INR]]></category>
		<category><![CDATA[John Mauldin]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[Koruna]]></category>
		<category><![CDATA[media training]]></category>
		<category><![CDATA[member]]></category>
		<category><![CDATA[Pacific Investment Management Co.]]></category>
		<category><![CDATA[Peso]]></category>
		<category><![CDATA[PIMCO portfolio-manager]]></category>
		<category><![CDATA[PLN;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Reserve Bank Of Australia]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[SEK]]></category>
		<category><![CDATA[Swiss National Bank]]></category>
		<category><![CDATA[Thomas Jordan]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[VANCOUVER]]></category>
		<category><![CDATA[Washington D C]]></category>
		<category><![CDATA[Westclox BIG BEN 1939  Clock Radio;]]></category>
		<category><![CDATA[ZAR]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=20013</guid>
		<description><![CDATA[pNo currency movement to speak of#8230;                 Buffett calls out the deficits#8230;            PIMCO does too!                                SNB selling francs to stem gains#8230; nd Now#8230; Today#8217;s Pfennig!/p
pGood day#8230; And a Wonderful Wednesday to you! Another day with the medicine in my knee and it feels better yet today#8230; I did have to ice it last night though, I guess I#8217;m still not out of the woods here, but I can see the exit!/p
pThere was very little in the way of movement in the currencies yesterday. The euro moved to 1.4150, but was brought back down to the 1.41 handle overnight. Stocks rebounded yesterday, which gave a few risk takers the intestinal fortitude to dip their toes back into the risk assets water#8230; But#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/real-estate/a-gusher-of-federal-money%e2%80%a6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jobless recovery – a brief overview</title>
		<link>http://www.straightstocks.com/market-commentary/jobless-recovery-%e2%80%93-a-brief-overview/</link>
		<comments>http://www.straightstocks.com/market-commentary/jobless-recovery-%e2%80%93-a-brief-overview/#comments</comments>
		<pubDate>Tue, 11 Aug 2009 08:29:44 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Asha Bangalore]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[consultant]]></category>
		<category><![CDATA[Federal Reserve Bank Of San Francisco]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Financial & Economic Strategies Corporation]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Northern Trust Company;]]></category>
		<category><![CDATA[vice president and economist]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=9886</guid>
		<description><![CDATA[The employment report of July included several signs suggesting that the labor market is stabilizing. The next question is what comes after stabilization, and is the subject of this guest post by Asha Bangalore.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/jobless-recovery-%e2%80%93-a-brief-overview/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Exchange Rates: New Papers</title>
		<link>http://www.straightstocks.com/market-commentary/exchange-rates-new-papers/</link>
		<comments>http://www.straightstocks.com/market-commentary/exchange-rates-new-papers/#comments</comments>
		<pubDate>Tue, 11 Aug 2009 03:20:06 +0000</pubDate>
		<dc:creator>Menzie Chinn</dc:creator>
				<category><![CDATA[Economics]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Alex Nikolsko-Rzhevskyy]]></category>
		<category><![CDATA[Bank Of Canada]]></category>
		<category><![CDATA[Bank of Canada-European Central]]></category>
		<category><![CDATA[Boston College]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[British Columbia]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cass Business School]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[David Papell]]></category>
		<category><![CDATA[Emory University]]></category>
		<category><![CDATA[European Central Bank]]></category>
		<category><![CDATA[European University Institute]]></category>
		<category><![CDATA[Fabio Ghironi]]></category>
		<category><![CDATA[Federal Reserve Bank Of New York]]></category>
		<category><![CDATA[Federal Reserve Bank Of San Francisco]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[G. D'Annunzio University]]></category>
		<category><![CDATA[Geneva Graduate Institute]]></category>
		<category><![CDATA[Georgetown University]]></category>
		<category><![CDATA[Guy Meredith]]></category>
		<category><![CDATA[Harvard University]]></category>
		<category><![CDATA[International Monetary Fund]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Jordi Gali]]></category>
		<category><![CDATA[Linda Goldberg]]></category>
		<category><![CDATA[Martin Evans]]></category>
		<category><![CDATA[NBER International Finance and Macroeconomics Summer Institute]]></category>
		<category><![CDATA[Nelson Mark]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[new york university]]></category>
		<category><![CDATA[Nicolas Berman]]></category>
		<category><![CDATA[P. Della Corte]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[Paris School of Economics]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Philippe Martin]]></category>
		<category><![CDATA[producer]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[straightforward solution;]]></category>
		<category><![CDATA[Tanya Molodstva]]></category>
		<category><![CDATA[The Bank of Canada-ECB]]></category>
		<category><![CDATA[Thierry Mayer]]></category>
		<category><![CDATA[UCLA]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of British Columbia]]></category>
		<category><![CDATA[University of Houston]]></category>
		<category><![CDATA[University of Lausanne]]></category>
		<category><![CDATA[University of Memphis]]></category>
		<category><![CDATA[University Of Pennsylvania]]></category>
		<category><![CDATA[University of Virginia]]></category>
		<category><![CDATA[University of Warwick]]></category>
		<category><![CDATA[University Of Washington]]></category>
		<category><![CDATA[University Of Wisconsin]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[Virginia Tech]]></category>
		<category><![CDATA[Wisconsin]]></category>

		<guid isPermaLink="false">http://www.econbrowser.com/archives/2009/08/exchange_rates_1.html</guid>
		<description><![CDATA[<p>During the summer, I had the good fortune to attend two excellent conferences focused on new findings in exchange rate economics (yes, not all economic research is focused on the financial crisis and recession). The first was a Bank of Canada-European Central Bank conference <a href="http://www.ecb.eu/events/conferences/html/jointbocecb-workshop2009.en.html">Exchange rates: The global perspective</a>, and the second was the <a href="http://www.nber.org/confer/2009/SI2009/ifmprg.html">NBER International Finance and Macroeconomics Summer Institute</a> session "Exchange Rates and Relative Prices".</p>
<img alt="narrowdollar.gif" src="http://www.econbrowser.com/archives/2009/08/narrowdollar.gif" />

<br /><b>Figure 1:</b> Log nominal value of US dollar (blue) and real value of US dollar (red), against currencies of major trading partners. NBER defined recession dates shaded gray, assuming the recession has not ended by July 2009. Source: Federal Reserve Board.

<p>The Bank of Canada-ECB conference papers are <a href="http://www.ecb.eu/events/conferences/html/jointbocecb-workshop2009.en.html">here</a>. All the papers, as well as powerpoint files of the presenters and discussants, are available from the conference website; I've reproduced some of the abstracts below.</p>

<blockquote><p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Evans.pdf?c77af082706b2b5a1c2eee7950fb3bd4">Order flows and the exchange rate disconnect puzzle</a></b></p>
<p>M. Evans (Georgetown University)</p>
<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Vitale.pdf?8789d1a102c59137de14c9720ea73217">Discussant: P. Vitale</a> (G. D'Annunzio University)</p></blockquote>

<p>This paper was also presented at the NBER conference -- see below for the abstract and my discussion of the paper.</p>

<blockquote>
<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Chen.pdf?41282b773ca7fadc371c44aaccc10848">What does the yield curve tell us about exchange rate predictability?</a></b></p>
<p>Y. Chen (University of Washington), K. P. Tsang (Virginia Tech)</p>

<p>This paper uses information contained in the cross-country yield curves to test the asset pricing approach to exchange rate determination, which models the nominal exchange rate as the discounted present value of its expected future fundamentals. Since the term structure of interest rates embodies information about future economic activity such as GDP growth and inflation, we extract the Nelson-Siegel (1987) factors of <i>relative</i> level, slope, and curvature from cross-country yield differences to proxy expected movements in future exchange rate fundamentals. Using monthly data between 1985-2005 for the United Kingdom, Canada, Japan and the US, we show that the yield curve factors predict bilateral exchange rate movements and explain excess currency returns one month to two years ahead. They also outperform the random walk in forecasting short-term exchange rate returns out of sample. Our findings provide an intuitive explanation to the uncovered interest parity puzzle by relating excess currency returns to inflation and business cycle risk.</p>

<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Alquist.pdf?858ae2f9ba23ac91555bd4df6268819f">Discussant: R. Alquist</a> (Bank of Canada)</p>

</blockquote>

<p>I found this paper quite interesting as it links up, in an atheoretical/empirical fashion, with the findings Guy Meredith and I obtained -- namely that short term interest rate differentials mispredict exchange rate changes, but long term interest rate differentials do not.</p>

<blockquote><p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Bacchetta.pdf?72b4252ba3cecd763416fa521b7ae90b">On the unstable relationship between exchange rates and fundamentals</a></b></p>
<p>*P. Bacchetta (University of Lausanne), E. van Wincoop (University of Virginia)</p>

<p>It is well known from anecdotal, survey and econometric evidence that the relationship between the exchange rate and macro fundamentals is highly unstable. This could be explained when structural parameters are known and very volatile, neither of which seems plausible. Instead we argue that large and frequent variations in the relationship between the exchange rate and macro fundamentals naturally develop when structural parameters in the economy are unknown and change very slowly. We show that the reduced form relationship between exchange rates and fundamentals is driven not by the structural parameters themselves, but rather by expectations of these parameters. These expectations can be highly unstable as a result of perfectly rational "scapegoat" effects. This happens when parameters can potentially change much more in the long run than the short run. This generates substantial uncertainty about the level of parameters, even though monthly or annual changes are small. This mechanism can also be relevant in other contexts of forward looking variables and could explain the widespread evidence of parameter instability found in macroeconomic and financial data. Finally, we show that parameter instability has remarkably little effect on the volatility of exchange rates, the in-sample explanatory power of macro fundamentals and the ability to forecast out of sample.</p>

<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Engel.pdf?c41c5b31f171170e50257bbeb24684e7">Discussant: C. Engel</a> (University of Wisconsin)</p>
</blockquote>
<p>This paper is closely related to another <a href="http://www.nber.org/~confer/2009/ISOM09/wincoop.pdf">paper</a> by Bacchetta, Wincoop, and Beutler, discussed in <a href="http://www.econbrowser.com/archives/2009/06/new_papers_on_i.html">this post</a> from June.</p>

<blockquote>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Maier.pdf?9396a7d4df55eda2d7c1137878cf2935">What is driving exchange rates? New evidence from a panel of US dollar bilateral exchange rates</a></b></p>
<p>J. Cayen (Bank of Canada), D. Coletti (Bank of Canada), R. Lalonde (Bank of Canada), *P. Maier (Bank of Canada)</p>

<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Bouakez.pdf?705c1fcd73543658728c37f01048ef25">Discussant: H. Bouakez</a> (HEC Montreal)</p>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Lustig.pdf?8e2b63157d1c2eff2215b39888248f09">Common risk factors in currency markets</a></b></p>
<p>*H. Lustig (UCLA), N. Roussanov (University of Pennsylvania), A. Verdelhan (Boston University)</p>

<p>We identify a 'slope' factor in exchange rates. High interest rate currencies load more on this slope factor than low interest rate currencies. As a result, this factor can account for
most of the cross-sectional variation in average excess returns between high and low interest rate currencies. A standard, no-arbitrage model of interest rates with two factors -- a country-
specific factor and a global factor -- can replicate these findings, provided there is sufficient heterogeneity in exposure to the global risk factor. We show that our slope factor is global risk factor. By investing in high interest rate currencies and borrowing in low interest rate currencies, US investors load up on global risk, particularly during bad times.</p>

<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Fornari.pdf?c774f2c6ce942e3d0234c71af0971fa1">Discussant: F. Fornari</a> (European Central Bank)</p>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Farhi.pdf?89408011b63ac6f5eebebc1c6d0a87a6">Crash risk in currency markets</a></b></p>
<p>*E. Farhi (Harvard University), X. Gabaix (New York University), A. Verdelhan (Boston University)</p>

<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_DellaCorte.pdf?49f97a992718be837885a3b343abc06c">Discussant: P. Della Corte</a> (University of Warwick)</p>

<p><b>Dinner address: J. Murray (Bank of Canada)</b></p>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Corsetti.pdf?5db9492c3077bd9cc0f33f87ce4a5696">Demand imbalances, exchange rate misalignment and monetary policy</a></b></p>
<p> Corsetti (European University Institute), L. Dedola (European Central Bank)
S. Leduc (Federal Reserve Bank of San Francisco)</p>

<p>In standard open macro models with incomplete markets, monetary policy geared towards price stability may result in (rather than correcting) misalignments in important asset prices like the exchange rate, even when the latter only reflects fundamental-based valuation. We discuss instances in which optimal monetary policy redresses these inefficiencies, achieving significant welfare gains relative to price stability. These gains are obtained by leaning against an over- or under-valued exchange rate, associated with suboptimal cross-country demand and current account imbalances, consistent with flexible inflation targeting.</p>
<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Gali.pdf?7a37643d95c14568f7a8341f61d1f5ee">Discussant: J. Gali</a> (Centre de Recerca en Economia Internacional)</p>

</blockquote>

<p>I think this paper by Corsetti et al. is an important one, because it's one of the few papers I know that explicitly defines what real exchange rate misalignment is, in the context of a formal New Keynesian model. I think it, and the discussion by Jordi Gali, are required reading for anybody interested in thinking about equilibrium real exchange rates.</p>

<blockquote>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Goldberg.pdf?5636bac3cda30decd35bb88590992184">The dynamics of international trade invoicing</a></b></p>
<p>*L. Goldberg (Federal Reserve Bank of New York), C. Tille (Geneva Graduate Institute)</p>

<p>International trade transactions can be invoiced in the producer currency, in the destination currency, or in some third vehicle currency. This paper shows how an exporter's invoicing choice is affected by her market share, industry structure, the role of imported inputs, the hedging of macroeconomic shocks, and exchange rate regimes. We address a shortcoming in the existing literature by invoicing choices as the outcome of a bargaining game between exporting producers and their customers abroad. Using a new dataset of 45 million individual Canadian import transactions, we examine the roles of the various invoicing determinants, documenting the importance of each of these factors in the invoicing decisions of specific industry exporters, distinguishing between U.S. exporters and those from other countries.</p>
<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Devereux.pdf?c3107d3fad9cb73bc81ebb6efe75410a">Discussant: M. Devereux</a> (University of British Columbia) </p>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Sarno.pdf?03adbaa97bb885884aed5b9f419ea265">The predictive information content of external imbalances for exchange rate returns: How much is it worth?</a></b></p>
<p>*P. Della Corte (University of Warwick), L. Sarno (Cass Business School), G. Sestieri (European Central Bank)</p>

<p><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/discussion_Milesi_Ferretti.pdf?d7954388e0dc0e0cf63a529a734dc467">Discussant: G. M. Milesi-Ferretti</a> (International Monetary Fund)</p>

<p><b><a href="http://www.ecb.eu/events/pdf/conferences/jointbocecb2009/paper_Frankel.pdf?e83a09b10a4c35089ad14519ac22ec81">Keynote speech: On Global Currencies</a></b></p><p> *J. Frankel (Harvard University)</p>
<p>
I approach the state of global currency issues by identifying eight concepts that I see as having recently "peaked" and eight more that I see as currently rising in relevance. Those that I see as having already seen their best days are: the G-7, global savings glut, corners hypothesis, proliferating currency unions, inflation targeting (narrowly defined), exorbitant privilege, Bretton Woods II, and currency manipulation. Those that I see as receiving increased emphasis in the future are: the G-20, the IMF, SDR, credit cycle, reserves, intermediate exchange rate regimes, commodity currencies, and multiple international currency system.</p>
</blockquote>
<p>I've discussed some of the points Frankel lays out in a previous <a href="http://www.econbrowser.com/archives/2009/06/the_global_savi.html">post</a>, including the idea that “global savings glut” is an idea that is over.</p>

<blockquote>
<p><b>Policy panel discussion: Exchange rate behaviour and policy: Before, during and after the global economic crisis</b></p>
<p>Chairman: L. Papademos (European Central Bank)</p>
<p>M. Chinn (University of Wisconsin) <a href="http://www.ssc.wisc.edu/~mchinn/chinn_boc_ecb_2009.pdf">[presentation]</a></p>
<p>C. Engel ( University of Wisconsin )</p> 
<p>J. Murray (Bank of Canada)</p>
</blockquote>
<p>The second meeting (organized by <a href="http://www2.bc.edu/~ghironi/">Fabio Ghironi</a>, Boston College, and <a href="http://www.nd.edu/~nmark/">Nelson Mark</a>, Notre Dame) devoted the Wednesday session to exchange rates:</p>
<blockquote>
<p><b><a href="http://www.nber.org/~confer/2009/SI2009/IFM/Evans.pdf">Order Flows and the Exchange Rate Disconnect Puzzle</a></b></p>
 <p>Martin Evans, Georgetown University and NBER</p>
<p>The aim of this paper is to establish the link between the high frequency dynamics of spot exchange rates and developments in the macroeconomy. To do so, I first present a theoretical model of exchange-rate determination that bridges the gap between existing microstructure and traditional models. The model examines how dispersed microeconomic information known to individual agents outside the foreign exchange market is aggregated and transmitted to dealers via transaction flows (i.e., order flow); and how the information is then embedded in the spot exchange rate. I then report empirical evidence that strongly supports the presence of the link between the macroeconomy, order flow, and high frequency exchange rate returns implied by the model. In fact, my empirical results indicate that between 20 and 30 percent of the variance in excess currency returns over one- and two-month horizons can be linked back to developments in the macroeconomy. This level of explanatory power is an order of magnitude higher than that found in traditional models -- even the newly developed monetary models incorporating central banks reaction functions. Moreover, it provides a straightforward solution to the exchange-rate disconnect puzzle. Namely, the high frequency behavior of spot exchange rates reflects the flow of new information reaching dealers concerning the slowly evolving state of the macroeconomy, rather than the effects of shocks that drive rapidly changing macroeconomic conditions.</p>
  
 <p>Discussant: Menzie Chinn, University of Wisconsin-Madison and NBER <a href="http://www.nber.org/~confer/2009/SI2009/IFM/IFM_Discuss07_Chinn.pdf">[presentation]</a></p>


<p><b><a href="http://www.nber.org/~confer/2009/SI2009/IFM/Molodtsova_Nikolsko-Rzhevskyy_Papell.pdf">Taylor Rules and the Euro</a></b></p>
<p>Tanya Molodstva, Emory University, Alex Nikolsko-Rzhevskyy, University of Memphis, David Papell, University of Houston</p>
 
<p>This paper uses real-time data to show that inflation and either the output gap or unemployment, the variables which normally enter central banks' Taylor rules for interest-rate-setting, can provide evidence of out-of-sample predictability and forecasting ability for the United States Dollar/Euro exchange rate from the inception of the Euro in 1999 to the end of 2007. We also present less formal evidence that, with real-time data, the Taylor rule provides a better description of ECB than of Fed policy during this period. The strongest evidence is found for specifications that neither incorporate interest rate smoothing nor include the real exchange rate in the forecasting regression, and the results are robust to whether or not the coefficients on inflation and the real economic activity measure are constrained to be the same for the U.S. and the Euro Area. The evidence is stronger with inflation forecasts than with inflation rates and with real-time data than with revised data. Bad news about inflation and good news about real economic activity both lead to out-of sample predictability and forecasting ability through forecasted exchange rate appreciation.</p>
  
<p>Discussant: Yu-chin Chen, University of Washington <a href="http://www.nber.org/~confer/2009/SI2009/IFM/IFM_Discuss08_Chen.pdf">[presentation]</a></p>

<p><b><a href="http://www.nber.org/~confer/2009/SI2009/IFM/Berman_Mayer_Martin.pdf">How Do Different Exporters React to Exchange Rate Changes? Theory, Empirics, and Aggregate Implications</a></b></p>
 <p>Nicolas Berman, European University Institute, Philippe Martin, Science Po, Paris,  Thierry Mayer, Paris School of Economics</p> 
 
<p>This paper analyzes the reaction of exporters to exchange rate changes. We show that, in the presence of distribution costs in the export market, high and low productivity firms react differently to a depreciation . Whereas high productivity firms optimally raise their markup rather than the volume they export, low productivity firms choose the opposite strategy. This heterogeneity has important consequences for the aggregate impact of exchange rate movements. The presence of fixed costs to export means that only high productivity firms can export, firms which precisely react to an exchange rate depreciation by increasing their export price rather than their sales. We show that this selection effect can explain the weak impact of exchange rate movements on aggregate export volumes. We then test the main predictions of the model on a very rich French firm level data set with destination specific export values and volumes on the period 1995-2005. Our results confirm that high performance firms react to a depreciation by increasing their export price rather than their export volume. The reverse is true for low productivity exporters. Pricing to market by exporters is also more pervasive in sectors and destination countries with higher distribution costs. Another result consistent with our theoretical framework is that the probability of firms to enter the export market following a depreciation increases. The extensive margin response to exchange rate changes is modest at the aggregate level because firms that enter, following a depreciation, are less productive and smaller relative to existing firms.</p>
  
 <p>Discussant: Linda Goldberg, Federal Reserve Bank of New York and NBER <a href="http://www.nber.org/~confer/2009/SI2009/IFM/IFM_Discuss09_Goldberg.pdf">[presentation]</a></p>

</blockquote>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/exchange-rates-new-papers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: American Tower Corp., Crown Castle International, Tata Teleservices, Vodafone Plc and Medtronic Inc. &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-american-tower-corp-crown-castle-international-tata-teleservices-vodafone-plc-and-medtronic-inc-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-american-tower-corp-crown-castle-international-tata-teleservices-vodafone-plc-and-medtronic-inc-press-releases/#comments</comments>
		<pubDate>Mon, 10 Aug 2009 13:40:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AGA Medical Corp.]]></category>
		<category><![CDATA[American Tower Corp;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Aster Infrastructure]]></category>
		<category><![CDATA[Bharti Airtel]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Idea]]></category>
		<category><![CDATA[implantable and interventional therapy devices]]></category>
		<category><![CDATA[Independent Mobile Infrastructure Ltd.]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indus Towers]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[medical technology company specializing]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[metal alloys]]></category>
		<category><![CDATA[mobile tower operator]]></category>
		<category><![CDATA[Quippo Telecom Infrastructure Ltd.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Tata Teleservices;]]></category>
		<category><![CDATA[Tata-Quippo]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vascular plug products]]></category>
		<category><![CDATA[Vodafone plc;]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[wireless services]]></category>
		<category><![CDATA[wireless tower sights]]></category>
		<category><![CDATA[XCEL Telecom Pvt Ltd]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23367/Zacks+Analyst+Blog+Highlights%3A+American+Tower+Corp.%2C+Crown+Castle+International%2C+Tata+Teleservices%2C+Vodafone+Plc+and+Medtronic+Inc.+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; August 10, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>American Tower Corp. </strong>(<a href="void(0)">AMT</a>), <strong>Crown Castle International </strong>(<a href="void(0)">CCI</a>), <strong>Tata Teleservices </strong>(<a href="void(0)">TCL</a>), <strong>Vodafone Plc </strong>(<a href="void(0)">VOD</a>) and <strong>Medtronic Inc. </strong>(<a href="void(0)">MDT</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left">Here are highlights from Friday&#8217;s <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><strong>U.S. Tower Giants India-Bound </strong></p>
<p align="left">Recently, <strong>American Tower Corp. </strong>(<a href="void(0)">AMT</a>) acquired XCEL Telecom Pvt Ltd., a mobile tower operator in India. XCEL owns 1,667 towers and has another 70 towers in various stages of development. The acquisition increases the total number of American Tower controlled wireless tower sights to over 26,000. Previous to this acquisition, American Tower had entered a build-to-suit agreement with a Tier1 wireless carrier in India to construct 200 tower sites.</p>
<p align="left"><strong>Crown Castle International </strong>(<a href="void(0)">CCI</a>) is currently in negotiations with two Indian tower operators, Aster Infrastructure and Independent Mobile Infrastructure Ltd. Aster is holding simultaneous negotiation with American Tower.</p>
<p align="left">After China, India is the second largest growth market for wireless services where the subscriber base is expected to be 737 million by 2012. This provides a significant revenue opportunity for the U.S. tower operators. At the same time, operations in India will be low-cost for these companies, which will boost their respective bottom line.</p>
<p align="left">In addition to the U.S. companies, existing major tower operators in India are also trying to merge with small players to achieve the required economies of scale to compete with global giants. Tata-Quippo, a joint venture between <strong>Tata Teleservices </strong>(<a href="void(0)">TCL</a>) and Quippo Telecom Infrastructure Ltd., Indus Towers, a joint venture between <strong>Vodafone Plc </strong>(<a href="void(0)">VOD</a>), Bharti Airtel and Idea cellular, and Reliance Telecom Infrastructure are moving aggressively to increase their size of operations.</p>
<p align="left"><strong>Medtronic Wins Settlement</strong></p>
<p align="left"><strong>Medtronic Inc. </strong>(<a href="void(0)">MDT</a>) won $57 million in settlement from AGA Medical Corp. after the federal U.S. district court jury in San Francisco ruled in its favor. AGA had infringed upon two U.S. patents owned by Medtronic through the use and sale of Amplatzer Occluder and vascular plug products. Medtronic will also receive 11% in royalties from future sales of these products by AGA through 2018.</p>
<p align="left">The two patents in question are U.S. Patent Nos. 6,306,141 and 5,067,957, commonly known as the Jervis patents. These patents involve technologies that require the use of metal alloys to facilitate the working of doctors in different surgical operations. Medtronic has patents for these technologies.</p>
<p align="left">The new ruling is a shot in the arm for Medtronic. The additional revenue generated from this settlement will take care of the company&#8217;s bottom-line. Medtronic is a leading global medical technology company specializing in implantable and interventional therapy devices and products. The company&#8217;s deep product pipeline and strong R&#38;D program position it well for long-term organic growth, rather than having it rely purely on acquisitions.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-american-tower-corp-crown-castle-international-tata-teleservices-vodafone-plc-and-medtronic-inc-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PG&amp;E Misses by a Penny &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/pge-misses-by-a-penny-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/pge-misses-by-a-penny-analyst-blog/#comments</comments>
		<pubDate>Fri, 07 Aug 2009 16:12:55 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Electric Company]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[gas utility;]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[natural gas customers]]></category>
		<category><![CDATA[PG&E]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[utility infrastructure;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/23335/PG%26E+Misses+by+a+Penny+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
PG&#38;E Corp.</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/PCG">PCG</a>) second-quarter earnings of 83 cents per share stopped a penny short of the Zacks Consensus EPS estimate. However, it surpassed the year-ago profit of 80 cents a share. Also, quarterly GAAP EPS rose to $1.02 boosted by tax refund and recovery of Hydro divestiture costs, compared to 80 cents in the year-ago period.
<p align="left">San Francisco, California-based PG&#38;E&#8217;s earnings grew 32% to $388 million due to one-time gains and higher power rates. Operating income grew 12% to $656 million but revenue fell to $3.19 billion from $3.58 billion year over year. Revenue for both electricity and natural gas was down.</p>
<p align="left">The quarter-over-quarter increase in earnings from operations was due to higher authorized revenue on superior capital investments in improvement of utility infrastructure. This was partially offset by expenses for environmental remediation activities.</p>
<p align="left">PG&#38;E raised long-term debt of $2.2 billion in 2008 and $1.2 billion in 2007 for financing its expansion plans. The utility&#8217;s investments in property, plant and equipment totaled $3.7 billion in 2008 and $2.8 billion in 2007.</p>
<p align="left">The company has $13 billion of planned capital expenditures in the pipeline for the 2009 to 2011 period, including approximately $3.6 billion in this year. This means that its debt load will not lighten anytime soon. PG&#38;E deployed $2.1 billion towards capital expenditure in the first half of the year.</p>
<p align="left">The company reaffirmed its previous guidance for earnings from operations in the range of $3.15-$3.25 per share for fiscal 2009, $3.35-$3.50 per share for fiscal 2010 and $3.65-$3.85 per share for fiscal 2011.</p>
<p align="left">PG&#38;E is the parent company of California&#8217;s largest regulated electric and gas utility, Pacific Gas and Electric Company, which serves approximately 5.1 million electric and 4.3 million natural gas customers in northern and central California. The utility also operates hydro-electric, nuclear and fossil-fueled power plants.</p>
<p align="left">Going forward, growth will came from PG&#38;E&#8217;s focus on regulated utility operations, positive investment factors including favorable decisions from the CPUC and FERC (including a CPUC authorized 11.35% ROE until 2011), long-term supply agreements and infrastructure improvement programs. However, due to risks from pending regulatory approvals, earnings-dilutive stock issuances and an over-leveraged balance sheet, we maintain our Neutral recommendation on PG&#38;E.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PCG">Read the full analyst report on "PCG"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pge-misses-by-a-penny-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 8/06/09, CAL, IGT, MDT, MYL, WFC, MNRTA</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-80609-cal-igt-mdt-myl-wfc-mnrta/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-80609-cal-igt-mdt-myl-wfc-mnrta/#comments</comments>
		<pubDate>Thu, 06 Aug 2009 17:29:21 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AGA Medical Corp.]]></category>
		<category><![CDATA[Amplatzer Occluder]]></category>
		<category><![CDATA[Amplatzer(R) Occluder]]></category>
		<category><![CDATA[Best Consumer Internet Bank]]></category>
		<category><![CDATA[Bill Clinton]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Continental Airlines]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Fiji]]></category>
		<category><![CDATA[Founder and Vice Chairman]]></category>
		<category><![CDATA[Guam]]></category>
		<category><![CDATA[HIV/AIDS]]></category>
		<category><![CDATA[Honolulu;]]></category>
		<category><![CDATA[International Game Technology]]></category>
		<category><![CDATA[Internet Banks]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Matrix  Laboratories Founder]]></category>
		<category><![CDATA[Matrix Laboratories]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Monmouth Real Estate Investment Corporation]]></category>
		<category><![CDATA[Mylan;]]></category>
		<category><![CDATA[N. Prasad]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[Online Deposits Acquisition]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Robert J. Coury]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Shalov Stone Bonner & Rocco LLP]]></category>
		<category><![CDATA[therapy for HIV]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Web  Site Design]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2533</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Thursday August 6, 2009


**************************************************************

Continental Airlines  (NYSE: CAL) today announced new service from its Guam hub and Honolulu  to Nadi, Fiji beginning Dec. 18, 2009. The flights will also offer convenient  connections from the U.S. mainland, Japan and Continental&#8217;s Micronesian network  to Nadi.

Shalov Stone Bonner &#38;  Rocco LLP [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-80609-cal-igt-mdt-myl-wfc-mnrta/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prana Biotechnology Ltd. (PRAN) Gains Key Patent for Alzheimer Compound</title>
		<link>http://www.straightstocks.com/market-commentary/prana-biotechnology-ltd-pran-gains-key-patent-for-alzheimer-compound/</link>
		<comments>http://www.straightstocks.com/market-commentary/prana-biotechnology-ltd-pran-gains-key-patent-for-alzheimer-compound/#comments</comments>
		<pubDate>Wed, 05 Aug 2009 15:33:23 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Buck Institute for Age Research]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[European Office;]]></category>
		<category><![CDATA[European Patent Office;]]></category>
		<category><![CDATA[Geoffrey Kempler]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
		<category><![CDATA[Mental Health Research Institute of Victoria]]></category>
		<category><![CDATA[neurogenerative disorders]]></category>
		<category><![CDATA[Novato;]]></category>
		<category><![CDATA[PBT2]]></category>
		<category><![CDATA[Platform Technology]]></category>
		<category><![CDATA[Prana Biotechnology Ltd.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[treatment of neurological diseases]]></category>
		<category><![CDATA[University College]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[University of Melbourne]]></category>
		<category><![CDATA[Victoria]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=16962</guid>
		<description><![CDATA[Prana Biotechnology Ltd., an Australian company established to commercialize research into Alzheimer’s Disease and other major age-related neurogenerative disorders, today announced that it has secured a key patent protecting its clinical drug (PBT2) with the European Patent Office. The patent covers the composition of matter of selected families of 8-Hydroxyquinoline compounds, including PBT2, and the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/prana-biotechnology-ltd-pran-gains-key-patent-for-alzheimer-compound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BRE, KND, ESYM, DrStockPick Watch List! for Wednesday August 5, 2009, BRE Properties Inc., Kindred Healthcare Inc. and  EcoSystem Corp, ESYM.OB</title>
		<link>http://www.straightstocks.com/stock-watch/bre-knd-esym-drstockpick-watch-list-for-wednesday-august-5-2009-bre-properties-inc-kindred-healthcare-inc-and-ecosystem-corp-esym-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/bre-knd-esym-drstockpick-watch-list-for-wednesday-august-5-2009-bre-properties-inc-kindred-healthcare-inc-and-ecosystem-corp-esym-ob/#comments</comments>
		<pubDate>Wed, 05 Aug 2009 00:27:14 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[BRE Properties Inc.;]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[EcoSystem Corp]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Healthcare Services]]></category>
		<category><![CDATA[Kentucky]]></category>
		<category><![CDATA[Kindred Healthcare Inc]]></category>
		<category><![CDATA[KND]]></category>
		<category><![CDATA[Louisville]]></category>
		<category><![CDATA[O R SELL]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Real Estate Investment Trusts]]></category>
		<category><![CDATA[rehabilitation services]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[Second Quarter Results Exceed Company]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[www.breproperties.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2474</guid>
		<description><![CDATA[BRE, BRE Properties Inc.
KND, Kindred Healthcare Inc.
ESYM, EcoSystem Corp, ESYM.OB
DrStockPick Watch List! 
&#160;
DrStockPick Watch List! for Wednesday August 5, 2009



&#160;
My Picks for Wednesday August 5, 2009 are:
**************************************************************
BRE, BRE Properties Inc.



BRE, based in San Francisco, Calif., owns and manages apartment communities convenient to its residents&#8217; work, shopping, entertainment and transit in supply-constrained Western U.S. markets. BRE [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bre-knd-esym-drstockpick-watch-list-for-wednesday-august-5-2009-bre-properties-inc-kindred-healthcare-inc-and-ecosystem-corp-esym-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report!  8/03/09, OPEN, TZOO, IBAS, RSH, NUHC, THC</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-80309-open-tzoo-ibas-rsh-nuhc-thc/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-80309-open-tzoo-ibas-rsh-nuhc-thc/#comments</comments>
		<pubDate>Mon, 03 Aug 2009 17:18:04 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Blackberry]]></category>
		<category><![CDATA[BlackBerry(R)]]></category>
		<category><![CDATA[Board of Directors and James Estill]]></category>
		<category><![CDATA[Butler]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[consent]]></category>
		<category><![CDATA[Court of Chancery of the  State of Delaware]]></category>
		<category><![CDATA[Debbie L. Walsh]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[digital media]]></category>
		<category><![CDATA[director of the company]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Fountain Valley Regional Hospital]]></category>
		<category><![CDATA[free online reservations]]></category>
		<category><![CDATA[guest management systems]]></category>
		<category><![CDATA[iBasis Inc.]]></category>
		<category><![CDATA[Internet media]]></category>
		<category><![CDATA[James Estill]]></category>
		<category><![CDATA[Medical Center]]></category>
		<category><![CDATA[member of the board]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Nu Horizons Electronics Corp.]]></category>
		<category><![CDATA[OpenTable Inc.;]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[RadioShack Corporation]]></category>
		<category><![CDATA[Royal KPN N.V.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sausalito]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[Shine]]></category>
		<category><![CDATA[technology semiconductor]]></category>
		<category><![CDATA[Tender Offer]]></category>
		<category><![CDATA[Tenet Healthcare Corporation]]></category>
		<category><![CDATA[Travelzoo]]></category>
		<category><![CDATA[www.opentable.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2437</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Monday August 3, 2009


**************************************************************

OpenTable, Inc. (NASDAQ:OPEN) (www.opentable.com), a leading provider of  free online reservations for diners and guest management systems for  restaurants, today announced that its free application for BlackBerry(R)  smartphone users is available for download on BlackBerry App World(TM).  OpenTable for BlackBerry smartphones allows diners using BlackBerry [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-80309-open-tzoo-ibas-rsh-nuhc-thc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Green Investor News &#8211; Uptick in Q2 2009 US cleantech investment driven by large deals and improved investor confidence</title>
		<link>http://www.straightstocks.com/investing-in-energy-markets/green-investor-news-uptick-in-q2-2009-us-cleantech-investment-driven-by-large-deals-and-improved-investor-confidence/</link>
		<comments>http://www.straightstocks.com/investing-in-energy-markets/green-investor-news-uptick-in-q2-2009-us-cleantech-investment-driven-by-large-deals-and-improved-investor-confidence/#comments</comments>
		<pubDate>Mon, 03 Aug 2009 13:00:00 +0000</pubDate>
		<dc:creator>Dawn Van Zant</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Dow Jones]]></category>
		<category><![CDATA[Ernst Young LLP]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investorideas.com/News/080309a.asp</guid>
		<description><![CDATA[San Francisco - 3 August 2009 - US venture capital (VC) investment in cleantech companies in Q2 2009 reached $572 million, an increase of 73% in terms of capital, with 48 financing rounds, a 100% increase in number of transactions compared to Q1 2009, according to an Ernst  Young LLP analysis based on data from Dow Jones VentureSource.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-energy-markets/green-investor-news-uptick-in-q2-2009-us-cleantech-investment-driven-by-large-deals-and-improved-investor-confidence/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 7/31/09, SBGI, PC, CLSN, TSYS, CAT, AZN</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-73109-sbgi-pc-clsn-tsys-cat-azn/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-73109-sbgi-pc-clsn-tsys-cat-azn/#comments</comments>
		<pubDate>Fri, 31 Jul 2009 17:49:58 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[1-800-289-0462]]></category>
		<category><![CDATA[1-913-312-1415]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[atherosclerosis]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology drug development]]></category>
		<category><![CDATA[Boksburg]]></category>
		<category><![CDATA[Caterpillar Africa Pty. Ltd.]]></category>
		<category><![CDATA[Caterpillar Inc]]></category>
		<category><![CDATA[Celsion Corporation]]></category>
		<category><![CDATA[CHD]]></category>
		<category><![CDATA[coronary heart disease]]></category>
		<category><![CDATA[Cunningham Broadcasting Corporation]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Massachusetts]]></category>
		<category><![CDATA[massachusetts institute of technology]]></category>
		<category><![CDATA[mission critical  wireless communications]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[Panasonic Corporation]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sinclair Broadcast Group Inc;]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[Sybase 365 Inc.]]></category>
		<category><![CDATA[TeleCommunication Systems Inc]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Virginia]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=2397</guid>
		<description><![CDATA[
DrStockPick.com Stock  Report!

Friday July 31, 2009




**************************************************************

Sinclair Broadcast  Group, Inc. (Nasdaq: SBGI) was notified by Cunningham Broadcasting  Corporation that Cunningham&#8217;s lenders under its $33.5 million term loan  facility, which became due on July 31, 2009, have provided them an extension to  October 30, 2009. The extension requires that Cunningham make $200,000 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-73109-sbgi-pc-clsn-tsys-cat-azn/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gamba: Peru ETF Attracting Bigger Audience</title>
		<link>http://www.straightstocks.com/investing-in-exchange-traded-funds/gamba-peru-etf-attracting-bigger-audience/</link>
		<comments>http://www.straightstocks.com/investing-in-exchange-traded-funds/gamba-peru-etf-attracting-bigger-audience/#comments</comments>
		<pubDate>Fri, 31 Jul 2009 04:00:00 +0000</pubDate>
		<dc:creator>IndexUniverse Staff</dc:creator>
				<category><![CDATA[Exchange Traded Funds]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Barclays]]></category>
		<category><![CDATA[BGI]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[Daniel Gamba]]></category>
		<category><![CDATA[Eastern Europe]]></category>
		<category><![CDATA[editor]]></category>
		<category><![CDATA[ETF garner]]></category>
		<category><![CDATA[executive director]]></category>
		<category><![CDATA[executive director of Latin American operations]]></category>
		<category><![CDATA[index universe]]></category>
		<category><![CDATA[IndexUniverse.com]]></category>
		<category><![CDATA[iShares MSCI All Peru Capped Index Fund]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[MSCI All Peru Capped]]></category>
		<category><![CDATA[Murray Coleman]]></category>
		<category><![CDATA[niche product]]></category>
		<category><![CDATA[pension fund manager]]></category>
		<category><![CDATA[pension systems]]></category>
		<category><![CDATA[Peru]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">tag:www.indexuniverse.com://8cefa1c4123e9899d3bd34c5cc73750e</guid>
		<description><![CDATA[<p>How broad of a following can a country-specific ETF garner? BGI's new EPU is about to get a $300 million shot in the arm.</p>

<p> </p>
<p>How broad-based of an audience can an exchange-traded fund focused solely on companies based in Peru attract?</p>
<p>Since launching a little more than a month ago, the seemingly narrow-focused iShares MSCI All Peru Capped Index Fund (NYSEArca: EPU) has seen its assets top $33 million. That’s actually down a bit from a week ago when that number surpassed $35 million. (See related story <a target="_blank" href="http://www.indexuniverse.com/sections/newsinfocus/6064-in-peru-ishares-wins-first-to-market-honors.html">here</a>.)</p>
<p>So what’s driving such growth? Performance is one factor. In the past month, EPU’s returns have shot up by nearly 4 percentage points. More significantly to longer-term investors, the country has produced the best gross domestic product growth rate in the region—or near the top, depending on periods studied and data used—for more than a decade now.</p>
<p>And even more assets figure to start flowing EPU’s way. Shortly after coming out on June 22 (see related story here), iShares’ parent Barclays Global Investors announced that Peru’s pension fund manager has decided to invest some $300 million into the ETF over the next several months as a way to create more liquid and diversified portfolios for their investors.</p>
<p>It’s a theme that Daniel Gamba, BGI’s executive director of Latin American operations, says he’s seeing spread throughout the region.</p>
<p>IndexUniverse.com Editor Murray Coleman caught up with him at BGI’s headquarters in San Francisco on Thursday for a discussion of the growth of ETFs in Latin America. Below are excerpts from that conversation.</p>
<p><strong>IU:</strong> <strong> </strong>How much growth are you seeing in single-country Latin American ETFs?</p>
<p><strong>Gamba: </strong>The asset base for EPU since it launched in June has been growing. It was actually seeded with about $1.2 million in assets. The markets have come down in the past few days a little, but the fact that it has been growing by about $2 million a day make us fairly optimistic. The expectation is that EPU will continue to grow at least at that pace in the future. And Peru is within the top two Latin American markets currently being recommended by U.S. analysts.</p>
<p><strong>IU:</strong> In the U.S., a single-country ETF like EPU might seem like a niche product. But last year, Peru’s GDP grew at a 9% rate and it’s still Latin America’s fastest-growing economy, isn’t it?</p>
<p><strong>Gamba:</strong> Yes, and we’ve seen strong relative growth in that country for several years. Between 2002 through 2008, its GDP growth averaged 6.8%. That was larger than Brazil or any other country in Latin America. And the inflation rate in Peru continues to be one of the lowest in the region.</p>
<p><strong>IU:</strong> Do you see more pension managers in other countries investing in ETFs?</p>
<p><strong>Gamba:</strong> In Latin America, pension plans are starting to use ETFs more these days. In Chile, pension plans have about $100 billion in assets, of which around $5 billion are invested through ETFs. Our market share represents roughly 80% of those pension ETF assets. In Mexico, the total pension system is about $100 billion, with ETF pension plan assets of around $7 billion. And Peru’s pension portfolios have close to $25 billion total assets, with about $1 billion in ETFs. As a whole, our ETF market share is about 80-90% throughout Latin America.</p>
<p><strong>IU:</strong> How about Brazil?</p>
<p><strong>Gamba:</strong> We just listed local ETFs in Brazil at the end of last year. We currently have about $1.5 billion in assets through the local exchange. But across Latin America, there’s a big trend of pension plans moving into ETFs as a more liquid way to diversify their existing portfolios.</p>
<p><strong>IU:</strong> Isn’t the Latin American pension plan model being used in other parts of the world?</p>
<p><strong>Gamba:</strong> Yes, and as a result, we’re seeing ETFs being embraced in regions such as eastern Europe. Those countries are using a similar type of pension system to the one in Chile. That’s also the case in Latin America, which has also closely followed the model pioneered in Chile.</p>
<p><strong>IU:</strong> What similarities do these pension systems share?</p>
<p><strong>Gamba:</strong> Basically, we’re talking about a shared view that pension systems should obligate employees to contribute at least a certain percentage of their salaries. Then a group of select pension fund managers handle those assets. It’s similar to the U.S. 401(k) system, except in Latin America and eastern Europe, contributions are mandatory. The ETF structure is being viewed as a favorite with regulators in both of those regions as a means to diversify and add more transparency into the pension systems.</p>
<p><strong>IU:</strong> What do you expect for ETF growth rates in pension plans in the future?</p>
<p><strong>Gamba:</strong> We expect pension plan assets in Latin America to grow at an average annual rate of around 15% over the next five years. The big majority of that growth will be driven by inflows from employees, who average 28-30 years of age across the region. And again, they’re obligated to contribute.</p>
<p>By contrast, in developed markets around the world, we’re seeing pension plans growing in single digits, less than 10% a year.</p>
<p> </p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-exchange-traded-funds/gamba-peru-etf-attracting-bigger-audience/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beige Book: Bad, Not Worse &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/beige-book-bad-not-worse-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/beige-book-bad-not-worse-analyst-blog/#comments</comments>
		<pubDate>Wed, 29 Jul 2009 21:13:58 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[4th of July]]></category>
		<category><![CDATA[aerospace industry]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[architects services]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Atlanta District]]></category>
		<category><![CDATA[Atlantic coast]]></category>
		<category><![CDATA[Bhp Billiton]]></category>
		<category><![CDATA[Boston]]></category>
		<category><![CDATA[Building Materials]]></category>
		<category><![CDATA[business travel;]]></category>
		<category><![CDATA[Car Sales]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chicago District]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Chrysler]]></category>
		<category><![CDATA[clean technology]]></category>
		<category><![CDATA[Cleveland]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Dallas Districts]]></category>
		<category><![CDATA[defense-driven aerospace markets]]></category>
		<category><![CDATA[energy side]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[forward to slowly improving business]]></category>
		<category><![CDATA[gm]]></category>
		<category><![CDATA[high-tech manufacturers]]></category>
		<category><![CDATA[Information Technology]]></category>
		<category><![CDATA[information technology workers]]></category>
		<category><![CDATA[Kansas City]]></category>
		<category><![CDATA[Kansas City District]]></category>
		<category><![CDATA[legal services]]></category>
		<category><![CDATA[machinery]]></category>
		<category><![CDATA[military products]]></category>
		<category><![CDATA[Minneapolis]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[New York District]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[professional services]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[real estate category]]></category>
		<category><![CDATA[real estate leasing markets]]></category>
		<category><![CDATA[real estate lending]]></category>
		<category><![CDATA[real estate markets]]></category>
		<category><![CDATA[real estate outlook]]></category>
		<category><![CDATA[real estate sales volume]]></category>
		<category><![CDATA[reduced airline traffic]]></category>
		<category><![CDATA[residential real estate]]></category>
		<category><![CDATA[residential real estate lending]]></category>
		<category><![CDATA[residential real estate markets]]></category>
		<category><![CDATA[retail leasing sector]]></category>
		<category><![CDATA[Richmond]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Francisco District;]]></category>
		<category><![CDATA[Several Districts;]]></category>
		<category><![CDATA[sluggish retail activity]]></category>
		<category><![CDATA[St. Louis]]></category>
		<category><![CDATA[St. Louis District]]></category>
		<category><![CDATA[steel production]]></category>
		<category><![CDATA[technology sectors;]]></category>
		<category><![CDATA[transportation services]]></category>
		<category><![CDATA[travel allowances]]></category>
		<category><![CDATA[World Trade Center;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22980/Beige+Book%3A+Bad%2C+Not+Worse+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Below are some of the <em>key sections of the Summary of the Fed Beige Book</em> and my reaction to it interspersed. I have also bolded what I consider to be <strong>remarks worthy of emphasis in the report</strong>.<br />
<br />
<em>"Reports from the 12 Federal Reserve Districts suggest that economic activity continued to be weak going into the summer, but most Districts indicated that the pace of decline has moderated since the last report or that activity has begun to stabilize, albeit at a low level..." </em><br />
<br />
In other words, the economy is no longer falling off a cliff, but it has not started to climb back either. This is consistent with most of the other economic data we have been getting recently.<br />
<br />
<em>"<strong>Most Districts reported sluggish retail activity</strong>...Manufacturing activity showed some improvement in the Richmond, Chicago and Kansas City Districts; while St. Louis and Dallas reported some moderation of declines, Philadelphia and Minneapolis saw activity decrease and most other Districts indicated that manufacturing activity continued at low levels.</em><br />
<br />
<em>"Boston, Richmond, St. Louis, Minneapolis and San Francisco reported contractions in services industries. Banking sectors in the New York, Cleveland, Richmond, St. Louis, Kansas City and San Francisco Districts experienced weaker demand for some categories of loans. Residential real estate markets stayed soft in most Districts, although many noted some signs of improvement. By contrast, commercial real estate markets weakened further in recent months in two-thirds of the Districts and remained slow in the others."</em><br />
<br />
A very mixed picture, but that mixed picture represents a substantial improvement over the extremely dire presentation in previous months. Again, sort of what you would expect when we are bumping along the bottom.<br />
<br />
<em>"Districts reported varied -- but generally modest -- price changes across sectors and products, <strong>with competitive pressures damping increases</strong>; however, Boston, Cleveland, Chicago, Minneapolis and Dallas noted that some metals prices have increased in recent months. Most Districts indicated that <strong>labor markets were extremely soft, with minimal wage pressures</strong>, and cited the use of various methods of reducing compensation in addition to, or instead of, freezing or cutting wages."</em><br />
<br />
Inflation is not a problem at this time (but could become a more serious one in the future). The increase in metals prices is interesting, but most metals are easily traded goods, and the pick up in prices could be due to stronger demand abroad, particularly in China.<br />
<br />
This is good news for the big mining firms like <strong>Freeport McMoran</strong> (<a href="http://www.zacks.com/stock/quote/fcx">FCX</a>) and <strong>BHP Billiton</strong> (<a href="http://www.zacks.com/stock/quote/bhp">BHP</a>). It will be hard to get an old fashioned wage-price spiral going with the wage side having no traction whatsoever.<br />
<br />
To the extent inflation does show up, it will be on the food and energy side, not core inflation. The end result will be a reduction in the real standard of living of the average American, not a runway inflationary cycle like in the 1970&#8217;s.<br />
<br />
<em>"<strong>Consumer Spending and Tourism</strong></em><br />
<br />
<em>"<strong>Consumer spending in the early summer remained below previous-year levels</strong> in most Districts, as households continued to be price conscious. Boston, Kansas City and San Francisco experienced either modest sales increases or less negative sales results than in recent reporting periods. Philadelphia, Atlanta, St. Louis, New York and Dallas cited flat or mixed sales, while sales in the remaining Districts remained soft.</em><br />
<br />
<em>"Several Districts noted that consumers focused on purchasing less expensive necessities, while sales of big-ticket items languished. Retailers in Boston, Philadelphia and Dallas characterized their outlook as 'cautious.'</em><br />
<br />
<em>"Auto sales were mixed across the country. Chicago, Minneapolis and Kansas City saw modest increases in car sales, while New York, Philadelphia, Cleveland and Atlanta continued to experience subdued sales. The exception was sales of used vehicles, which continued to be strong or were strengthening, according to Philadelphia, Cleveland, Atlanta, Kansas City and San Francisco.</em><br />
<br />
<em>"Travel and tourism declined in the majority of Districts. The San Francisco District observed a sharp drop in luxury and business travel, while tourism activity in New York City was weak but stable since the last Beige Book report. Tourism contacts along the Atlantic coast reported that with the exception of July 4th holiday bookings, business was generally weaker than a year ago. Hotel room rates have declined in several Districts."</em><br />
<br />
People are reacting to substantially reduced wealth from both housing and the stock market, as well as slowing incomes due to layoffs and reduced hours or wages. They need to rebuild their balance sheets by increasing savings or paying down debts. As a result, they are keeping their wallets shut as much as they can.<br />
<br />
Discretionary spending is, well, discretionary -- at least in the short term. As such it is the hardest hit. Tourism is sort of the ultimate in discretionary spending, so it is among the hardest hit areas. I would expect the major hotel companies like <strong>Starwood</strong> (<a href="http://www.zacks.com/stock/quote/hot">HOT</a>) and <strong>Marriott </strong>(<a href="http://www.zacks.com/stock/quote/mar">MAR</a>) face a tough intermediate-term future.<br />
<br />
Auto sales got down to an unsustainably low level, well below the normal rate at which cars go to the scrap heap. Thus it not surprising to see some rebound, but it is doubtful we will see the over 15 million a year rate that was the norm earlier this decade and in the 1990&#8217;s for quite awhile.<br />
<br />
<em>"<strong>Nonfinancial Services</strong></em><br />
<em><br />
"District reports regarding<strong> nonfinancial services industries were largely negative</strong>, although they included a few bright spots. The Minneapolis, St. Louis, and Dallas Districts indicated that demand for professional services such as business support, architecture and legal services continued to decline or remained soft. By contrast, reports from the health care sector were largely positive, with the San Francisco, Minneapolis and Richmond Districts citing steady-to-increased demand for medical services, and the Atlanta, Cleveland, Chicago and Dallas Districts reporting hiring activity in health care.</em><br />
<br />
<em>"Technology-related firms in the Kansas City District also reported heightened activity, especially in the clean technology and defense-driven aerospace markets. Richmond and Minneapolis noted increased demand for information technology workers, and Atlanta saw hiring activity in the defense and aerospace industry.</em><br />
<br />
<em>"Staffing industry contacts in numerous Districts suggested a higher demand for temporary or part-time workers over permanent hires, and Atlanta noted that employers were taking advantage of a higher supply of skilled labor to improve the quality of their workforces.</em><br />
<br />
<em>"Nearly all Districts reporting on <strong>transportation services observed continued weakness</strong>. Freight transport respondents from the Atlanta, Dallas and Cleveland Districts noted that <strong>cargo volumes remain below year-earlier levels</strong>. While Cleveland contacts reported that competitive shipping rates are being maintained, trucking contacts from the Atlanta District noted that an oversupply of trucks relative to demand has exerted <strong>downward pressure on rates</strong>. A few Districts also reported reduced airline traffic, especially amongst business travelers."</em><br />
<br />
Well there is a surprise -- health care is still growing while the rest of the economy is shrinking. This has been a pretty consistent pattern for...oh, the last 30 years or so...as health care becomes an ever larger part of the economy.<br />
<br />
It would be nice if there were some evidence that such spending were making us healthier, but there isn&#8217;t that much, especially relative to other countries that spend far less on health care and where the spending is growing more slowly. The weakness in freight traffic is a pretty key metric of how the overall economy is doing, and it is worthwhile to note that while they say it is below year-ago levels, they do not mention further deterioration in volumes, just that the oversupply of trucks is putting downward pressure on prices.<br />
<br />
One more factor on the side of deflation currently -- the pick up in temp hires might be a positive straw in the wind. It shows some more demand, but businesses are not sure if it is permanent yet.<br />
<br />
<em>"<strong>Manufacturing</strong></em><br />
<br />
<em>"Reports on the manufacturing sector remained subdued but were slightly more positive than in the previous Beige Book. Many Districts characterized <strong>manufacturing activity as remaining depressed but with selected signs of modest improvement...albeit chiefly in nondurables</strong> industries. Districts attributed some of the recent increases in production to replenishment of finished-goods or customer inventories.</em><br />
<br />
<em>"Chicago indicated that the quick resolutions of the Chrysler and GM bankruptcies have boosted business confidence, and that automakers were scheduling a pickup in production for July...Steel production remained depressed but has leveled off or increased somewhat...Refineries increased their capacity utilization slightly over the past six weeks, but overall industry conditions remain weak because of low demand for fuels.</em><br />
<br />
<em>"Various District reports noted cancellations of orders for commercial aircraft and continued weak demand for most types of equipment and machinery. Among the positive developments in manufacturing, several Districts mentioned pickups in technology sectors, or cited strong or rising sales of military products or pharmaceuticals.</em><br />
<br />
<em>"Comments on the near-term outlook varied across Districts, but on the whole they appear consistent with a forecast of <strong>modest and uneven recovery in manufacturing output beginning during roughly the coming six to twelve months</strong>. New York, Philadelphia and Atlanta indicated that manufacturers have a generally positive or improved near-term outlook. Dallas reported that high-tech manufacturers 'are seeing some upside potential in their forecasts instead of just down-side risks,' but that construction-related manufacturers 'expect no improvement in the near term.'</em><br />
<br />
<em>"Boston indicated that many respondents expect continued sub-par revenue numbers for the remainder of the year, but 'look forward to slowly improving business in 2010,' while Cleveland and Kansas City reported that manufacturing contacts expect little or no change in demand through the end of 2009."</em><br />
<br />
It looks like we might be on the cusp of an improvement in manufacturing, but just to replenish inventories that have gotten down to very low levels. That would be welcome, but is not sustainable unless final demand also picks up, and with incomes under pressure and a desire to save a bigger proportion of that income, demand is likely to remain soft for the foreseeable future. The improvement in Tech is consistent with what we have been seeing in the estimate revisions data, where analysts have been generally raising their sights lately for Tech firms earnings.<br />
<br />
<em>"<strong>Real Estate and Construction</strong></em><br />
<em><br />
"<strong>Commercial real estate leasing markets were described as either 'weak' or 'slow' </strong>in all 12 Districts, although the severity of the downturn varied somewhat across Districts...<strong>resulting in sizable leasing concessions and/or declines in asking rents</strong>. Significant weakness in the retail leasing sector was reported for the Boston, Minneapolis and New York Districts, and industrial vacancy increased in the Atlanta, Dallas, Minneapolis and St. Louis Districts.</em><br />
<em><br />
"<strong>Commercial real estate sales volume remained low, even 'non-existent' in some Districts</strong>, reportedly due to a combination of tight credit and weak demand. Construction activity was limited and/or declining in most Districts, although exceptions were noted for health and institutional construction in the St. Louis District, public sector construction in the Chicago District, and the reconstruction of the World Trade Center in Manhattan. Tight credit was cited as an ongoing factor in the dearth of new construction activity.</em><br />
<br />
<em>"The commercial real estate outlook was mixed, both within and across Districts. Some contacts expect commercial real estate markets to improve within two quarters, and others predict further market deterioration for the remainder of 2009 and possibly through late 2010."</em><br />
<br />
Commercial Real Estate is proving to be to late 2009 and 2010 what residential real estate was to 2008 and early 2009. It is going to be the major source of new headaches for the banks. With rents falling and vacancies rising, declining construction activity is a good thing, although I am sure that construction workers do not agree with me on that.<br />
<br />
Most of the non-residential construction activity that is going on appears to be tied to the stimulus package or related to health care. Given the weakness for architects services noted above, commercial construction activity is likely to remain depressed for awhile.<br />
<br />
<em>"Residential real estate markets in most Districts remained weak, but many reported signs of improvement. The Minneapolis and San Francisco Districts cited large increases in home sales compared with 2008 levels, and other Districts reported rising sales in some submarkets.</em><br />
<br />
<em>"Of the areas that continued to experience year-over-year sales declines, all except St Louis -- where sales were down steeply --  also reported that the pace of decline was moderating. In general, the low end of the market, especially entry-level homes, continued to perform relatively well; contacts in the New York, Kansas City and Dallas Districts attributed this relative strength, at least in part, to the first--time homebuyer tax credit. Condo sales were still far below year-before levels according to the Boston and New York reports.</em><br />
<em><br />
"In general, home prices continued to decline in most markets, although a number of Districts saw possible signs of stabilization. The Boston, Atlanta and Chicago Districts mentioned that the increasing number of foreclosure sales was exerting downward pressure on home prices. Residential construction reportedly remains quite slow, with the Chicago, Cleveland and Kansas City Districts noting that financing is difficult."</em><br />
<br />
The housing market is awful, but has stopped getting worse. Sales are starting to pick up, but it is going to be awhile before prices start to recover. Foreclosures will continue to weigh on the market for at least the next few quarters. The first-time homebuyer tax credit program appears to be a success, and inventories are coming down to more manageable levels.<br />
<em><br />
"<strong>Banking and Financial Services</strong></em><br />
<br />
<em>"In most reporting Districts, overall lending activity was stable or weakened further for most loan categories. In contrast, Philadelphia reported a slight increase in business, consumer and residential real estate lending. <strong>As businesses remained pessimistic and reluctant to borrow, demand for commercial and industrial loans continued to fall or stay weak</strong> in the New York, Richmond, St. Louis, Kansas City, Dallas and San Francisco Districts. Consumer loan demand decreased in New York, St. Louis, Kansas City and San Francisco, stabilized at a low level in Chicago and Dallas, and was steady to up in Cleveland.</em><br />
<br />
<em>"Residential real estate lending decreased in New York, Richmond, and St. Louis. Dallas reported steady but low outstanding mortgage volumes, while Kansas City noted that the rise in mortgage loans slowed. Refinancing activity fell dramatically in Richmond, decreased in New York and Cleveland, and maintained its pace in Dallas. Bankers in the New York District indicated no change in delinquency rates in all loan categories except residential mortgages, while Cleveland, Atlanta and San Francisco reported rising delinquencies on loans linked to real estate.</em><br />
<br />
<em>"Banks continued to tighten credit standards in the New York, Philadelphia, Richmond, Chicago, Kansas City, Dallas and San Francisco Districts, and some have stepped up the requirements for the commercial real estate category, in particular, due to concern over declining loan quality. Meanwhile, Cleveland and Atlanta reported that higher credit standards remained in place, with no change expected in the near term. Credit quality deteriorated in Philadelphia, Cleveland, Kansas City and San Francisco, while loan quality exceeded expectations in Chicago and remained steady in Richmond."</em><br />
<br />
In an overleveraged country, I am not sure that the decline in lending activity is such a bad thing from a long-term point of view, however it does slow down economic growth. Given how fast public debt is growing, if loan demand were also strong in the private sector it is likely that interest rates would rise, perhaps rather sharply.<br />
<br />
We saw the same pattern in terms of lending activity with residential mortgages that is now happening on the commercial side. As prices fall, the bankers are not as sure about the value of the collateral and become more reluctant to lend. Then again, those falling prices are evidence of a glut of available resources, so adding to the inventory of unused offices and strip malls is probably not a good thing to do in any case.<br />
<br />
The decline in residential mortgage activity is probably a reflection of the recent rise in mortgage rates (relative to April and May). It does call into question the sustainability of the recent pick-up we saw in home sales (both new and used).<br />
<br />
<em>"</em><strong><em>Employment, Wages and Prices</em></strong><br />
<br />
<em>"<strong>All Districts indicated that labor markets remain slack, with most sectors either reducing jobs or holding steady, and aggregate employment continuing to decline</strong>, on net. However, Boston, Cleveland, Richmond, Atlanta, Chicago, St. Louis and Minneapolis noted selective hiring, including attempts by some firms to take advantage of layoffs elsewhere to pick up experienced talent.</em><br />
<br />
<em>"Richmond, Chicago, St. Louis and Dallas cited moderation in the pace of manufacturing employment decline since the last report, and New York noted some signs of labor market stabilization. But Atlanta reported further deterioration in labor market conditions and additional job cuts already planned for coming months.</em><br />
<br />
<em>"<strong>The weakness of labor markets has virtually eliminated upward wage pressure, and wages and compensation are steady or falling in most Districts</strong>; however, Boston cited some manufacturing and business services firms raising pay selectively, and Minneapolis said wage increases were moderate. Boston, Cleveland, Richmond, Chicago, Dallas and San Francisco cited a range of methods firms are using to limit compensation, i<strong>ncluding cutting or freezing wages or benefit contributions, deferral of future salary increases, trimming bonuses and travel allowances, reducing hours, temporary shutdowns, periodic furloughs and unpaid vacations</strong>.</em><br />
<br />
<em>"<strong>Most Districts reported that upward price pressures were minimal</strong>. Manufacturers in the Boston, Philadelphia, Atlanta, Minneapolis, Kansas City and Dallas Districts indicated that most materials costs were flat or down; however, several Districts mentioned price increases for some metals, petrochemicals and building materials.</em><br />
<br />
<em>"While the Boston, New York and Kansas City reports say a few firms are making modest price increases stick, selling prices of most manufacturers and retailers were reportedly held down by competitive pressures. Services firms have increased discounting and/or cut fees, according to contacts in Boston, Philadelphia, Atlanta, Dallas and San Francisco, while Richmond indicated price increases for services were mild."</em><br />
<br />
The current economic environment is by its nature deflationary, which tends to raise real interest rates and further slow economic activity. The private sector is attempting to deleverage and repair balance sheets. The policy responses to this have been explicitly inflationary to counteract the natural deflation.<br />
<br />
For the time being, it looks like the forces of deflation continue to have the upper hand. I don&#8217;t see where the increasing prices for building materials are coming from given the weak construction markets, unless they are being exported. I suspect the strength in metals prices is also mostly coming from China.<br />
<br />
Core inflation is likely to remain subdued, and businesses will have trouble making any attempted price increase stick. If inflation shows up, it is likely to first show up on the food and energy side, and will cause headline inflation to outpace the rate of compensation growth. Given the cutting or freezing of wages, etc. it will not take much in the way of headline inflation to reduce the real standard of living of most people.<br />
<br />
Overall, this was a downbeat report, but not as downbeat as we have seen in recent months. The picture is one of an economy stuck in the mud, not one falling off a cliff. For now, deflation remains a more significant threat than inflation, but given the increase in the size of the Fed balance sheet, it is not time to forget about potential inflation down the road.<br />
<br />
Unemployment is going to be a very big problem for quite awhile. That slack in the economy will make it hard for inflation to gain traction. People are not going to be seeing their incomes go up, and will want to save more of what they do earn.<br />
<br />
This will be a double-whammy on consumption. Over the long term, this is not a bad thing, since at over 70% consumption is a far bigger share of our economy than it is for most of our competitors. But at 70% of the economy, if consumption is weak, there is no way for the economy as a whole to avoid being weak.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FCX">Read the full analyst report on "FCX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BHP">Read the full analyst report on "BHP"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HOT">Read the full analyst report on "HOT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MAR">Read the full analyst report on "MAR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/beige-book-bad-not-worse-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Auxilio Inc. (AUXO.OB‏) is “One to Watch”</title>
		<link>http://www.straightstocks.com/market-commentary/auxilio-inc-auxo-ob%e2%80%8f-is-%e2%80%9cone-to-watch%e2%80%9d/</link>
		<comments>http://www.straightstocks.com/market-commentary/auxilio-inc-auxo-ob%e2%80%8f-is-%e2%80%9cone-to-watch%e2%80%9d/#comments</comments>
		<pubDate>Wed, 29 Jul 2009 18:15:23 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[and Huntington Hospital]]></category>
		<category><![CDATA[Auxilio Inc.]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[document management services]]></category>
		<category><![CDATA[health care systems;]]></category>
		<category><![CDATA[health systems]]></category>
		<category><![CDATA[Healthcare Industry]]></category>
		<category><![CDATA[integrated health delivery networks]]></category>
		<category><![CDATA[MemorialCare]]></category>
		<category><![CDATA[Mission Viejo;]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[Saint Barnabas Medical Center]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Scottsdale Healthcare]]></category>
		<category><![CDATA[St. Joseph Health System]]></category>
		<category><![CDATA[turnkey healthcare document-management services]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=16781</guid>
		<description><![CDATA[Headquartered in Mission Viejo, California, and trading on the OTCBB, Auxilio Inc. provides outsourced document management services to the healthcare industry. Founded in California in 2001, the company also has operations in Philadelphia, Pennsylvania, as well as San Francisco, California. Auxilio Inc. owns technology, systems, and methodologies that form the basis of their intellectual property [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/auxilio-inc-auxo-ob%e2%80%8f-is-%e2%80%9cone-to-watch%e2%80%9d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Seven Myths of U.S. Healthcare Reform</title>
		<link>http://www.straightstocks.com/market-commentary/the-seven-myths-of-u-s-healthcare-reform-2/</link>
		<comments>http://www.straightstocks.com/market-commentary/the-seven-myths-of-u-s-healthcare-reform-2/#comments</comments>
		<pubDate>Wed, 29 Jul 2009 12:58:38 +0000</pubDate>
		<dc:creator>Justice Litle</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[actor]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[AQR Capital Management]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Cliff Asness]]></category>
		<category><![CDATA[Clifford  Asness]]></category>
		<category><![CDATA[Co-Exist]]></category>
		<category><![CDATA[contrarian profits]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[experimental technology]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[free market healthcare]]></category>
		<category><![CDATA[George Soros]]></category>
		<category><![CDATA[government-run healthcare systems]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[Healthcare Industry]]></category>
		<category><![CDATA[Healthcare Reform]]></category>
		<category><![CDATA[healthcare technology;]]></category>
		<category><![CDATA[home entertainment equipment]]></category>
		<category><![CDATA[home entertainment technology]]></category>
		<category><![CDATA[humble editor]]></category>
		<category><![CDATA[Larry Ellison]]></category>
		<category><![CDATA[late actor]]></category>
		<category><![CDATA[leeching]]></category>
		<category><![CDATA[Mark Twain]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Oracle]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[Robert  Stack]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[serviceable DVD player]]></category>
		<category><![CDATA[stuffy fund manager]]></category>
		<category><![CDATA[super-expensive DVD player]]></category>
		<category><![CDATA[undeveloped real estate;]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Unsolved Mysteries]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[We Can]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=19506</guid>
		<description><![CDATA[pWhen it comes to healthcare reform, people believe some  very strange things. Or so says Cliff Asness, founder of AQR Capital  Management. Today, the seven biggest #8220;myths#8221; are exposed#8230;/p
pMy little brother and his fiancée dropped into Reno/Tahoe  for the weekend. They were wending their way west to go apartment hunting in  San Francisco, visiting friends and family along the way./p
pOn Saturday we took a two-hour catamaran cruise up at the  lake. It was as perfect a day as I#8217;d ever seen it. The water was so clear and  blue, you could see 30 feet down through the netting of the boat. The sky was  just as blue – not a cloud to be seen – and the day was just#8230;/p]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/the-seven-myths-of-u-s-healthcare-reform-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PennyOmega.com Stock Report! 7/28/09, CMCSA, ES, DRIV, EGLE, IBM, MHGC</title>
		<link>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-72809-cmcsa-es-driv-egle-ibm-mhgc/</link>
		<comments>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-72809-cmcsa-es-driv-egle-ibm-mhgc/#comments</comments>
		<pubDate>Tue, 28 Jul 2009 19:07:22 +0000</pubDate>
		<dc:creator>PennyOmega.com</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[American Express]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[business to business]]></category>
		<category><![CDATA[Comcast]]></category>
		<category><![CDATA[communications products]]></category>
		<category><![CDATA[Digital River Inc]]></category>
		<category><![CDATA[e-commerce site;]]></category>
		<category><![CDATA[e-commerce solutions]]></category>
		<category><![CDATA[Eagle Bulk Shipping Inc.]]></category>
		<category><![CDATA[East Bay]]></category>
		<category><![CDATA[energy savings]]></category>
		<category><![CDATA[EnergySolutions Inc.]]></category>
		<category><![CDATA[Hanford Site Waste Treatment Plant]]></category>
		<category><![CDATA[Ibm]]></category>
		<category><![CDATA[Information Technology]]></category>
		<category><![CDATA[leadership development products]]></category>
		<category><![CDATA[Lominger International]]></category>
		<category><![CDATA[Morgans Hotel Group Co.]]></category>
		<category><![CDATA[North Bay]]></category>
		<category><![CDATA[online store]]></category>
		<category><![CDATA[PennyOmega.com]]></category>
		<category><![CDATA[promotional campaigns]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Jose]]></category>
		<category><![CDATA[social network]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[The Escapist]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://pennyomega.com/?p=545</guid>
		<description><![CDATA[<p>&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;&#60;</p>
]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pennyomega-com-stock-report-72809-cmcsa-es-driv-egle-ibm-mhgc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pro-Tech Industries, Inc. (PTCK.OB) Subsidiary Secures Approximately $1.3 Million in Additional Contracts for 2009</title>
		<link>http://www.straightstocks.com/market-commentary/pro-tech-industries-inc-ptck-ob-subsidiary-secures-approximately-1-3-million-in-additional-contracts-for-2009/</link>
		<comments>http://www.straightstocks.com/market-commentary/pro-tech-industries-inc-ptck-ob-subsidiary-secures-approximately-1-3-million-in-additional-contracts-for-2009/#comments</comments>
		<pubDate>Tue, 28 Jul 2009 16:12:42 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Conesco Inc.]]></category>
		<category><![CDATA[design-build services]]></category>
		<category><![CDATA[local agencies]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Pro-Tech Fire Protection Systems Corp.]]></category>
		<category><![CDATA[Pro-Tech Industries Inc.]]></category>
		<category><![CDATA[Sacramento]]></category>
		<category><![CDATA[San Diego]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Sean McGuire]]></category>
		<category><![CDATA[telecommunications]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=16704</guid>
		<description><![CDATA[Pro-Tech Fire Protection Systems Corp., a wholly owned subsidiary of Pro-Tech Industries, Inc. and provider of design-build services for the fire protection, alarm and detection, telecommunications, network services, flooring and electrical contracting industries, recently announced that the company has secured new contracts totaling approximately $1.3 million for its fire protection business unit. Management anticipates that [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/pro-tech-industries-inc-ptck-ob-subsidiary-secures-approximately-1-3-million-in-additional-contracts-for-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Reed’s, Inc. (REED) Engages Boutique Investment Bank to Identify Strategic Partnership and Investment Opportunities</title>
		<link>http://www.straightstocks.com/market-commentary/reed%e2%80%99s-inc-reed-engages-boutique-investment-bank-to-identify-strategic-partnership-and-investment-opportunities/</link>
		<comments>http://www.straightstocks.com/market-commentary/reed%e2%80%99s-inc-reed-engages-boutique-investment-bank-to-identify-strategic-partnership-and-investment-opportunities/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 20:21:36 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Beverage Industry]]></category>
		<category><![CDATA[Brent Knudsen]]></category>
		<category><![CDATA[Chris Reed]]></category>
		<category><![CDATA[Founder and CEO]]></category>
		<category><![CDATA[Founder and Managing Partner]]></category>
		<category><![CDATA[natural food channel]]></category>
		<category><![CDATA[natural food industry]]></category>
		<category><![CDATA[Partnership Capital Growth Advisors]]></category>
		<category><![CDATA[PCGA]]></category>
		<category><![CDATA[Reed’s Inc.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=16451</guid>
		<description><![CDATA[Reed&#8217;s, Inc. announced earlier today that it has engaged the services of San Francisco-based Partnership Capital Growth Advisors (PCGA). As terms of the agreement, PCGA will introduce the company to potential strategic partners within the beverage industry. 
Chris Reed, Founder and CEO of Reed&#8217;s, Inc., commented, &#8220;Partnership Capital Growth is ideally suited to assist Reed&#8217;s [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/reed%e2%80%99s-inc-reed-engages-boutique-investment-bank-to-identify-strategic-partnership-and-investment-opportunities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cousins Properties Cuts Dividend &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/cousins-properties-cuts-dividend-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/cousins-properties-cuts-dividend-analyst-blog/#comments</comments>
		<pubDate>Fri, 17 Jul 2009 17:10:49 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[Charlotte]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[retail landlords]]></category>
		<category><![CDATA[Retail Space]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington DC]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22380/Cousins+Properties+Cuts+Dividend+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Cousins Properties Inc. </strong>(<a href="http://www.zacks.com/stock/quote/CUZ">CUZ</a>), a leading real estate investment trust (REIT), has drastically reduced its third quarter dividend in order to conserve cash in the current credit-constrained market. The company has declared a third quarter dividend of $0.15 per share, down from $0.25 in the previous quarter.</p>
<p>The reduction in the quarterly dividend payout was based on the current estimate of taxable income. In order to maintain the REIT standard, companies are required to pay annually at least 90% of the taxable income as shareholder dividends.</p>
<p>Cousins Properties will pay the third quarter dividend in a combination of cash and stock. The cash component would not exceed one-third of the total dividend. Shareholders would have the right to decide on the composition of the dividends.</p>
<p>With the reduction in dividend, the company expects to retain a significant portion of its resources to capitalize on potential investment opportunities surfacing during the current recession. Furthermore, in order to increase liquidity, Cousins Properties have also scaled back its retail and office development pipeline.</p>
<p>As of March 31, 2009, the owned portfolio (including development/redevelopment properties) of the company consisted of interest in 7.5 million square feet of office space, 4.7 million square feet of retail space, 2.0 million square feet of industrial space, and 9,529 acres of land for future sale or commercial development.</p>
<p>In addition, Cousins Properties (including JVs) had four retail and office projects in various stages of development, totaling 1.8 million square feet. The properties are spread throughout the US, including Atlanta, Charlotte, Austin, San Francisco, Los Angeles and Washington DC.</p>
<p>Market fundamentals are deteriorating for office and retail landlords throughout the country due to the continued economic downturn. With high market vacancies and no job growth, rental rate growth on new leases will also be non-existent for some time.</p>
<p>Consequently, with no short-term growth indicators, the company represents a bleak outlook. We reiterate our Sell rating of the company.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CUZ">Read the full analyst report on "CUZ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cousins-properties-cuts-dividend-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Taubman Finally Loses Oyster Bay  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/taubman-finally-loses-oyster-bay-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/taubman-finally-loses-oyster-bay-analyst-blog/#comments</comments>
		<pubDate>Mon, 13 Jul 2009 16:42:10 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Denver]]></category>
		<category><![CDATA[Detroit]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[New York State Court of Appeals]]></category>
		<category><![CDATA[Orlando]]></category>
		<category><![CDATA[Oyster Bay]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Spokesperson]]></category>
		<category><![CDATA[Tampa]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington DC]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/22127/Taubman+Finally+Loses+Oyster+Bay++-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Taubman Centers Inc.</strong> (<a href="http://www.zacks.com/stock/quote/tco">TCO</a>), a leading real estate investment trust (REIT), suffered a major setback recently as an unfavorable court ruling barred it from continuing construction of a proposed shopping mall in Oyster Bay, New York.
<p align="left">After 15 years of litigation, The New York State Court of Appeals &#8211; the highest court in the state &#8211; ruled against Taubman and upheld the plea of local activists on environmental grounds. In view of the court ruling, the company would probably have to write off over $150 million invested in the project.</p>
<p align="left">The recent court order forbids Taubman to develop a high-end mall at the site and leaves it with three options &#8211; a) accepting defeat and selling the land; b) contemplating a mixed-use development; or c) re-appealing against the court order. A spokesperson said that the company is currently evaluating all options before taking a final call on the decision.</p>
<p align="left">Taubman owns, develops, acquires and operates regional shopping centers throughout the US. A large number of these shopping centers are strategically located in major metropolitan areas, including Los Angeles, San Francisco, Denver, Detroit, Phoenix, Miami, Dallas, Tampa, Orlando and Washington DC.</p>
<p align="left">The Oyster Bay project had been a continuous drag on the company&#8217;s earnings. During the fourth quarter of 2008, Taubman recorded $116 million as impairment charges for the project due to continued delay and uncertainty regarding completion of the project.</p>
<p align="left">Taubman has a high quality roster of high-end and specialty retailers at its malls and commands some of the highest rents in its sector. High-end and specialty retailers have been the hit hardest in the current recession and this trend will continue through at least the end of this year.</p>
<p align="left">The recent spate of unfavorable court rulings would also add to the woes of the company. However, we think Taubman is better positioned than many peers due to its clean balance sheet and minimal debt maturities. We reiterate our Hold rating of the company.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TCO">Read the full analyst report on "TCO"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taubman-finally-loses-oyster-bay-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Bull and Bear of the Day Highlights: MIPS Technologies, Altria Group, Citigroup, Bank of America and JPMorgan Chase &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-mips-technologies-altria-group-citigroup-bank-of-america-and-jpmorgan-chase-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-mips-technologies-altria-group-citigroup-bank-of-america-and-jpmorgan-chase-press-releases/#comments</comments>
		<pubDate>Thu, 09 Jul 2009 13:55:12 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Altria Group]]></category>
		<category><![CDATA[analog]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[broadband access;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[embedded processors;]]></category>
		<category><![CDATA[Jpmorgan Chase]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[MIPS Technologies]]></category>
		<category><![CDATA[moist smokeless tobacco manufacturer]]></category>
		<category><![CDATA[negative commercial real estate credit quality trends]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[real estate categories]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Jose]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[UST]]></category>
		<category><![CDATA[Williams]]></category>
		<category><![CDATA[wireless communications]]></category>
		<category><![CDATA[Zacks Equity Research]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21993/Zacks+Bull+and+Bear+of+the+Day+Highlights%3A+MIPS+Technologies%2C+Altria+Group%2C+Citigroup%2C+Bank+of+America+and+JPMorgan+Chase+-+Press+Releases</guid>
		<description><![CDATA[<strong>For Immediate Release</strong>
<p align="left">Chicago, IL &#8211; July 9, 2009 &#8211; Zacks Equity Research highlights <strong>MIPS Technologies </strong>(<a href="void(0)">MIPS</a>) as the Bull of the Day and <strong>Altria Group </strong>(<a href="void(0)">MO</a>) the Bear of the Day. In addition, Zacks Equity Research provides analysis on <strong>Citigroup </strong>(<a href="void(0)">C</a>), <strong>Bank of America </strong>(<a href="void(0)">BAC</a>) and <strong>JPMorgan Chase </strong>(<a href="void(0)">JPM</a>).</p>
<p align="left">Full analysis of all these stocks is available at http://at.zacks.com/?id=2676.</p>
<p align="left">Here is a synopsis of all five stocks:</p>
<p align="left"><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=6">Bull of the Day</a>:</p>
<p align="left"><strong>MIPS Technologies </strong>(<a href="void(0)">MIPS</a>) develops embedded processors and intellectual property for use in performance-oriented markets such as digital entertainment, wired and wireless communications (including broadband access), office automation, security and automotive markets.</p>
<p align="left">The firm continues to drive bottom-line margins higher in a very difficult environment. The valuation on MIPS has become very compelling as the stock has shed significant value from its 52-week high and the new acquisition has the potential to drive margin expansion.</p>
<p align="left">Further, MIPS recently sold its analog business, which is highly accretive. We would be buyers of the stock at these levels.</p>
<p align="left"><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=7">Bear of the Day</a>:</p>
<p align="left"><strong>Altria Group </strong>(<a href="void(0)">MO</a>) is the leading domestic tobacco company, which generates significant cash flow and the stock has a high dividend yield. In an effort to expand into adjacent categories, Altria acquired UST, the world's leading moist smokeless tobacco manufacturer.</p>
<p align="left">However, the company is engaged in numerous tobacco liability suits. Several large punitive damage awards have been upheld, most recently the $79.5 million judgment in the Williams case in 2009.</p>
<p align="left">In addition, the 150+% federal excise tax increase should dramatically reduce cigarette volume. A Sell rating is recommended.</p>
<p align="left">Latest Posts on the Zacks <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><em>Even Landlords May Be Hurting</em></p>
<p align="left">2Q09 asking rent fell 0.7% year-over-year to $1,040 a month, and down 0.6% from on a linked quarter basis. In the U.S.&#8217;s largest U.S.&#8217;s apartment market, New York, vacancies fell 0.5% on a linked quarter basis and a 4.0% declined year-over-yearto 2.9%, despite a 1.7% decrease in rent to the $2,680 level. In addition, other areas of the country (such as Las Vegas, San Francisco and San Jose, California) had effective rents that dropped more than 2.0% year-over-year.</p>
<p align="left">Nationally the picture may grow worse, with approximately 45% of the more than 100,000 units from new construction for 2009 already on the market. As unemployment has continued to mount, the largest tenant group -- 18-24-year-olds -- has been hardest hit.</p>
<p align="left">With general expectations of an economic recovery pushed back to early 2010, lower rents and higher vacancies should be expected to continue over the near term.</p>
<p align="left">With the apartment buildings sector typically the leader for all commercial real estate categories with respect to defaults, it is extremely probable that financial institutions such as (but not limited to) <strong>Citigroup </strong>(<a href="void(0)">C</a>), <strong>Bank of America </strong>(<a href="void(0)">BAC</a>) and <strong>JPMorgan Chase </strong>(<a href="void(0)">JPM</a>) will continue to experience negative commercial real estate credit quality trends during the coming quarters.</p>
<p align="left">Get the full analysis of all these stocks by going to <a href="http://at.zacks.com/?id=5507">http://at.zacks.com/?id=5507</a>.</p>
<p align="left"><strong>About the Bull and Bear of the Day</strong></p>
<p align="left">Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.</p>
<p align="left"><strong>About the Analyst Blog</strong></p>
<p align="left">Updated throughout every trading day, the <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a> provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks <a href="http://at.zacks.com/?id=5508">"Profit from the Pros"</a> e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting <a href="http://at.zacks.com/?id=5508">http://at.zacks.com/?id=5508</a>.</p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of <a href="http://www.zacks.com/">Zacks Investment Research</a>, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the <a href="http://www.zacks.com/rank/index.php">Zacks Rank</a>, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5509">http://at.zacks.com/?id=5509</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/ZacksInvestment">http://twitter.com/ZacksInvestment</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-mips-technologies-altria-group-citigroup-bank-of-america-and-jpmorgan-chase-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Even Landlords May Be Hurting &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/even-landlords-may-be-hurting-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/even-landlords-may-be-hurting-analyst-blog/#comments</comments>
		<pubDate>Wed, 08 Jul 2009 17:44:39 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Jpmorgan Chase]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[negative commercial real estate credit quality trends]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[real estate categories]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[San Jose]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Bancorp]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21953/Even+Landlords+May+Be+Hurting+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Given our current economic environment, what appears to be a counter-intuitive trend has evolved. At 7.5%, the national vacancy rate for U.S. apartments is poised to broach the highest rate of 7.8% recorded in 1986 since the data has been tracked.<br />
<br />
As of 2Q09, the vacancy rate was 20 bps higher on a linked quarter basis, and up from the 5.5% cyclical attained during 2006. In order to retain some of the occupancy levels, many landlords have sacrificed rental income and enhanced renter concessions/incentives. When these concessions/incentives (such as free months of rent and other items), the effective vacancy rate was down 0.9% on a linked quarter basis and down 1.9% year-over-year.<br />
<br />
As a result, 2Q09 asking rent fell 0.7% year-over-year to $1,040 a month, and down 0.6% from on a linked quarter basis. In the U.S.&#8217;s largest U.S.&#8217;s apartment market, New York, vacancies fell 0.5% on a linked quarter basis and a 4.0% declined year-over-yearto 2.9%, despite a 1.7% decrease in rent to the $2,680 level. In addition, other areas of the country (such as Las Vegas, San Francisco and San Jose, California) had effective rents that dropped more than 2.0% year-over-year.<br />
<br />
Nationally the picture may grow worse, with approximately 45% of the more than 100,000 units from new construction for 2009 already on the market. As unemployment has continued to mount, the largest tenant group -- 18-24-year-olds -- has been hardest hit.<br />
<br />
With general expectations of an economic recovery pushed back to early 2010, lower rents and higher vacancies should be expected to continue over the near term.<br />
<br />
With the apartment buildings sector typically the leader for all commercial real estate categories with respect to defaults, it is extremely probable that financial institutions such as (but not limited to) <strong>Citigroup</strong> (<a href="http://www.zacks.com/stock/quote/c">C</a>), <strong>Bank of America </strong>(<a href="http://www.zacks.com/stock/quote/bac">BAC</a>), <strong>JPMorgan Chase </strong>(<a href="http://www.zacks.com/stock/quote/jpm">JPM</a>), <strong>US Bancorp</strong> (<a href="http://www.zacks.com/stock/quote/usb">USB</a>) and <strong>Wells Fargo</strong> (<a href="http://www.zacks.com/stock/quote/wfc">WFC</a>) will continue to experience negative commercial real estate credit quality trends during the coming quarters.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=C">Read the full analyst report on "C"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAC">Read the full analyst report on "BAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JPM">Read the full analyst report on "JPM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=USB">Read the full analyst report on "USB"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WFC">Read the full analyst report on "WFC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/even-landlords-may-be-hurting-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bell Tolling for Office REITs  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/bell-tolling-for-office-reits-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/bell-tolling-for-office-reits-analyst-blog/#comments</comments>
		<pubDate>Tue, 07 Jul 2009 19:00:50 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[Birmingham]]></category>
		<category><![CDATA[Charlotte]]></category>
		<category><![CDATA[Cousins Properties Inc.]]></category>
		<category><![CDATA[Dallas]]></category>
		<category><![CDATA[Georgia]]></category>
		<category><![CDATA[Liberty Property Trust;]]></category>
		<category><![CDATA[Los Angeles]]></category>
		<category><![CDATA[Mack-Cali Realty Corp.;]]></category>
		<category><![CDATA[Mid-Atlantic]]></category>
		<category><![CDATA[Midwest]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Real Estate Investment Trusts]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[Washington DC]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21895/Bell+Tolling+for+Office+REITs++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
According to a report released by Reis Inc., a leading real estate research firm, the US office market vacancy rate has surged to 15.9% in the second quarter of 2009 &#8211; the highest in four years. With deteriorating demand for office space, rent decreased by 2.7% during the quarter &#8211; the largest plunge in seven years.
<p align="left">Most real estate companies were forced to lower rents to attract and keep tenants. In addition, tenants are demanding more concessions in the form of free rent and capital improvements.</p>
<p align="left">During the quarter, asking rent in the office segment decreased 1.4% to $28.43 per square foot. Taking into account the rent-free months and improvement costs to landlords, effective rents or net cash received as rent decreased 2.7% in the quarter to $23.42 per square foot. Consequently, with decreasing cash flows the risk of loan defaults has increased considerably in the office segment.</p>
<p align="left">According to Reis, the US office market has declined at a steady pace since the third quarter of 2007 when vacancy was 12.5%. The weakening office market does not bode well for most real estate investment trusts (REITs) like <strong>Liberty Property Trust</strong> (<a href="http://www.zacks.com/stock/quote/lry">LRY</a>), <strong>Mack-Cali Realty Corp.</strong> (<a href="http://www.zacks.com/stock/quote/cli">CLI</a>), and <strong>Cousins Properties Inc.</strong> (<a href="http://www.zacks.com/stock/quote/cuz">CUZ</a>).</p>
<p align="left">Based in Pennsylvania, Liberty Property focuses primarily on prime suburban properties in the Southeast, Mid-Atlantic, and Midwest regions of the United States. Fundamentals are declining in most of the company&#8217;s office markets as corporate expansion continues to slow. We are projecting negative rental growth rate on new/renewal leases in markets that are characterized by high vacancies and negative job growth. We reiterate our Sell rating of Liberty Property.</p>
<p align="left">Mack-Cali Realty owns, leases, manages, and develops Class A office and industrial/flex properties, primarily in suburban markets in the northeastern US. We think the company will have a difficult time raising rents as leases roll over the next couple of quarters. We don&#8217;t think the company can continue to outpace occupancy market averages over the long term. We maintain our Sell rating of Mack-Cali Realty.</p>
<p align="left">Atlanta, Georgia-based Cousins Properties controls properties throughout the U.S., in the office markets of Atlanta, Charlotte, Austin, San Francisco, Los Angeles, and Washington DC. Many of the company&#8217;s office markets &#8211; Atlanta, Austin, Birmingham, Dallas, and Charlotte &#8211; are seeing large jumps in office vacancies. With high market vacancies and no job growth in most of its markets, growth of rental rate on new leases will be non-existent for some time. We reiterate our Sell rating of Cousins Properties.</p>
<p align="left"> </p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LRY">Read the full analyst report on "LRY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CLI">Read the full analyst report on "CLI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CUZ">Read the full analyst report on "CUZ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bell-tolling-for-office-reits-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PG&amp;E: Modestly Positive Results &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/pge-modestly-positive-results-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/pge-modestly-positive-results-analyst-blog/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 21:20:18 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Cfo]]></category>
		<category><![CDATA[comparable diversified energy utilities industry peers]]></category>
		<category><![CDATA[Dupont]]></category>
		<category><![CDATA[Electric Company]]></category>
		<category><![CDATA[Equity]]></category>
		<category><![CDATA[gas utility;]]></category>
		<category><![CDATA[natural gas customers]]></category>
		<category><![CDATA[PG&E Corporation]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21856/PG%26E%3A+Modestly+Positive+Results+-+Analyst+Blog</guid>
		<description><![CDATA[<br />Going forward, as the utility continues to focus primarily on regulated utility operations, positive investment factors for <span style="font-weight: bold;">PG&#38;E</span> (<a href="http://www.zacks.com/stock/quote/pcg">PCG</a>) including favorable decisions from the CPUC and FERC such as a CPUC authorized 11.35% ROE until 2010, long-term supply agreements, diversification into alternative power sources and infrastructure improvement programs such as the Cornerstone-Smart Meter-Tesla generating station, long-term supply agreements, diversification into alternative power sources and an increased dividend may be partially offset by risks including rising natural gas prices, increased purchased power costs, earnings dilutive stock issuances, and an over-leveraged balance sheet.<br /><br />PG&#38;E reported financial results for the 1st quarter and year ended March 31, 2009. In the reported quarter, GAAP net income after dividends on preferred stock was $241 million, or $0.65 per share, up from the same period last year when net income after dividends on preferred stock was $224 million, or $0.62 per share.<br />  <br />On a non-GAAP basis, PG&#38;E's operation earnings was $246 million, or $0.66 per share, in the 1st quarter of 2009, up from the same period last year with operating earnings of $224 million, or $0.62 per share. The quarter-over-quarter increase in operating earnings primarily reflects higher authorized revenues associated with additional capital investments in Pacific Gas and Electric Company's (Utility) core infrastructure and lower storm-related costs, partially offset by expenses due to a rise in uncollectible customer debt, severances associated with the consolidation of regional facilities, and several other miscellaneous items.<br /> <br /><span style="font-weight: bold; font-style: italic;">Return-on-Equity (ROE) DuPont Decomposition Analysis:</span><br /> <br /><img src="http://www.zacks.com/images/upload_dir/1246908387.jpg" alt="" /><br /> <br />The company has been earning impressive returns on equity of over 10% since 2003, often surpassing the utility's authorized 11.4% ROE. ROE reached a peak of 18.4% in 2004 as a result of the implementation of its reorganization plan that included the utility's recognition of a $2.9 billion, after-tax Settlement Regulatory Asset and other regulatory assets. Although operating profit margins declined significantly in 2005 and remained at the same level in 2006, the negative impact on ROE was partially offset by greater revenue per dollar of assets, significant improvements in net income and higher leverage after the company repurchased $2.2 billion of common stock under accelerated share repurchases arrangements.<br /><br />In 2006, ROE decreased from the previous year due to greater leverage as in 2005 shareholder's equity decreased from repurchase of shares. This trend continued in 2007 with ROE declining again due primarily to greater leverage at a higher cost of debt as well as lower operating margins. In 2008, however, ROE improved on account of lower leverage as well as improved tax retention; partially offset by a lower cost of debt.<br /><br />Looking ahead through 2009, we expect ROE to decline modestly into single-digit percentage range on account of lower operating margin and higher debt for financing its capital expenditure plans; as well as lower tax retention; all of which we expect to be partially offset by a lower cost of debt.<br /><span style="font-style: italic; font-weight: bold;">    </span><br /><span style="font-style: italic; font-weight: bold;">Free Cash Flow to Equity (FCFE) Analysis:</span><br /> <br /><img src="http://www.zacks.com/images/upload_dir/1246908408.jpg" alt="" /><br /><span style="font-style: italic;">  </span><br /><span style="font-style: italic;">(All figures in millions)</span><br /> <br />Free cash flow to equity has been positive, though declining significantly, since 2004, as shown in the table above, with increasing cash flow from operations more than offset by increasing capital expenditures and debt service. In 2004, FCFE was greater than $4.3 billion primarily on account of a $6.7 billion public offering of first mortgage bonds. However, in 2005 free cash flow declined sharply due to debt repayment, despite an 11% decline in CFO. In 2006 and 2008, free cash flow decreased to only $33 million and $271 million, respectively, mainly due to higher capital expenditures. FCFE improved in 2007 primarily due to significant long-term debt issuance, despite a significant decline in CFO and greater capital expenditures.<br /><br />Looking ahead through 2009, we expect FCFE to improve further with increasing CFO partially offset by lower issue of new debt. PCG common stock trades at 12.0x and 11.3x, respectively, our 2009 and 2010 earnings per share estimates, or in-line with the broad electric utility industry yet above some of its more comparable diversified energy utilities industry peers.<br /><br />Likewise, PCG trades at a modest premium to its industry peers with respect to book value and sales multiples yet at a discount relative to cash flow multiples. Accordingly, with a mixed outlook for the company and partially conflicting valuation metrics, we note a bias toward the upside yet maintain a market-neutral Hold recommendation on PCG common stock with a six-month target price of $39.75, or 12.5x and 11.8x, respectively, our 2009 and 2010 EPS estimates.<br /><br />Price appreciation to our near-term valuation target, coupled with a $0.42 per share quarterly cash dividend -- which we deem sustainable and secure based on reasonable projected earnings payouts of 53.0% and 49.7%, respectively, of our 2009 and 2010 EPS estimates -- represents annualized total return potential of 13.5%.<br /><br />San Francisco, California-based PG&#38;E Corporation is the parent holding company of California's largest regulated electric and gas utility, Pacific Gas and Electric Company (Pacific Gas), which serves approximately 5.1 million electric and 4.3 million natural gas customers in northern and central California. The utility also operates hydro-electric, nuclear and fossil-fueled power plants. <br /><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PCG">Read the full analyst report on "PCG"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pge-modestly-positive-results-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AMB Poised to Weather Downturn  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/amb-poised-to-weather-downturn-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/amb-poised-to-weather-downturn-analyst-blog/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 20:10:56 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[San Bruno]]></category>
		<category><![CDATA[San Bruno station]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Tanforan shopping center]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/21850/AMB+Poised+to+Weather+Downturn++-+Analyst+Blog</guid>
		<description><![CDATA[<p><b></b></p>
<p><b>AMB Property Corp.</b> (<a href="http://www.zacks.com/stock/quote/hpq">AMB</a>), a leading global owner, operator, and developer of industrial real estate, has recently signed a 172,000 square foot leasing agreement in South San Francisco. The deal was signed with DBI Beverage Inc., one of the leading beverage distributors in the U.S. The 10-year agreement was the largest industrial leasing deal signed in a decade in the region. </p>
<p align="left">The 21.5 acre property, located at 245 Spruce Avenue in San Francisco, currently has 560,000 square feet of space, out of which only 172,000 square feet was leased to DBI. AMB intends to utilize the space for transit-oriented development. However, with market fundamentals deteriorating in the housing, retail and office properties, the company has decided to lease the space for distribution and warehousing facilities. </p>
<p align="left">The leased facility is strategically located in the close proximity of the San Bruno station - a Bay Area Rapid Transit (BART) station located adjacent to the Tanforan shopping center in suburban San Bruno, California. With the deal, DBI has gained a tactical advantage of access to superior transport facilities, which will better serve its customers. </p>
<p align="left">The majority of AMB's portfolio comprises high throughput distribution (HTD), which provides multiple options for quick movement and the distribution of goods to the customer. HTD properties are warehouses or other industrial properties that are located near airports, seaports, and ground transportation facilities, which enable rapid distribution of customers' products. These HTD centers are typically located in areas characterized by global ports in supply-constrained, in-fill markets, which enable the company to gain a significant pricing advantage. </p>
<p align="left">The company has a concentration of assets in high-barrier gateway markets that hold up better in a recessionary environment. While 2009 will be a more difficult year for industry-focused REITs, AMB is well positioned to weather the downturn. </p>
<p align="left">With a strong balance sheet, AMB is much better prepared than private developers and smaller public companies to tide over the continued global economic slump. We reiterate our Hold rating of AMB. </p>
<p align="left"></p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMB">Read the full analyst report on "AMB"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amb-poised-to-weather-downturn-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clean Technology Venture Investment Rebounds in 2Q09 After Two Consecutive Quarterly Declines</title>
		<link>http://www.straightstocks.com/investing-in-energy-markets/clean-technology-venture-investment-rebounds-in-2q09-after-two-consecutive-quarterly-declines/</link>
		<comments>http://www.straightstocks.com/investing-in-energy-markets/clean-technology-venture-investment-rebounds-in-2q09-after-two-consecutive-quarterly-declines/#comments</comments>
		<pubDate>Thu, 02 Jul 2009 13:00:00 +0000</pubDate>
		<dc:creator>Dawn Van Zant</dc:creator>
				<category><![CDATA[Energy Markets]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[advisory services]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[clean technology venture investments]]></category>
		<category><![CDATA[Cleantech Group]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[financial advisory services;]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[renewable energy]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investorideas.com/News/070209b.asp</guid>
		<description><![CDATA[SAN FRANCISCO -- July 2, 2009 -- The Cleantech Group, founders of the cleantech sector and providers of leading global market research, events and advisory services for the cleantech ecosystem, along with Deloitte, which provides audit, tax, consulting and financial advisory services to cleantech companies, today released preliminary 2Q09 results for clean technology venture investments in North America, Europe, China and India, totaling $1.2 billion across 94 companies.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-in-energy-markets/clean-technology-venture-investment-rebounds-in-2q09-after-two-consecutive-quarterly-declines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are Israeli Stocks and Currency Set to Outperform Over Next 12 Months?</title>
		<link>http://www.straightstocks.com/investing-education-center/investing/are-israeli-stocks-and-currency-set-to-outperform-over-next-12-months/</link>
		<comments>http://www.straightstocks.com/investing-education-center/investing/are-israeli-stocks-and-currency-set-to-outperform-over-next-12-months/#comments</comments>
		<pubDate>Tue, 30 Jun 2009 14:29:20 +0000</pubDate>
		<dc:creator>Aaron Katsman</dc:creator>
				<category><![CDATA[Investing]]></category>
		<category><![CDATA[Israel]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Barclays Capital]]></category>
		<category><![CDATA[energy sources]]></category>
		<category><![CDATA[high tech goods]]></category>
		<category><![CDATA[high-tech recovery]]></category>
		<category><![CDATA[Information Technology]]></category>
		<category><![CDATA[information technology sector]]></category>
		<category><![CDATA[israel]]></category>
		<category><![CDATA[Nasdaq 100]]></category>
		<category><![CDATA[obama]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Federal Reserve]]></category>
		<category><![CDATA[Water Technology]]></category>

		<guid isPermaLink="false">http://israelnewsletter.com/?p=946</guid>
		<description><![CDATA[Keep in mind that the Israeli economy was late to the 'recession game' and looks to be an early 'exiter' from economic turmoil as well.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-education-center/investing/are-israeli-stocks-and-currency-set-to-outperform-over-next-12-months/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
